BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
661824	OC(=O)c1ccc(NC(=O)C2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)	HRLKIYSEPAYSAH-UHFFFAOYSA-N	335746	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 1	Coagulation factor XI	Homo sapiens	 13.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335746&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86298144	384987904							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661825	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)/t23-/m1/s1	HRLKIYSEPAYSAH-HSZRJFAPSA-N	335747	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 2	Coagulation factor XI	Homo sapiens	 5582								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335747	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335747&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86298145	384987905							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661826	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)/t23-/m0/s1	HRLKIYSEPAYSAH-QHCPKHFHSA-N	335748	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 3::US9738655, Example 4	Coagulation factor XI	Homo sapiens	 6.44								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335748&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602305	384987906							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661827	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)/t23-/m0/s1	HRLKIYSEPAYSAH-QHCPKHFHSA-N	335748	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 3::US9738655, Example 4	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335748&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602305	384987906							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661828	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3ccccc23)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C27H21ClFN3O5/c28-20-7-3-6-19(23(20)29)21-14-22(37-31-21)26(34)32-13-12-15-4-1-2-5-18(15)24(32)25(33)30-17-10-8-16(9-11-17)27(35)36/h1-11,22,24H,12-14H2,(H,30,33)(H,35,36)/t22-,24-/m1/s1	YPBHIZULGJULIC-ISKFKSNPSA-N	335750	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 5	Coagulation factor XI	Homo sapiens	 555								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335750&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602560	384987907							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661829	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)	QBESKCQOPGRWTA-UHFFFAOYSA-N	335751	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 6	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335751&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86298354	384987908							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661830	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C38H35ClFN7O5/c1-22-33(43-44-47(22)31-9-5-8-30(39)32(31)40)37(50)46-20-18-28-27(23-10-12-24(13-11-23)35(48)41-19-21-45(2)3)6-4-7-29(28)34(46)36(49)42-26-16-14-25(15-17-26)38(51)52/h4-17,34H,18-21H2,1-3H3,(H,41,48)(H,42,49)(H,51,52)	WHXXBNXPFFJZMV-UHFFFAOYSA-N	335752	4-(2-(1-(3-Chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 7	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335752&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86298355	384987909							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661831	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C38H34ClFN6O5/c1-44(2)20-18-41-35(47)24-11-9-23(10-12-24)28-5-3-6-30-29(28)17-19-45(34(30)36(48)43-27-15-13-25(14-16-27)38(50)51)37(49)26-21-42-46(22-26)32-8-4-7-31(39)33(32)40/h3-16,21-22,34H,17-20H2,1-2H3,(H,41,47)(H,43,48)(H,50,51)	ASWKOTUOPISDTN-UHFFFAOYSA-N	335753	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 8	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335753&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86298356	384987910							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661832	CN(C)C(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H30ClFN6O5/c1-20-31(40-41-44(20)29-9-5-8-28(37)30(29)38)35(47)43-19-18-26-25(21-10-12-22(13-11-21)34(46)42(2)3)6-4-7-27(26)32(43)33(45)39-24-16-14-23(15-17-24)36(48)49/h4-17,32H,18-19H2,1-3H3,(H,39,45)(H,48,49)	UTWSISMNNOGZOP-UHFFFAOYSA-N	335754	4-(2-(1-(3-Chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylcarbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 9	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335754&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86298357	384987911							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661833	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)/t33-/m0/s1	QBESKCQOPGRWTA-XIFFEERXSA-N	335755	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 10	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335755&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295514	384987912							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661834	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)/t33-/m1/s1	QBESKCQOPGRWTA-MGBGTMOVSA-N	335756	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid TFA salt::US9738655, Example 11	Coagulation factor XI	Homo sapiens	 165								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335756&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295305	384987913							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661835	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)	WNUYVQYWNLTYDS-UHFFFAOYSA-N	335757	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 12	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335757&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295306	384987914							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661836	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)/t27-/m1/s1	WNUYVQYWNLTYDS-HHHXNRCGSA-N	335758	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 13	Coagulation factor XI	Homo sapiens	 11.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335758&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626242	384987915							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661837	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)/t27-/m0/s1	WNUYVQYWNLTYDS-MHZLTWQESA-N	335759	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 14	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335759&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601612	384987916							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661838	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc(nc2)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H21ClFN7O4/c33-25-5-2-6-27(28(25)34)41-17-26(38-39-41)31(43)40-14-13-23-22(19-9-12-21(15-35)36-16-19)3-1-4-24(23)29(40)30(42)37-20-10-7-18(8-11-20)32(44)45/h1-12,16-17,29H,13-14H2,(H,37,42)(H,44,45)/t29-/m1/s1	HETUUWMBFBHOTJ-GDLZYMKVSA-N	335760	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-cyanopyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 15	Coagulation factor XI	Homo sapiens	 9.12								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335760&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295307	384987917							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661839	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2ccc(nc2)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H21ClFN7O4/c33-25-5-2-6-27(28(25)34)41-17-26(38-39-41)31(43)40-14-13-23-22(19-9-12-21(15-35)36-16-19)3-1-4-24(23)29(40)30(42)37-20-10-7-18(8-11-20)32(44)45/h1-12,16-17,29H,13-14H2,(H,37,42)(H,44,45)/t29-/m0/s1	HETUUWMBFBHOTJ-LJAQVGFWSA-N	335761	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-cyanopyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 16	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335761	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335761&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601910	384987918							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661840	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN5O5/c32-24-6-2-5-23(27(24)33)25-13-26(43-37-25)30(40)38-12-11-21-20(18-14-34-16-35-15-18)3-1-4-22(21)28(38)29(39)36-19-9-7-17(8-10-19)31(41)42/h1-10,14-16,26,28H,11-13H2,(H,36,39)(H,41,42)/t26-,28+/m1/s1	DZCHJSRSEJTLGM-IAPPQJPRSA-N	335762	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 17	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335762&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295308	384987919							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661841	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN5O5/c32-24-6-2-5-23(27(24)33)25-13-26(43-37-25)30(40)38-12-11-21-20(18-14-34-16-35-15-18)3-1-4-22(21)28(38)29(39)36-19-9-7-17(8-10-19)31(41)42/h1-10,14-16,26,28H,11-13H2,(H,36,39)(H,41,42)/t26-,28-/m1/s1	DZCHJSRSEJTLGM-IXCJQBJRSA-N	335763	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 18	Coagulation factor XI	Homo sapiens	 44.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335763&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602165	384987920							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661842	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN5O6/c1-37-31(42)26-13-10-19(17-38-26)21-4-2-5-23-22(21)14-15-41(30(23)32(43)39-20-11-8-18(9-12-20)34(45)46)33(44)28-16-27(40-47-28)24-6-3-7-25(35)29(24)36/h2-13,17,28,30H,14-16H2,1H3,(H,37,42)(H,39,43)(H,45,46)/t28-,30+/m1/s1	RZCBNXHMENKKFK-DGPALRBDSA-N	335764	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 19	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335764&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601679	384987921							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661843	CNC(=O)c1ccc(cn1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN5O6/c1-37-31(42)26-13-10-19(17-38-26)21-4-2-5-23-22(21)14-15-41(30(23)32(43)39-20-11-8-18(9-12-20)34(45)46)33(44)28-16-27(40-47-28)24-6-3-7-25(35)29(24)36/h2-13,17,28,30H,14-16H2,1H3,(H,37,42)(H,39,43)(H,45,46)/t28-,30-/m1/s1	RZCBNXHMENKKFK-PQHLKRTFSA-N	335765	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 20	Coagulation factor XI	Homo sapiens	 78.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335765&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602054	384987922							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661844	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H23ClF2N4O5/c33-25-6-2-5-24(28(25)35)26-14-27(44-38-26)31(41)39-12-11-22-21(18-13-19(34)16-36-15-18)3-1-4-23(22)29(39)30(40)37-20-9-7-17(8-10-20)32(42)43/h1-10,13,15-16,27,29H,11-12,14H2,(H,37,40)(H,42,43)/t27-,29+/m1/s1	WWPQQFMLZRWSKU-PXJZQJOASA-N	335766	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-fluoropyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 21	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335766&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602235	384987923							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661845	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H23ClF2N4O5/c33-25-6-2-5-24(28(25)35)26-14-27(44-38-26)31(41)39-12-11-22-21(18-13-19(34)16-36-15-18)3-1-4-23(22)29(39)30(40)37-20-9-7-17(8-10-20)32(42)43/h1-10,13,15-16,27,29H,11-12,14H2,(H,37,40)(H,42,43)/t27-,29-/m1/s1	WWPQQFMLZRWSKU-XRKRLSELSA-N	335767	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-fluoropyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 22	Coagulation factor XI	Homo sapiens	 19.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335767&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601893	384987924							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661846	COc1cncc(c1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN4O6/c1-44-21-14-19(16-36-17-21)22-4-2-5-24-23(22)12-13-39(30(24)31(40)37-20-10-8-18(9-11-20)33(42)43)32(41)28-15-27(38-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,37,40)(H,42,43)/t28-,30+/m1/s1	DQPLJHAOKDIZJN-DGPALRBDSA-N	335768	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-methoxypyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 23	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335768&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602040	384987925							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661847	COc1cncc(c1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN4O6/c1-44-21-14-19(16-36-17-21)22-4-2-5-24-23(22)12-13-39(30(24)31(40)37-20-10-8-18(9-11-20)33(42)43)32(41)28-15-27(38-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,37,40)(H,42,43)/t28-,30-/m1/s1	DQPLJHAOKDIZJN-PQHLKRTFSA-N	335769	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-methoxypyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 24	Coagulation factor XI	Homo sapiens	 5.61								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335769&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601496	384987926							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661848	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-11,14-17,28H,12-13H2,1H3,(H,36,41)/t28-/m1/s1	WUUCSGOLHNCBKX-MUUNZHRXSA-N	335770	(R)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 25	Coagulation factor XI	Homo sapiens	 3550								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335770&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295515	384987927							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661849	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-11,14-17,28H,12-13H2,1H3,(H,36,41)/t28-/m0/s1	WUUCSGOLHNCBKX-NDEPHWFRSA-N	335771	(S)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 26	Coagulation factor XI	Homo sapiens	 7.07								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335771&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626327	384987928							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661850	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(=O)OC	InChI=1S/C34H27ClFN7O5/c1-37-31(44)26-14-11-20(17-38-26)22-5-3-6-24-23(22)15-16-42(30(24)32(45)39-21-12-9-19(10-13-21)34(47)48-2)33(46)27-18-43(41-40-27)28-8-4-7-25(35)29(28)36/h3-14,17-18,30H,15-16H2,1-2H3,(H,37,44)(H,39,45)/t30-/m0/s1	CSJGZBYRICNEJG-PMERELPUSA-N	335772	(S)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, TFA salt::US9738655, Example 27	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335772&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626355	384987929							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661851	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O5/c1-43-32(42)18-8-10-20(11-9-18)37-30(40)29-23-5-2-4-21(19-15-35-17-36-16-19)22(23)12-13-39(29)31(41)27-14-26(38-44-27)24-6-3-7-25(33)28(24)34/h2-11,15-17,27,29H,12-14H2,1H3,(H,37,40)/t27-,29+/m1/s1	FAARZNRHKXNPTK-PXJZQJOASA-N	335773	Methyl 4-((S)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 28	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335773&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601981	384987930							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661852	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O5/c1-43-32(42)18-8-10-20(11-9-18)37-30(40)29-23-5-2-4-21(19-15-35-17-36-16-19)22(23)12-13-39(29)31(41)27-14-26(38-44-27)24-6-3-7-25(33)28(24)34/h2-11,15-17,27,29H,12-14H2,1H3,(H,37,40)/t27-,29-/m1/s1	FAARZNRHKXNPTK-XRKRLSELSA-N	335774	Methyl 4-((R)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 29	Coagulation factor XI	Homo sapiens	 58.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335774&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602065	384987931							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661853	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(N)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H26ClFN6O5/c1-44-31(43)17-8-10-19(11-9-17)38-29(41)28-22-5-2-4-20(18-15-36-32(35)37-16-18)21(22)12-13-40(28)30(42)26-14-25(39-45-26)23-6-3-7-24(33)27(23)34/h2-11,15-16,26,28H,12-14H2,1H3,(H,38,41)(H2,35,36,37)/t26-,28-/m1/s1	PKWKUSFGPORMHY-IXCJQBJRSA-N	335775	4-(5-(2-aminopyrimidin-5- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 30	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335775&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752685	384987932							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661854	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(OC)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O6/c1-44-32(43)18-9-11-20(12-10-18)38-30(41)29-23-6-3-5-21(19-16-36-33(45-2)37-17-19)22(23)13-14-40(29)31(42)27-15-26(39-46-27)24-7-4-8-25(34)28(24)35/h3-12,16-17,27,29H,13-15H2,1-2H3,(H,38,41)/t27-,29-/m1/s1	BHULQGCNQYHAQM-XRKRLSELSA-N	335776	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methoxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 31	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335776&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752686	384987933							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661855	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(nc2)C#N)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H24ClFN6O5/c1-45-33(44)18-8-10-20(11-9-18)39-31(42)30-23-5-2-4-21(19-16-37-28(15-36)38-17-19)22(23)12-13-41(30)32(43)27-14-26(40-46-27)24-6-3-7-25(34)29(24)35/h2-11,16-17,27,30H,12-14H2,1H3,(H,39,42)/t27-,30-/m1/s1	FDSLGCZUIUTCAB-POURPWNDSA-N	335777	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- cyanopyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 32	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335777&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752687	384987934							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661856	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cccnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H26ClFN4O5/c1-43-33(42)19-10-12-21(13-11-19)37-31(40)30-24-7-2-6-22(20-5-4-15-36-18-20)23(24)14-16-39(30)32(41)28-17-27(38-44-28)25-8-3-9-26(34)29(25)35/h2-13,15,18,28,30H,14,16-17H2,1H3,(H,37,40)/t28-,30-/m1/s1	VMYPYDBRMJCEQI-PQHLKRTFSA-N	335778	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 33	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335778&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752688	384987935							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661857	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(O)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O6/c1-44-31(42)17-8-10-19(11-9-17)37-29(40)28-22-5-2-4-20(18-15-35-32(43)36-16-18)21(22)12-13-39(28)30(41)26-14-25(38-45-26)23-6-3-7-24(33)27(23)34/h2-11,15-16,26,28H,12-14H2,1H3,(H,37,40)(H,35,36,43)/t26-,28-/m1/s1	DNGPLVNRQZAENL-IXCJQBJRSA-N	335779	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- hydroxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 34	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335779&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752689	384987936							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661858	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H25ClF2N4O5/c1-44-33(43)18-8-10-21(11-9-18)38-31(41)30-24-5-2-4-22(19-14-20(35)17-37-16-19)23(24)12-13-40(30)32(42)28-15-27(39-45-28)25-6-3-7-26(34)29(25)36/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,38,41)/t28-,30-/m1/s1	ITJJRCDKHPPSSS-PQHLKRTFSA-N	335780	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- fluoropyridin-3-yl)- 1.2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 35	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335780&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752690	384987937							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661859	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(OC)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C34H28ClFN4O6/c1-44-22-15-20(17-37-18-22)23-5-3-6-25-24(23)13-14-40(31(25)32(41)38-21-11-9-19(10-12-21)34(43)45-2)33(42)29-16-28(39-46-29)26-7-4-8-27(35)30(26)36/h3-12,15,17-18,29,31H,13-14,16H2,1-2H3,(H,38,41)/t29-,31-/m1/s1	RLHOWYGHDLUQRW-BVRKHOPBSA-N	335781	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- methoxypyridin-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 36	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335781&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752691	384987938							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661860	CNC(=O)c1cncc(c1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(=O)OC	InChI=1S/C35H29ClFN5O6/c1-38-32(43)21-15-20(17-39-18-21)23-5-3-6-25-24(23)13-14-42(31(25)33(44)40-22-11-9-19(10-12-22)35(46)47-2)34(45)29-16-28(41-48-29)26-7-4-8-27(36)30(26)37/h3-12,15,17-18,29,31H,13-14,16H2,1-2H3,(H,38,43)(H,40,44)/t29-,31-/m1/s1	BRCVBPCFQZEAOB-BVRKHOPBSA-N	335782	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- (methylcarbamoyl)pyridin- 3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 37	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335782&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752692	384987939							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661861	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(N)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O5/c1-44-33(43)18-8-10-21(11-9-18)38-31(41)30-24-5-2-4-22(19-14-20(36)17-37-16-19)23(24)12-13-40(30)32(42)28-15-27(39-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15,36H2,1H3,(H,38,41)/t28-,30-/m1/s1	XPDXBPGISHRRGJ-PQHLKRTFSA-N	335783	4-(5-(2-aminopyridin-4- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 38	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335783&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752693	384987940							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661862	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc(N)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O5/c1-44-33(43)18-8-11-20(12-9-18)38-31(41)30-23-5-2-4-21(19-10-13-28(36)37-17-19)22(23)14-15-40(30)32(42)27-16-26(39-45-27)24-6-3-7-25(34)29(24)35/h2-13,17,27,30H,14-16H2,1H3,(H2,36,37)(H,38,41)/t27-,30-/m1/s1	BCGVTAKTYPSRQS-POURPWNDSA-N	335784	4-(5-(6-aminopyridin-3- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 39	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335784&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752694	384987941							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661863	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc3CNCCc3c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C37H32ClFN4O5/c1-47-37(46)21-10-12-25(13-11-21)41-35(44)34-28-5-2-4-26(23-8-9-24-20-40-16-14-22(24)18-23)27(28)15-17-43(34)36(45)32-19-31(42-48-32)29-6-3-7-30(38)33(29)39/h2-13,18,32,34,40H,14-17,19-20H2,1H3,(H,41,44)/t32-,34-/m1/s1	FENPKALJPSEIAL-ZFEZZJPFSA-N	335785	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,1',2,2',3,3',4,4'- octahydro-[5,6'- biisoquinoline]-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 40	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335785&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752695	384987942							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661864	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cn[nH]c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1			335786	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (1H-pyrazol-4-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 41	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335786&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752696	384987943							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661865	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccnn2C)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H27ClFN5O5/c1-38-26(13-15-35-38)21-5-3-6-22-20(21)14-16-39(29(22)30(40)36-19-11-9-18(10-12-19)32(42)43-2)31(41)27-17-25(37-44-27)23-7-4-8-24(33)28(23)34/h3-13,15,27,29H,14,16-17H2,1-2H3,(H,36,40)/t27-,29-/m1/s1	HPQUBGDPTRWPBQ-XRKRLSELSA-N	335787	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-pyrazol-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 42	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335787&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752697	384987944							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661866	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccn(C)n2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H27ClFN5O5/c1-38-15-14-25(36-38)21-5-3-6-22-20(21)13-16-39(29(22)30(40)35-19-11-9-18(10-12-19)32(42)43-2)31(41)27-17-26(37-44-27)23-7-4-8-24(33)28(23)34/h3-12,14-15,27,29H,13,16-17H2,1-2H3,(H,35,40)/t27-,29-/m1/s1	BRRKPQDJNOUSDE-XRKRLSELSA-N	335788	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-pyrazol-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 43	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335788&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752698	384987945							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661867	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H25ClFN7O5/c1-36-30(43)25-13-10-19(16-37-25)21-4-2-5-23-22(21)14-15-41(29(23)31(44)38-20-11-8-18(9-12-20)33(46)47)32(45)26-17-42(40-39-26)27-7-3-6-24(34)28(27)35/h2-13,16-17,29H,14-15H2,1H3,(H,36,43)(H,38,44)(H,46,47)/t29-/m0/s1	MNYQVTQMJHBGTD-LJAQVGFWSA-N	335789	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 44	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335789&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295516	384987946							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661868	CNC(=O)c1ccc(cn1)-c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H25ClFN7O5/c1-36-30(43)25-13-10-19(16-37-25)21-4-2-5-23-22(21)14-15-41(29(23)31(44)38-20-11-8-18(9-12-20)33(46)47)32(45)26-17-42(40-39-26)27-7-3-6-24(34)28(27)35/h2-13,16-17,29H,14-15H2,1H3,(H,36,43)(H,38,44)(H,46,47)/t29-/m1/s1	MNYQVTQMJHBGTD-GDLZYMKVSA-N	335790	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 45	Coagulation factor XI	Homo sapiens	 20.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335790&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602009	384987947							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661869	Nc1c(cnn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H23ClFN7O4/c32-24-5-2-6-25(26(24)33)40-28(34)23(15-37-40)30(42)39-12-11-21-20(18-13-35-16-36-14-18)3-1-4-22(21)27(39)29(41)38-19-9-7-17(8-10-19)31(43)44/h1-10,13-16,27H,11-12,34H2,(H,38,41)(H,43,44)	DYZTYGBGDOZFGS-UHFFFAOYSA-N	335791	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 46	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335791&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602105	384987948							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661870	CNC(=O)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN7O5/c1-38-31(44)26-13-10-19(16-39-26)21-4-2-5-23-22(21)14-15-42(29(23)32(45)41-20-11-8-18(9-12-20)34(47)48)33(46)24-17-40-43(30(24)37)27-7-3-6-25(35)28(27)36/h2-13,16-17,29H,14-15,37H2,1H3,(H,38,44)(H,41,45)(H,47,48)	JWUMGKLUPFRBEL-UHFFFAOYSA-N	335792	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 47	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335792&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295517	384987949							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661871	CNC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN7O4/c1-35-20-12-15-39(16-13-20)26-6-2-4-23-22(26)14-17-40(29(23)30(42)36-21-10-8-19(9-11-21)32(44)45)31(43)25-18-41(38-37-25)27-7-3-5-24(33)28(27)34/h2-11,18,20,29,35H,12-17H2,1H3,(H,36,42)(H,44,45)/t29-/m1/s1	TZOHATLRQAUOQP-GDLZYMKVSA-N	335793	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 48	Coagulation factor XI	Homo sapiens	 89.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335793&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			130346376	384987950							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661872	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H33ClFN7O4/c1-39(2)22-13-16-40(17-14-22)27-7-3-5-24-23(27)15-18-41(30(24)31(43)36-21-11-9-20(10-12-21)33(45)46)32(44)26-19-42(38-37-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H,36,43)(H,45,46)/t30-/m0/s1	IRADZYNYESBTAE-PMERELPUSA-N	335794	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 49	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335794&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348905	384987951							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661873	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)	FBPUIWCXHWSFDU-UHFFFAOYSA-N	335795	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 50	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335795&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348819	384987952							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661874	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m1/s1	FBPUIWCXHWSFDU-WJOKGBTCSA-N	335796	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 51	Coagulation factor XI	Homo sapiens	 54.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335796&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348873	384987953							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661875	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m0/s1	FBPUIWCXHWSFDU-HKBQPEDESA-N	335797	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 52	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335797&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348857	384987954							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661876	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)	TUTDFHYFDVWALK-UHFFFAOYSA-N	335799	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 53	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335799&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348865	384987956							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661877	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m1/s1	TUTDFHYFDVWALK-WJOKGBTCSA-N	335800	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 54	Coagulation factor XI	Homo sapiens	 8.83								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335800&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348863	384987957							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661878	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m0/s1	TUTDFHYFDVWALK-HKBQPEDESA-N	335801	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 55	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335801&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348942	384987958							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661879	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)	MGKYNQMITPWKCX-UHFFFAOYSA-N	335802	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 56	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335802&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295725	384987959							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661880	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)/t30-/m1/s1	MGKYNQMITPWKCX-SSEXGKCCSA-N	335803	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 57	Coagulation factor XI	Homo sapiens	 33.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335803&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348973	384987960							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661881	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)/t30-/m0/s1	MGKYNQMITPWKCX-PMERELPUSA-N	335804	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 58	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335804&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348922	384987961							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661882	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)	OSEVVJFCRIBXMR-UHFFFAOYSA-N	335805	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 59	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335805&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295726	384987962							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661883	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m1/s1	OSEVVJFCRIBXMR-WJOKGBTCSA-N	335806	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 60	Coagulation factor XI	Homo sapiens	 47.8								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335806&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348889	384987963							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661884	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m0/s1	OSEVVJFCRIBXMR-HKBQPEDESA-N	335807	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 61	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335807&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348844	384987964							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661885	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-25-24(28)15-18-43(31(25)32(44)39-23-11-9-22(10-12-23)35(47)48)34(46)27-19-42(20-38-27)29-8-4-6-26(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m1/s1	DUQMUTYXYZUOHC-WJOKGBTCSA-N	335808	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 62	Coagulation factor XI	Homo sapiens	 74.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335808&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348950	384987965							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661886	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-25-24(28)15-18-43(31(25)32(44)39-23-11-9-22(10-12-23)35(47)48)34(46)27-19-42(20-38-27)29-8-4-6-26(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m0/s1	DUQMUTYXYZUOHC-HKBQPEDESA-N	335809	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 63	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335809&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348854	384987966							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661887	CC(C)c1nnc2CN(CCn12)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)	NNFFYYPCMGFLPV-UHFFFAOYSA-N	335810	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 64	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335810&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295727	384987967							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661888	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)/t30-/m1/s1	NNFFYYPCMGFLPV-SSEXGKCCSA-N	335811	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboximido)benzoic acid,  TFA salt::US9738655, Example 65	Coagulation factor XI	Homo sapiens	 18.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335811&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348941	384987968							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661889	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)/t30-/m0/s1	NNFFYYPCMGFLPV-PMERELPUSA-N	335812	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 66	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335812&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348923	384987969							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661890	CC1(O)CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-32(45)13-16-38(17-14-32)25-6-2-4-22-21(25)12-15-39(28(22)29(41)35-20-10-8-19(9-11-20)31(43)44)30(42)24-18-40(37-36-24)26-7-3-5-23(33)27(26)34/h2-11,18,28,45H,12-17H2,1H3,(H,35,41)(H,43,44)	FIWQHMLLHCSPLW-UHFFFAOYSA-N	335813	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- hydroxy-4-methylpiperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 67	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335813&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			86295728	384987970							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661891	CC1(O)CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-33(45)13-16-38(17-14-33)26-6-2-4-24-23(26)12-15-39(29(24)30(41)37-22-10-8-20(9-11-22)32(43)44)31(42)21-18-36-40(19-21)27-7-3-5-25(34)28(27)35/h2-11,18-19,29,45H,12-17H2,1H3,(H,37,41)(H,43,44)	VEDPYHVUKWTDSO-UHFFFAOYSA-N	335814	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-hydroxy-4- methylpiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 68	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335814&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348850	384987971							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661892	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCOCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H24ClFN6O6/c31-21-4-2-6-24(26(21)32)38-15-22(34-35-38)29(41)37-12-11-19-20(3-1-5-23(19)36-13-14-44-16-25(36)39)27(37)28(40)33-18-9-7-17(8-10-18)30(42)43/h1-10,15,27H,11-14,16H2,(H,33,40)(H,42,43)	XTLAPAGGJSLEHW-UHFFFAOYSA-N	335815	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 69	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335815&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348814	384987972							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661893	CN1CCN(c2cccc3C(N(CCc23)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C(=O)CC1	InChI=1S/C33H30ClFN6O5/c1-38-14-13-28(42)39(17-16-38)26-6-2-4-24-23(26)12-15-40(30(24)31(43)37-22-10-8-20(9-11-22)33(45)46)32(44)21-18-36-41(19-21)27-7-3-5-25(34)29(27)35/h2-11,18-19,30H,12-17H2,1H3,(H,37,43)(H,45,46)	XQFKNIZFWNFDAV-UHFFFAOYSA-N	335816	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-methyl-7-oxo- 1,4-diazepan-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 70	Coagulation factor XI	Homo sapiens	 29.3								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335816&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348891	384987973							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661894	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClF2N4O6/c1-47-22-11-14-39(15-12-22)27-4-2-3-24-23(27)13-16-40(30(24)32(43)38-21-7-5-19(6-8-21)34(45)46)33(44)20-17-28(42)41(18-20)31-26(36)10-9-25(35)29(31)37/h2-10,20,22,30H,11-18H2,1H3,(H,38,43)(H,45,46)	MOURHNDDHSTRPL-UHFFFAOYSA-N	335817	4-(2-(1-(3-chloro-2,6- difluorophenyl)-5- oxopyrrolidine-3-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 71	Coagulation factor XI	Homo sapiens	 913								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335817&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348809	384987974							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661895	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H33ClFN7O5/c36-26-5-2-7-29(31(26)37)44-20-27(39-40-44)34(47)43-19-15-24-25(32(43)33(46)38-22-11-9-21(10-12-22)35(48)49)4-1-6-28(24)41-17-13-23(14-18-41)42-16-3-8-30(42)45/h1-2,4-7,9-12,20,23,32H,3,8,13-19H2,(H,38,46)(H,48,49)	WQWGGABJZOMIBL-UHFFFAOYSA-N	335819	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4-(2- oxopyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 72	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335819&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348920	384987976							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661896	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCS(=O)(=O)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H26ClFN6O6S/c31-22-4-2-6-25(26(22)32)38-17-23(34-35-38)29(40)37-12-11-20-21(3-1-5-24(20)36-13-15-45(43,44)16-14-36)27(37)28(39)33-19-9-7-18(8-10-19)30(41)42/h1-10,17,27H,11-16H2,(H,33,39)(H,41,42)	TZMZVJYUKWQYBS-UHFFFAOYSA-N	335820	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1,1- dioxidothiomorpholino)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 73	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335820&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348816	384987977							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661897	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H34ClFN6O5/c37-28-5-2-7-30(32(28)38)44-21-23(20-39-44)35(47)43-19-15-26-27(33(43)34(46)40-24-11-9-22(10-12-24)36(48)49)4-1-6-29(26)41-17-13-25(14-18-41)42-16-3-8-31(42)45/h1-2,4-7,9-12,20-21,25,33H,3,8,13-19H2,(H,40,46)(H,48,49)	DUMHALQWYMKJRI-UHFFFAOYSA-N	335821	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-(2- oxopyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 74	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335821&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348817	384987978							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661898	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H31ClFN5O6/c36-26-4-2-6-28(30(26)37)42-20-22(19-38-42)33(45)41-16-12-24-25(31(41)32(44)39-23-9-7-21(8-10-23)34(46)47)3-1-5-27(24)40-17-14-35(15-18-40)13-11-29(43)48-35/h1-10,19-20,31H,11-18H2,(H,39,44)(H,46,47)	KCJXOPXQHIVGOD-UHFFFAOYSA-N	335822	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(2-oxo-1-oxa-8- azaspiro[4.5]-decan-8-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 75	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335822	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335822&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348802	384987979							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661899	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C34H30ClFN6O6/c35-24-4-2-6-27(29(24)36)42-19-25(38-39-42)32(45)41-16-12-22-23(30(41)31(44)37-21-9-7-20(8-10-21)33(46)47)3-1-5-26(22)40-17-14-34(15-18-40)13-11-28(43)48-34/h1-10,19,30H,11-18H2,(H,37,44)(H,46,47)	XPKQMZKAEDLRFG-UHFFFAOYSA-N	335823	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2-oxo- 1-oxa-8-azaspiro[4.5]decan-8- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboximido)benzoic acid,  TFA::US9738655, Example 76	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335823&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348949	384987980							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661900	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H31ClFN5O6/c36-25-4-2-6-28(30(25)37)41-19-26(38-20-41)33(45)42-16-12-23-24(31(42)32(44)39-22-9-7-21(8-10-22)34(46)47)3-1-5-27(23)40-17-14-35(15-18-40)13-11-29(43)48-35/h1-10,19-20,31H,11-18H2,(H,39,44)(H,46,47)	ZCFREWNYRKHFJI-UHFFFAOYSA-N	335824	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(2-oxo-1-oxa-8- azaspiro[4.5]decan-8-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 77	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335824	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335824&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348904	384987981							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661901	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN6O4/c32-23-7-5-9-26(27(23)33)39-18-24(35-36-39)30(41)38-17-14-21-22(6-4-8-25(21)37-15-2-1-3-16-37)28(38)29(40)34-20-12-10-19(11-13-20)31(42)43/h4-13,18,28H,1-3,14-17H2,(H,34,40)(H,42,43)	MMIGYNHOZGOKSR-UHFFFAOYSA-N	335825	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 78	Coagulation factor XI	Homo sapiens	 9.16								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335825	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335825&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348881	384987982							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661902	CN1CCN(C(=O)C1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(26(41)17-37)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m1/s1	IJPZYJYAKOUZKY-MUUNZHRXSA-N	335826	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methyl-2-oxopiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 79	Coagulation factor XI	Homo sapiens	 114								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335826	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335826&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348893	384987983							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661903	CN1CCN(C(=O)C1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(26(41)17-37)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m0/s1	IJPZYJYAKOUZKY-NDEPHWFRSA-N	335849	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methyl-2-oxopiprazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  HCl::US9738655, Example 80	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335849&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348974	384988006							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661904	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN6O5/c32-22-6-4-8-25(27(22)33)39-17-23(35-36-39)30(42)38-16-14-20-21(5-3-7-24(20)37-15-2-1-9-26(37)40)28(38)29(41)34-19-12-10-18(11-13-19)31(43)44/h3-8,10-13,17,28H,1-2,9,14-16H2,(H,34,41)(H,43,44)	YKRLXMNVDVQBIC-UHFFFAOYSA-N	335850	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- oxopiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 81	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335850&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348836	384988007							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661905	CCOC1CN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c1-2-44-20-15-37(16-20)25-7-3-5-22-21(25)13-14-38(28(22)29(40)34-19-11-9-18(10-12-19)31(42)43)30(41)24-17-39(36-35-24)26-8-4-6-23(32)27(26)33/h3-12,17,20,28H,2,13-16H2,1H3,(H,34,40)(H,42,43)	MQJWOKRUYVLVHD-UHFFFAOYSA-N	335851	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- ethoxyazetidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 82	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335851&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348875	384988008							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661906	COC1CN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H26ClFN6O5/c1-43-19-14-36(15-19)24-6-2-4-21-20(24)12-13-37(27(21)28(39)33-18-10-8-17(9-11-18)30(41)42)29(40)23-16-38(35-34-23)25-7-3-5-22(31)26(25)32/h2-11,16,19,27H,12-15H2,1H3,(H,33,39)(H,41,42)	MYNRGUFJJDMWTG-UHFFFAOYSA-N	335852	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- methoxyazetidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 83	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335852&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348960	384988009							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661907	CO[C@@H]1CCN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c1-44-20-12-14-37(16-20)25-6-2-4-22-21(25)13-15-38(28(22)29(40)34-19-10-8-18(9-11-19)31(42)43)30(41)24-17-39(36-35-24)26-7-3-5-23(32)27(26)33/h2-11,17,20,28H,12-16H2,1H3,(H,34,40)(H,42,43)/t20-,28?/m1/s1	SJPWVCKRLGPILA-HFLPEKOISA-N	335853	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-((R)-3- methoxypyrrolidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 84	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335853&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348879	384988010							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661908	OC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c32-23-4-2-6-26(27(23)33)39-17-24(35-36-39)30(42)38-16-13-21-22(3-1-5-25(21)37-14-11-20(40)12-15-37)28(38)29(41)34-19-9-7-18(8-10-19)31(43)44/h1-10,17,20,28,40H,11-16H2,(H,34,41)(H,43,44)	PJWXABPIRATKKW-UHFFFAOYSA-N	335854	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- hydroxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 85	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335854&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348777	384988011							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661909	OC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c32-23-4-2-6-26(27(23)33)39-17-24(35-36-39)30(42)38-16-13-21-22(3-1-5-25(21)37-14-11-20(40)12-15-37)28(38)29(41)34-19-9-7-18(8-10-19)31(43)44/h1-10,17,20,28,40H,11-16H2,(H,34,41)(H,43,44)/t28-/m0/s1	PJWXABPIRATKKW-NDEPHWFRSA-N	335855	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- hydroxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 86	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335855	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335855&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348846	384988012							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661910	OC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c32-23-4-2-6-26(27(23)33)39-17-24(35-36-39)30(42)38-16-13-21-22(3-1-5-25(21)37-14-11-20(40)12-15-37)28(38)29(41)34-19-9-7-18(8-10-19)31(43)44/h1-10,17,20,28,40H,11-16H2,(H,34,41)(H,43,44)/t28-/m1/s1	PJWXABPIRATKKW-MUUNZHRXSA-N	335856	US9738655, Example 87	Coagulation factor XI	Homo sapiens	 43.0								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335856	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335856&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348878	384988013							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661911	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-24-4-2-6-26(27(24)33)38-18-20(17-34-38)30(40)37-12-11-22-23(3-1-5-25(22)36-13-15-43-16-14-36)28(37)29(39)35-21-9-7-19(8-10-21)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m1/s1	AZMXBQFTTJWWIS-MUUNZHRXSA-N	335857	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 88	Coagulation factor XI	Homo sapiens	 391								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335857&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601721	384988014							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661912	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-24-4-2-6-26(27(24)33)38-18-20(17-34-38)30(40)37-12-11-22-23(3-1-5-25(22)36-13-15-43-16-14-36)28(37)29(39)35-21-9-7-19(8-10-21)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m0/s1	AZMXBQFTTJWWIS-NDEPHWFRSA-N	335858	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 89	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335858&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601534	384988015							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661913	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H26ClFN6O5/c31-22-4-2-6-25(26(22)32)38-17-23(34-35-38)29(40)37-12-11-20-21(3-1-5-24(20)36-13-15-43-16-14-36)27(37)28(39)33-19-9-7-18(8-10-19)30(41)42/h1-10,17,27H,11-16H2,(H,33,39)(H,41,42)/t27-/m0/s1	UCSKYPRDSCVAMS-MHZLTWQESA-N	335859	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 90	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335859&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601974	384988016							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661914	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-23-4-2-6-26(27(23)33)37-17-24(34-18-37)30(40)38-12-11-21-22(3-1-5-25(21)36-13-15-43-16-14-36)28(38)29(39)35-20-9-7-19(8-10-20)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m0/s1	DVLBZAYUFSXDAP-NDEPHWFRSA-N	335860	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 91	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335860&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602090	384988017							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661915	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H34ClFN6O5/c37-27-5-2-7-30(32(27)38)42-20-28(39-21-42)35(47)44-19-15-25-26(33(44)34(46)40-23-11-9-22(10-12-23)36(48)49)4-1-6-29(25)41-17-13-24(14-18-41)43-16-3-8-31(43)45/h1-2,4-7,9-12,20-21,24,33H,3,8,13-19H2,(H,40,46)(H,48,49)	OHZPVCRHBZYZJT-UHFFFAOYSA-N	335861	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-(4-(2-oxopyrrolidin-1-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 92	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335861&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602164	384988018							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661916	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncco1	InChI=1S/C36H35ClFN7O3/c1-42(2)26-13-17-43(18-14-26)30-7-3-5-28-27(30)15-19-44(36(47)24-21-40-45(22-24)31-8-4-6-29(37)32(31)38)33(28)34(46)41-25-11-9-23(10-12-25)35-39-16-20-48-35/h3-12,16,20-22,26,33H,13-15,17-19H2,1-2H3,(H,41,46)	DJUCOOVKTPLJLE-UHFFFAOYSA-N	335862	2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-N-(4-(oxazol-2-yl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 93	Coagulation factor XI	Homo sapiens	 6.65								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335862&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602110	384988019							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661917	CCn1nnc(n1)-c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N(C)C)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H38ClFN10O2/c1-4-48-42-34(41-43-48)23-11-13-25(14-12-23)40-35(49)33-28-7-5-9-30(45-18-15-26(16-19-45)44(2)3)27(28)17-20-46(33)36(50)24-21-39-47(22-24)31-10-6-8-29(37)32(31)38/h5-14,21-22,26,33H,4,15-20H2,1-3H3,(H,40,49)	RKJMKFUCSWGOSU-UHFFFAOYSA-N	335863	2-(1-(3-chloro 2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-(2-ethyl-2H-tetrazol-5- yl)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 94	Coagulation factor XI	Homo sapiens	 23.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335863&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348887	384988020							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661918	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(OCC2CCCO2)cc1	InChI=1S/C38H42ClFN6O4/c1-43(2)27-15-18-44(19-16-27)33-9-3-7-31-30(33)17-20-45(38(48)25-22-41-46(23-25)34-10-4-8-32(39)35(34)40)36(31)37(47)42-26-11-13-28(14-12-26)50-24-29-6-5-21-49-29/h3-4,7-14,22-23,27,29,36H,5-6,15-21,24H2,1-2H3,(H,42,47)	RKRFJYCLJSOKBN-UHFFFAOYSA-N	335864	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-((tetrahydrofuran-2- yl)methoxy)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 95	Coagulation factor XI	Homo sapiens	 14.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335864&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348781	384988021							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661919	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(OC(F)F)cc1	InChI=1S/C34H34ClF3N6O3/c1-41(2)23-13-16-42(17-14-23)28-7-3-5-26-25(28)15-18-43(31(26)32(45)40-22-9-11-24(12-10-22)47-34(37)38)33(46)21-19-39-44(20-21)29-8-4-6-27(35)30(29)36/h3-12,19-20,23,31,34H,13-18H2,1-2H3,(H,40,45)	AUTKGNDQORIBBN-UHFFFAOYSA-N	335865	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-N-(4- (difluoromethoxy)phenyl)-5-(4- (dimethylamino)piperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 96	Coagulation factor XI	Homo sapiens	 20.3								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335865&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348838	384988022							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661920	COc1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N(C)C)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C34H36ClFN6O3/c1-39(2)24-14-17-40(18-15-24)29-8-4-6-27-26(29)16-19-41(32(27)33(43)38-23-10-12-25(45-3)13-11-23)34(44)22-20-37-42(21-22)30-9-5-7-28(35)31(30)36/h4-13,20-21,24,32H,14-19H2,1-3H3,(H,38,43)	BYWCUUZBTKXTQC-UHFFFAOYSA-N	335866	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-methoxyphenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 97	Coagulation factor XI	Homo sapiens	 9.13								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335866&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348861	384988023							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661921	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1noc(C)n1	InChI=1S/C35H35ClFN9O3/c1-21-38-33(41-49-21)22-10-12-23(13-11-22)39-34(47)32-26-6-4-8-29(44-17-14-24(15-18-44)43(2)3)25(26)16-19-45(32)35(48)28-20-46(42-40-28)30-9-5-7-27(36)31(30)37/h4-13,20,24,32H,14-19H2,1-3H3,(H,39,47)	PGRXFTCYMWPHKW-UHFFFAOYSA-N	335867	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino) piperidin-1-yl)-N-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 98	Coagulation factor XI	Homo sapiens	 6.69								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335867&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601898	384988024							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661922	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)	NMESXYFWTSUGKH-UHFFFAOYSA-N	335868	N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 99	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335868	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335868&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602100	384988025							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661923	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)/t30-/m1/s1	NMESXYFWTSUGKH-SSEXGKCCSA-N	335869	(R)-N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 100	Coagulation factor XI	Homo sapiens	 289								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335869&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601365	384988026							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661924	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)/t30-/m0/s1	NMESXYFWTSUGKH-PMERELPUSA-N	335870	(S)-N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 101	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335870&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601517	384988027							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661925	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335871	N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 102	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335871&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601936	384988028							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661926	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335872	(R)-N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 103	Coagulation factor XI	Homo sapiens	 17.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335872&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601934	384988029							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661927	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335873	(S)-N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 104	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335873&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602077	384988030							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661928	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1nnn[nH]1			335874	N-(4-(1H-Tetrazol-5-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 105	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335874&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601367	384988031							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661929	CN1CCC2(CCN(CC2)c2cccc3C(N(CCc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C1=O	InChI=1S/C35H33ClFN7O5/c1-41-17-13-35(34(41)49)14-18-42(19-15-35)27-6-2-4-24-23(27)12-16-43(30(24)31(45)38-22-10-8-21(9-11-22)33(47)48)32(46)26-20-44(40-39-26)28-7-3-5-25(36)29(28)37/h2-11,20,30H,12-19H2,1H3,(H,38,45)(H,47,48)	LDBRXJJCOCLPDO-UHFFFAOYSA-N	335875	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-methyl-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 106	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335875&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602434	384988032							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661930	CN1CCC2(CCN(CC2)c2cccc3C(N(CCc23)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C1=O	InChI=1S/C36H34ClFN6O5/c1-41-17-13-36(35(41)49)14-18-42(19-15-36)28-6-2-4-26-25(28)12-16-43(31(26)32(45)40-24-10-8-22(9-11-24)34(47)48)33(46)23-20-39-44(21-23)29-7-3-5-27(37)30(29)38/h2-11,20-21,31H,12-19H2,1H3,(H,40,45)(H,47,48)	IVMRSEGVRIIAGV-UHFFFAOYSA-N	335876	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(2-methyl-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 107	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335876&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602252	384988033							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661931	OC(=O)c1ccc(NC(=O)C2N(CCc3c(cccc23)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C27H18ClFN6O4/c28-20-5-2-6-22(23(20)29)35-14-21(32-33-35)26(37)34-12-11-18-16(13-30)3-1-4-19(18)24(34)25(36)31-17-9-7-15(8-10-17)27(38)39/h1-10,14,24H,11-12H2,(H,31,36)(H,38,39)	RMICWTGTVHFVQN-UHFFFAOYSA-N	335877	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-cyano-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 108	Coagulation factor XI	Homo sapiens	 48.8								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335877&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602058	384988034							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661932	NCc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H22ClFN6O4/c28-20-5-2-6-22(23(20)29)35-14-21(32-33-35)26(37)34-12-11-18-16(13-30)3-1-4-19(18)24(34)25(36)31-17-9-7-15(8-10-17)27(38)39/h1-10,14,24H,11-13,30H2,(H,31,36)(H,38,39)	YTULCQGNUIGFGU-UHFFFAOYSA-N	335878	4-(5-(Aminomethyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 109	Coagulation factor XI	Homo sapiens	 14.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335878&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602249	384988035							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661933	OC(=O)c1ccc(NC(=O)C2N(CCc3c(Br)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H18BrClFN5O4/c27-18-4-1-3-17-16(18)11-12-33(23(17)24(35)30-15-9-7-14(8-10-15)26(37)38)25(36)20-13-34(32-31-20)21-6-2-5-19(28)22(21)29/h1-10,13,23H,11-12H2,(H,30,35)(H,37,38)	FTJKBBGXMSWJLV-UHFFFAOYSA-N	335879	4-(5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 110	Coagulation factor XI	Homo sapiens	 72.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335879&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601996	384988036							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661934	OCCNc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H24ClFN6O5/c29-20-4-2-6-23(24(20)30)36-15-22(33-34-36)27(39)35-13-11-18-19(3-1-5-21(18)31-12-14-37)25(35)26(38)32-17-9-7-16(8-10-17)28(40)41/h1-10,15,25,31,37H,11-14H2,(H,32,38)(H,40,41)	NYQZRXFSTDWBHC-UHFFFAOYSA-N	335880	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((2-hydroxyethyl)amino)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 111	Coagulation factor XI	Homo sapiens	 6.04								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335880&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602499	384988037							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661935	OC(=O)c1ccc(NC(=O)C2N(CCc3c(OC4CCNCC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN6O5/c32-23-4-2-5-25(27(23)33)39-17-24(36-37-39)30(41)38-16-13-21-22(3-1-6-26(21)44-20-11-14-34-15-12-20)28(38)29(40)35-19-9-7-18(8-10-19)31(42)43/h1-10,17,20,28,34H,11-16H2,(H,35,40)(H,42,43)	DRTJXWBTRVZLSH-UHFFFAOYSA-N	335881	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(piperidin-4-yloxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 112	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335881&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602076	384988038							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661936	OCCCOc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H25ClFN5O6/c30-21-5-2-6-23(25(21)31)36-16-22(33-34-36)28(39)35-13-12-19-20(4-1-7-24(19)42-15-3-14-37)26(35)27(38)32-18-10-8-17(9-11-18)29(40)41/h1-2,4-11,16,26,37H,3,12-15H2,(H,32,38)(H,40,41)	ZKEMSABRIROBTJ-UHFFFAOYSA-N	335882	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 113	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335882&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752699	384988039							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661937	OCCCOc1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H27ClFN3O7/c31-22-6-1-5-21(26(22)32)23-16-25(42-34-23)29(38)35-13-12-19-20(4-2-7-24(19)41-15-3-14-36)27(35)28(37)33-18-10-8-17(9-11-18)30(39)40/h1-2,4-11,25,27,36H,3,12-16H2,(H,33,37)(H,39,40)/t25-,27+/m1/s1	GQEFKPHQGKFWAI-VPUSJEBWSA-N	335883	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, and 4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 114	Coagulation factor XI	Homo sapiens	 28.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335883&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752700	384988040							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661938	OCCCOc1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H27ClFN3O7/c31-22-6-1-5-21(26(22)32)23-16-25(42-34-23)29(38)35-13-12-19-20(4-2-7-24(19)41-15-3-14-36)27(35)28(37)33-18-10-8-17(9-11-18)30(39)40/h1-2,4-11,25,27,36H,3,12-16H2,(H,33,37)(H,39,40)/t25-,27-/m1/s1	GQEFKPHQGKFWAI-XNMGPUDCSA-N	335884	US9738655, Example 115	Coagulation factor XI	Homo sapiens	 21.3								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335884&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752701	384988041							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661939	CCOC(=O)Cc1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc(nc2)C(=O)NC)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H31ClFN7O5/c1-3-50-31(46)18-21-10-13-23(14-11-21)41-35(48)33-26-7-4-6-24(22-12-15-28(40-19-22)34(47)39-2)25(26)16-17-44(33)36(49)29-20-45(43-42-29)30-9-5-8-27(37)32(30)38/h4-15,19-20,33H,3,16-18H2,1-2H3,(H,39,47)(H,41,48)	RSPKBHVBCVXNMS-UHFFFAOYSA-N	335885	Ethyl 2-(4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)phenyl)acetate, TFA salt::US9738655, Example 116	Coagulation factor XI	Homo sapiens	 13.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335885&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626246	384988042							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661940	CNC(=O)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CC(O)=O)cc1	InChI=1S/C34H27ClFN7O5/c1-37-32(46)26-13-10-20(17-38-26)22-4-2-5-24-23(22)14-15-42(31(24)33(47)39-21-11-8-19(9-12-21)16-29(44)45)34(48)27-18-43(41-40-27)28-7-3-6-25(35)30(28)36/h2-13,17-18,31H,14-16H2,1H3,(H,37,46)(H,39,47)(H,44,45)	PCKDHIDIRRZJKO-UHFFFAOYSA-N	335886	2-(4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)phenyl)acetic acid, TFA salt::US9738655, Example 117	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335886&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626270	384988043					C03768		1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661941	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccccc1	InChI=1S/C31H30ClFN6O3/c1-42-21-13-16-37(17-14-21)26-11-5-9-23-22(26)15-18-38(29(23)30(40)34-20-7-3-2-4-8-20)31(41)25-19-39(36-35-25)27-12-6-10-24(32)28(27)33/h2-12,19,21,29H,13-18H2,1H3,(H,34,40)	OYJMUKCJZWQNIM-UHFFFAOYSA-N	335887	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 118	Coagulation factor XI	Homo sapiens	 38.0								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335887&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602103	384988044							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661942	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(Br)cccc2C1C(=O)Nc1ccccc1	InChI=1S/C25H18BrClFN5O2/c26-18-9-4-8-17-16(18)12-13-32(23(17)24(34)29-15-6-2-1-3-7-15)25(35)20-14-33(31-30-20)21-11-5-10-19(27)22(21)28/h1-11,14,23H,12-13H2,(H,29,34)	YQDIROVALXIHCO-UHFFFAOYSA-N	335888	5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 119	Coagulation factor XI	Homo sapiens	 4444								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335888&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601337	384988045							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661943	OCc1ccc(NC(=O)C2N(CCc3c(Br)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H20BrClFN5O3/c27-19-4-1-3-18-17(19)11-12-33(24(18)25(36)30-16-9-7-15(14-35)8-10-16)26(37)21-13-34(32-31-21)22-6-2-5-20(28)23(22)29/h1-10,13,24,35H,11-12,14H2,(H,30,36)	UVSSXHYWEKOUGV-UHFFFAOYSA-N	335889	5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 120	Coagulation factor XI	Homo sapiens	 3936								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335889&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626330	384988046							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661944	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CO)cc1	InChI=1S/C32H32ClFN6O4/c1-44-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-39(30(24)31(42)35-21-10-8-20(19-41)9-11-21)32(43)26-18-40(37-36-26)28-7-3-5-25(33)29(28)34/h2-11,18,22,30,41H,12-17,19H2,1H3,(H,35,42)/t30-/m1/s1	IKSYNZROZSKPEA-SSEXGKCCSA-N	335890	(R)-2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 121	Coagulation factor XI	Homo sapiens	 1047								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335890&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601941	384988047							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661945	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CO)cc1	InChI=1S/C32H32ClFN6O4/c1-44-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-39(30(24)31(42)35-21-10-8-20(19-41)9-11-21)32(43)26-18-40(37-36-26)28-7-3-5-25(33)29(28)34/h2-11,18,22,30,41H,12-17,19H2,1H3,(H,35,42)/t30-/m0/s1	IKSYNZROZSKPEA-PMERELPUSA-N	335891	(S)-2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 122	Coagulation factor XI	Homo sapiens	 16.8								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335891&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601458	384988048							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661946	OC(=O)c1ccc(NC(=O)C2N(CCc3c(OC4COC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C29H23ClFN5O6/c30-21-4-2-5-23(25(21)31)36-13-22(33-34-36)28(38)35-12-11-19-20(3-1-6-24(19)42-18-14-41-15-18)26(35)27(37)32-17-9-7-16(8-10-17)29(39)40/h1-10,13,18,26H,11-12,14-15H2,(H,32,37)(H,39,40)	AMHCONOGPXXSHI-UHFFFAOYSA-N	335892	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(oxetan-3-yloxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 123	Coagulation factor XI	Homo sapiens	 7.69								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335892&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602453	384988049							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661947	CC1(COc2cccc3C(N(CCc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)COC1	InChI=1S/C31H27ClFN5O6/c1-31(15-43-16-31)17-44-25-7-2-4-21-20(25)12-13-37(27(21)28(39)34-19-10-8-18(9-11-19)30(41)42)29(40)23-14-38(36-35-23)24-6-3-5-22(32)26(24)33/h2-11,14,27H,12-13,15-17H2,1H3,(H,34,39)(H,41,42)	LEGCVLXVQJXNEL-UHFFFAOYSA-N	335893	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((3-methyloxetan-3-yl)methoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 124	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335893&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626334	384988050							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661948	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc2ncccc2c1	InChI=1S/C32H22ClFN8O2/c33-25-7-2-8-28(29(25)34)42-17-27(39-40-42)32(44)41-13-11-23-22(20-15-35-18-36-16-20)5-1-6-24(23)30(41)31(43)38-21-9-10-26-19(14-21)4-3-12-37-26/h1-10,12,14-18,30H,11,13H2,(H,38,43)/t30-/m1/s1	AOJOJDICJYHDFM-SSEXGKCCSA-N	335894	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-N-(quinolin-6-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 125	Coagulation factor XI	Homo sapiens	 9.62								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335894&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121357622	384988051							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661949	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335895	N-(4-(1H-imidazol-2-yl)phenyl)-2-(1- (3-chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahy-droisoquinoline-1- carboxamide, TFA salt::US9738655, Example 126	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335895&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348927	384988052							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661950	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1cc[nH]n1			335896	N-(4-(1H-pyrazol-3-yl)phenyl)-2-(1-(3- chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 127	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335896&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348768	384988053							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661951	COC(=O)c1ccc2cc(NC(=O)C3N(CCc4c3cccc4-c3cncnc3)C(=O)c3cn(nn3)-c3cccc(Cl)c3F)ccc2n1	InChI=1S/C34H24ClFN8O4/c1-48-34(47)27-10-8-19-14-21(9-11-26(19)40-27)39-32(45)31-24-5-2-4-22(20-15-37-18-38-16-20)23(24)12-13-43(31)33(46)28-17-44(42-41-28)29-7-3-6-25(35)30(29)36/h2-11,14-18,31H,12-13H2,1H3,(H,39,45)	KIPVHPIVDXTMIZ-UHFFFAOYSA-N	335897	US9738655, Example 128::methyl 6-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) quinoline-2-carboxylate, TFA salt	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335897&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348964	384988054							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661952	OC(=O)c1ccc2cc(NC(=O)C3N(CCc4c3cccc4-c3cncnc3)C(=O)c3cn(nn3)-c3cccc(Cl)c3F)ccc2n1	InChI=1S/C33H22ClFN8O4/c34-24-5-2-6-28(29(24)35)43-16-27(40-41-43)32(45)42-12-11-22-21(19-14-36-17-37-15-19)3-1-4-23(22)30(42)31(44)38-20-8-10-25-18(13-20)7-9-26(39-25)33(46)47/h1-10,13-17,30H,11-12H2,(H,38,44)(H,46,47)	CBWGFRXFDKEMRZ-UHFFFAOYSA-N	335898	6-(2-(1-(3-chloro-2-fluorophenyl)-1H- 1,2,3-triazole-4-carbonyl)-5- (pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) quinoline-2-carboxylic acid, TFA salt::US9738655, Example 129	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335898&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348962	384988055							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661953	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc2cnccc2c1	InChI=1S/C32H22ClFN8O2/c33-26-5-2-6-28(29(26)34)42-17-27(39-40-42)32(44)41-12-10-24-23(21-15-36-18-37-16-21)3-1-4-25(24)30(41)31(43)38-22-8-7-20-14-35-11-9-19(20)13-22/h1-9,11,13-18,30H,10,12H2,(H,38,43)	JNENWLQOWWWAGJ-UHFFFAOYSA-N	335899	2-(1-(3-chloro-2-fluorophenyl)-1H- 1,2,3-triazol-4-carbonyl)-N- (isoquinolin-6-yl)-5-(pyrimidin-5-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 130	Coagulation factor XI	Homo sapiens	 28.3								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335899&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348762	384988056							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661954	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncn[nH]1			335900	N-(4-(1H-1,2,4-triazol-5-yl)phenyl)-2- (1-(3-chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 131	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335900&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348776	384988057							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661955	COC(=O)[C@@H]1CC[C@@H](CC1)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C31H29ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-7,14-18,20,28H,8-13H2,1H3,(H,36,41)/t18-,20+,28?	KRPMWHOIXWBEJN-NWNQRXDVSA-N	335901	(1R,4R)-methyl 4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) cyclohexanecarboxylate::US9738655, Example 132	Coagulation factor XI	Homo sapiens	 124								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335901&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348820	384988058							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661956	OC(=O)[C@@H]1CC[C@@H](CC1)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C30H27ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-6,13-17,19,27H,7-12H2,(H,35,40)(H,42,43)/t17-,19+,27?	BKPBNEGPJBNSTD-MEXJIUHXSA-N	335902	(1R,4R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) cyclohexanecarboxylic acid::US9738655, Example 133	Coagulation factor XI	Homo sapiens	 12.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335902&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348874	384988059							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661957	Fc1c(Cl)cccc1C1=NO[C@H](C1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335903	(1S)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt, and (1R)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 134	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335903&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602084	384988060							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661958	Fc1c(Cl)cccc1C1=NO[C@H](C1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335904	US9738655, Example 135	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335904&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601929	384988061							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661959	Cc1c(ncn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335905	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA salt::US9738655, Example 136	Coagulation factor XI	Homo sapiens	 6.97								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335905&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601342	384988062							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661960	Fc1c(Cl)cccc1-n1cnc(c1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335906	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA::US9738655, Example 137	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335906&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601909	384988063							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661961	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335907	(S)-N-(4-(H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt, and (R)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 138	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335907&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602016	384988064							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661962	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335910	US9738655, Example 139	Coagulation factor XI	Homo sapiens	 133								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335910&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601485	384988067							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661963	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335911	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA salt::US9738655, Example 140	Coagulation factor XI	Homo sapiens	 39.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335911&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601331	384988068							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661964	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335912	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA::US9738655, Example 141	Coagulation factor XI	Homo sapiens	 5.95								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335912&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601344	384988069							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661965	COC(=O)C12CCC(CC1)(CC2)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C33H31ClFN7O4/c1-46-31(45)32-9-12-33(13-10-32,14-11-32)38-29(43)28-23-5-2-4-21(20-16-36-19-37-17-20)22(23)8-15-41(28)30(44)25-18-42(40-39-25)26-7-3-6-24(34)27(26)35/h2-7,16-19,28H,8-15H2,1H3,(H,38,43)	XUSXNGCEKZUXPA-UHFFFAOYSA-N	335913	Methyl 4-(2-{[1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylate, TFA salt::US9738655, Example 142	Coagulation factor XI	Homo sapiens	 56.2								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335913&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626226	384988070							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661966	OC(=O)C12CCC(CC1)(CC2)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)	PAUFAVZBDGYZEP-UHFFFAOYSA-N	335914	4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA::US9738655, Example 143	Coagulation factor XI	Homo sapiens	 5.23								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335914&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626271	384988071							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661967	OC(=O)C12CCC(CC1)(CC2)NC(=O)[C@H]1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)/t27-,31?,32?/m0/s1	PAUFAVZBDGYZEP-ZHGDCFTFSA-N	335915	4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA (enantiomer A), and 4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA (enantiomer B)::US9738655, Example 144	Coagulation factor XI	Homo sapiens	 3029								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335915&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752702	384988072							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661968	OC(=O)C12CCC(CC1)(CC2)NC(=O)[C@@H]1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)/t27-,31?,32?/m1/s1	PAUFAVZBDGYZEP-XJRVHGQPSA-N	335916	US9738655, Example 145	Coagulation factor XI	Homo sapiens	 7.87								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335916&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752703	384988073							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661969	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1sc(nc1C)-c1cccnc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H33N5O5S/c1-20-29(44-31(35-20)22-5-4-15-34-19-22)32(40)38-18-14-25-26(6-3-7-27(25)37-16-12-24(43-2)13-17-37)28(38)30(39)36-23-10-8-21(9-11-23)33(41)42/h3-11,15,19,24,28H,12-14,16-18H2,1-2H3,(H,36,39)(H,41,42)	LLLXEIXZHFLWRN-UHFFFAOYSA-N	335917	4-(5-(4-methoxypiperidin-1- yl)-2-(4-methyl-2-(pyridin-3- yl)thiazole-5-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 146	Coagulation factor XI	Homo sapiens	 1197								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335917&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626275	384988074							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661970	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(C)n(c1C)-c1ccc(Cl)cc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClN4O5/c1-22-21-31(23(2)41(22)27-13-9-25(37)10-14-27)35(43)40-20-17-29-30(5-4-6-32(29)39-18-15-28(46-3)16-19-39)33(40)34(42)38-26-11-7-24(8-12-26)36(44)45/h4-14,21,28,33H,15-20H2,1-3H3,(H,38,42)(H,44,45)	JUDGQBWJCBBMPL-UHFFFAOYSA-N	335918	4-(2-(1-(4-chlorophenyl)-2,5- dimethyl-1H-pyrrole-3- carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 147	Coagulation factor XI	Homo sapiens	 2687								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335918&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626253	384988075							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661971	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1ccccc1Cl)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClN4O6/c1-43-22-13-16-37(17-14-22)28-8-4-6-24-23(28)15-18-38(30(24)31(39)35-21-11-9-20(10-12-21)33(41)42)32(40)29-19-27(36-44-29)25-5-2-3-7-26(25)34/h2-12,19,22,30H,13-18H2,1H3,(H,35,39)(H,41,42)	FBWHUCZKOUXAFK-UHFFFAOYSA-N	335919	4-(2-(3-(2-chlorophenyl) isoxazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 148	Coagulation factor XI	Homo sapiens	 69.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335919&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626257	384988076							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661972	CCOc1ccc(cc1)N1CCC(C(=O)N2CCc3c(cccc3N3CCC(CC3)OC)C2C(=O)Nc2ccc(cc2)C(O)=O)C1=O	InChI=1S/C36H40N4O7/c1-3-47-27-13-11-25(12-14-27)39-21-18-30(34(39)42)35(43)40-22-17-28-29(5-4-6-31(28)38-19-15-26(46-2)16-20-38)32(40)33(41)37-24-9-7-23(8-10-24)36(44)45/h4-14,26,30,32H,3,15-22H2,1-2H3,(H,37,41)(H,44,45)	WHWPMFNTGXNHIS-UHFFFAOYSA-N	335920	4-(2-(1-(4- isopropoxyphenyl)-2- oxopyrrolidine-3-carbonyl)- 5-(4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 149	Coagulation factor XI	Homo sapiens	 7159								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335920	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335920&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121357623	384988077							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661973	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1C(F)(F)F)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF3N5O5/c1-48-24-12-15-41(16-13-24)28-7-3-6-26-25(28)14-17-42(29(26)31(44)40-22-10-8-20(9-11-22)33(46)47)32(45)27-19-39-43(30(27)34(36,37)38)23-5-2-4-21(35)18-23/h2-11,18-19,24,29H,12-17H2,1H3,(H,40,44)(H,46,47)	UOAJSVQRAORWBH-UHFFFAOYSA-N	335921	4-(2-(1-(3-chlorophenyl)-5- (trifluoromethyl)-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 150	Coagulation factor XI	Homo sapiens	 2604								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335921&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348851	384988078							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661974	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(F)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31FN4O6/c1-43-24-12-15-37(16-13-24)28-7-3-6-26-25(28)14-17-38(30(26)31(39)35-23-10-8-20(9-11-23)33(41)42)32(40)29-19-27(36-44-29)21-4-2-5-22(34)18-21/h2-11,18-19,24,30H,12-17H2,1H3,(H,35,39)(H,41,42)	CZQIYQUQRWMSNN-UHFFFAOYSA-N	335922	4-(2-(3-(3-fluorophenyl) isoxazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 152	Coagulation factor XI	Homo sapiens	 466								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335922	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335922&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626254	384988079							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661975	COc1ncccc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H24ClFN6O5/c1-45-30-23(7-4-15-35-30)20-5-2-6-22-21(20)14-16-39(28(22)29(41)36-19-12-10-18(11-13-19)32(43)44)31(42)25-17-40(38-37-25)26-9-3-8-24(33)27(26)34/h2-13,15,17,28H,14,16H2,1H3,(H,36,41)(H,43,44)	IGZAIPQOJHCWHB-UHFFFAOYSA-N	335924	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methoxypyridin-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 153	Coagulation factor XI	Homo sapiens	 5.73								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335924&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626316	384988081							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661976	CN(C)Cc1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H30ClFN6O4/c1-41(2)19-21-9-11-22(12-10-21)25-5-3-6-27-26(25)17-18-42(32(27)33(44)38-24-15-13-23(14-16-24)35(46)47)34(45)29-20-43(40-39-29)30-8-4-7-28(36)31(30)37/h3-16,20,32H,17-19H2,1-2H3,(H,38,44)(H,46,47)	ZVZJRSQLHVSFCT-UHFFFAOYSA-N	335925	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- ((dimethylamino)methyl) phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 154	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335925	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335925&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626305	384988082							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661977	NS(=O)(=O)c1cccc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H24ClFN6O6S/c33-25-8-3-9-27(28(25)34)40-17-26(37-38-40)31(42)39-15-14-23-22(19-4-1-5-21(16-19)47(35,45)46)6-2-7-24(23)29(39)30(41)36-20-12-10-18(11-13-20)32(43)44/h1-13,16-17,29H,14-15H2,(H,36,41)(H,43,44)(H2,35,45,46)	WIFGOOCSSHFCOL-UHFFFAOYSA-N	335926	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- sulfamoylphenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 155	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335926&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626308	384988083							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661978	Cn1ncc2cc(ccc12)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-28-13-10-20(16-21(28)17-37-41)23-4-2-5-25-24(23)14-15-42(31(25)32(44)38-22-11-8-19(9-12-22)34(46)47)33(45)27-18-43(40-39-27)29-7-3-6-26(35)30(29)36/h2-13,16-18,31H,14-15H2,1H3,(H,38,44)(H,46,47)	PEYSPUAISONHGJ-UHFFFAOYSA-N	335927	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-indazol-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 156	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335927&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626313	384988084							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661979	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3OCOc3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C33H23ClFN5O6/c34-24-5-2-6-26(29(24)35)40-16-25(37-38-40)32(42)39-14-13-22-21(19-9-12-27-28(15-19)46-17-45-27)3-1-4-23(22)30(39)31(41)36-20-10-7-18(8-11-20)33(43)44/h1-12,15-16,30H,13-14,17H2,(H,36,41)(H,43,44)	YMKJYIGERWZMBD-UHFFFAOYSA-N	335928	4-(5-(benzo[d][1,3]dioxol-5- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 157	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335928	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335928&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626227	384988085							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661980	COc1nc(CO)ncc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H25ClFN7O6/c1-47-30-22(14-35-26(16-42)37-30)19-4-2-5-21-20(19)12-13-40(28(21)29(43)36-18-10-8-17(9-11-18)32(45)46)31(44)24-15-41(39-38-24)25-7-3-6-23(33)27(25)34/h2-11,14-15,28,42H,12-13,16H2,1H3,(H,36,43)(H,45,46)	KEIUQGAQXZMPMF-UHFFFAOYSA-N	335929	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2,4- dimethoxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 158	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335929&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752704	384988086							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661981	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cnoc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C29H20ClFN6O5/c30-22-5-2-6-24(25(22)31)37-14-23(34-35-37)28(39)36-12-11-20-19(17-13-32-42-15-17)3-1-4-21(20)26(36)27(38)33-18-9-7-16(8-10-18)29(40)41/h1-10,13-15,26H,11-12H2,(H,33,38)(H,40,41)	KNHSJHYZPJNHQS-UHFFFAOYSA-N	335930	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (isoxazol-4-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 159	Coagulation factor XI	Homo sapiens	 13.2								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335930&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626229	384988087							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661982	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cccc3cc[nH]c23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335931	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- indol-7-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 160	Coagulation factor XI	Homo sapiens	 30.3								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335931&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626230	384988088							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661983	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3cn[nH]c3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335932	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- indazol-6-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 161	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335932	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335932&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626374	384988089							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661984	Cn1cc2ccc(cc2n1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-17-21-9-8-20(16-27(21)39-41)23-4-2-5-25-24(23)14-15-42(31(25)32(44)37-22-12-10-19(11-13-22)34(46)47)33(45)28-18-43(40-38-28)29-7-3-6-26(35)30(29)36/h2-13,16-18,31H,14-15H2,1H3,(H,37,44)(H,46,47)	KHUVYEDRWCEEIA-UHFFFAOYSA-N	335933	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methyl-2H-indazol-6-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 162	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335933&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626372	384988090							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661985	NCc1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN6O4/c34-26-5-2-6-28(29(26)35)41-18-27(38-39-41)32(43)40-16-15-24-23(20-9-7-19(17-36)8-10-20)3-1-4-25(24)30(40)31(42)37-22-13-11-21(12-14-22)33(44)45/h1-14,18,30H,15-17,36H2,(H,37,42)(H,44,45)	OLJACQUBYGSMNM-UHFFFAOYSA-N	335934	4-(5-(4-(aminomethyl) phenyl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 163	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335934	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335934&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626373	384988091							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661986	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cccc(c2)-c2ccn[nH]2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335935	4-(5-(3-(1H-pyrazol-5- yl)phenyl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 164	Coagulation factor XI	Homo sapiens	 9.17								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335935	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335935&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626375	384988092							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661987	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3C2=CCOCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H25ClFN5O5/c32-24-5-2-6-26(27(24)33)38-17-25(35-36-38)30(40)37-14-11-22-21(18-12-15-43-16-13-18)3-1-4-23(22)28(37)29(39)34-20-9-7-19(8-10-20)31(41)42/h1-10,12,17,28H,11,13-16H2,(H,34,39)(H,41,42)	BIVWSUFIOZOXDH-UHFFFAOYSA-N	335936	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3,6- dihydro-2H-pyran-4-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 165	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335936&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626336	384988093							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661988	CNC(=O)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H25ClFN7O5/c1-36-30(43)25-13-10-19(16-37-25)21-4-2-5-23-22(21)14-15-41(29(23)31(44)38-20-11-8-18(9-12-20)33(46)47)32(45)26-17-42(40-39-26)27-7-3-6-24(34)28(27)35/h2-13,16-17,29H,14-15H2,1H3,(H,36,43)(H,38,44)(H,46,47)	MNYQVTQMJHBGTD-UHFFFAOYSA-N	335937	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(6- (methylcarbamoyl)pyridin-3- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 166	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335937&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601983	384988094							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661989	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cccc3cn[nH]c23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335938	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- indazol-7-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 167	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335938&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348886	384988095							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661990	NS(=O)(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H24ClFN6O6S/c33-25-5-2-6-27(28(25)34)40-17-26(37-38-40)31(42)39-16-15-23-22(18-9-13-21(14-10-18)47(35,45)46)3-1-4-24(23)29(39)30(41)36-20-11-7-19(8-12-20)32(43)44/h1-14,17,29H,15-16H2,(H,36,41)(H,43,44)(H2,35,45,46)	RPUVAQQZKOZFQJ-UHFFFAOYSA-N	335939	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- sulfamoylphenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 168	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335939&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626335	384988096							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661991	Cn1ncc2c(cccc12)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-28-9-3-6-22(25(28)17-37-41)21-5-2-7-24-23(21)15-16-42(31(24)32(44)38-20-13-11-19(12-14-20)34(46)47)33(45)27-18-43(40-39-27)29-10-4-8-26(35)30(29)36/h2-14,17-18,31H,15-16H2,1H3,(H,38,44)(H,46,47)	AKTOOYOLPGZHDR-UHFFFAOYSA-N	335940	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-indazol-4-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 169	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335940	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335940&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626306	384988097							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661992	Cn1ncc2ccc(cc12)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-29-16-20(8-9-21(29)17-37-41)23-4-2-5-25-24(23)14-15-42(31(25)32(44)38-22-12-10-19(11-13-22)34(46)47)33(45)27-18-43(40-39-27)28-7-3-6-26(35)30(28)36/h2-13,16-18,31H,14-15H2,1H3,(H,38,44)(H,46,47)	YAKHHYVFPMBUOW-UHFFFAOYSA-N	335941	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-indazol-6-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 170	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335941	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335941&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626309	384988098							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661993	Cc1nnc(o1)-c1cccc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H25ClFN7O5/c1-19-39-41-33(49-19)22-6-2-5-21(17-22)24-7-3-8-26-25(24)15-16-43(31(26)32(45)38-23-13-11-20(12-14-23)35(47)48)34(46)28-18-44(42-40-28)29-10-4-9-27(36)30(29)37/h2-14,17-18,31H,15-16H2,1H3,(H,38,45)(H,47,48)	PPQOVPYUXWDMRP-UHFFFAOYSA-N	335942	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3-(5- methyl-1,3,4-oxadiazol-2- yl)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 171	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335942&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626310	384988099							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661994	CN(C)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H27ClFN7O4/c1-40(2)28-14-11-20(17-36-28)22-5-3-6-24-23(22)15-16-41(30(24)31(43)37-21-12-9-19(10-13-21)33(45)46)32(44)26-18-42(39-38-26)27-8-4-7-25(34)29(27)35/h3-14,17-18,30H,15-16H2,1-2H3,(H,37,43)(H,45,46)	BLZAZYOJFDTIIS-UHFFFAOYSA-N	335943	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(6- (dimethylamino)pyridin-3- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 172	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335943&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348898	384988100							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661995	NCc1cccc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN6O4/c34-26-8-3-9-28(29(26)35)41-18-27(38-39-41)32(43)40-15-14-24-23(21-5-1-4-19(16-21)17-36)6-2-7-25(24)30(40)31(42)37-22-12-10-20(11-13-22)33(44)45/h1-13,16,18,30H,14-15,17,36H2,(H,37,42)(H,44,45)	LBUCPZNCRRKCFI-UHFFFAOYSA-N	335944	4-(5-(3-(aminomethyl) phenyl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 173	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335944	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335944&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626377	384988101							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661996	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3nccnc3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C34H23ClFN7O4/c35-25-5-2-6-29(30(25)36)43-18-28(40-41-43)33(45)42-16-13-23-22(20-9-12-26-27(17-20)38-15-14-37-26)3-1-4-24(23)31(42)32(44)39-21-10-7-19(8-11-21)34(46)47/h1-12,14-15,17-18,31H,13,16H2,(H,39,44)(H,46,47)	DJQBJXLYHQOLEU-UHFFFAOYSA-N	335945	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (quinoxalin-6-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 174	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335945&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626376	384988102							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661997	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3occc(=O)c3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H23ClFN5O6/c36-26-5-2-6-28(31(26)37)42-18-27(39-40-42)34(45)41-15-13-23-22(20-9-12-30-25(17-20)29(43)14-16-48-30)3-1-4-24(23)32(41)33(44)38-21-10-7-19(8-11-21)35(46)47/h1-12,14,16-18,32H,13,15H2,(H,38,44)(H,46,47)	XNEVJXQNFIYVKV-UHFFFAOYSA-N	335946	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- oxo-4H-chromen-6-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 175	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335946&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752705	384988103							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661998	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc(cc2)S(=O)(=O)NC2CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H28ClFN6O6S/c36-28-5-2-6-30(31(28)37)43-19-29(39-41-43)34(45)42-18-17-26-25(20-9-15-24(16-10-20)50(48,49)40-23-13-14-23)3-1-4-27(26)32(42)33(44)38-22-11-7-21(8-12-22)35(46)47/h1-12,15-16,19,23,32,40H,13-14,17-18H2,(H,38,44)(H,46,47)	HHVNRFGHPXGOBY-UHFFFAOYSA-N	335949	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4-(N- cyclopropylsulfamoyl) phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 176	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335949&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348931	384988106							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
661999	CN(C)S(=O)(=O)c1cccc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H28ClFN6O6S/c1-40(2)49(47,48)23-7-3-6-21(18-23)24-8-4-9-26-25(24)16-17-41(31(26)32(43)37-22-14-12-20(13-15-22)34(45)46)33(44)28-19-42(39-38-28)29-11-5-10-27(35)30(29)36/h3-15,18-19,31H,16-17H2,1-2H3,(H,37,43)(H,45,46)	QFXZGWJWTQRZAY-UHFFFAOYSA-N	335950	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- (N,N-dimethylsulfamoyl) phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 177	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335950&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626338	384988107							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662000	CCOc1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN6O5/c1-2-46-28-14-11-20(17-36-28)22-5-3-6-24-23(22)15-16-40(30(24)31(42)37-21-12-9-19(10-13-21)33(44)45)32(43)26-18-41(39-38-26)27-8-4-7-25(34)29(27)35/h3-14,17-18,30H,2,15-16H2,1H3,(H,37,42)(H,44,45)	SRHCUHHMVYNQCG-UHFFFAOYSA-N	335951	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(6- ethoxypyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 178	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335951&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348967	384988108							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662001	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccccc2CN2CCOCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C37H32ClFN6O5/c38-30-9-4-10-32(33(30)39)45-22-31(41-42-45)36(47)44-16-15-28-27(26-6-2-1-5-24(26)21-43-17-19-50-20-18-43)7-3-8-29(28)34(44)35(46)40-25-13-11-23(12-14-25)37(48)49/h1-14,22,34H,15-21H2,(H,40,46)(H,48,49)	STTGJAAMEUHJSZ-UHFFFAOYSA-N	335952	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- (morpholinomethyl)phenyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 179	Coagulation factor XI	Homo sapiens	 5.92								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335952&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626339	384988109							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662002	OCc1cccc(c1F)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H24ClF2N5O5/c34-25-8-3-9-27(29(25)36)41-16-26(38-39-41)32(44)40-15-14-22-21(23-6-1-4-19(17-42)28(23)35)5-2-7-24(22)30(40)31(43)37-20-12-10-18(11-13-20)33(45)46/h1-13,16,30,42H,14-15,17H2,(H,37,43)(H,45,46)	WSKRRTIYMGMDTR-UHFFFAOYSA-N	335953	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- fluoro-3-methoxyphenyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 180	Coagulation factor XI	Homo sapiens	 5.20								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335953	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335953&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752706	384988110							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662003	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cnc3[nH]ccc3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335954	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- pyrrolo[2,3-b]pyridin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 181	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335954&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626379	384988111							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662004	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc(nc2)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H21ClFN7O4/c33-25-5-2-6-27(28(25)34)41-17-26(38-39-41)31(43)40-14-13-23-22(19-9-12-21(15-35)36-16-19)3-1-4-24(23)29(40)30(42)37-20-10-7-18(8-11-20)32(44)45/h1-12,16-17,29H,13-14H2,(H,37,42)(H,44,45)	HETUUWMBFBHOTJ-UHFFFAOYSA-N	335955	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(6- cyanopyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 182	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335955&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601880	384988112							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662005	CN(C)c1ncc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H26ClFN8O4/c1-40(2)32-35-15-19(16-36-32)21-5-3-6-23-22(21)13-14-41(28(23)29(43)37-20-11-9-18(10-12-20)31(45)46)30(44)25-17-42(39-38-25)26-8-4-7-24(33)27(26)34/h3-12,15-17,28H,13-14H2,1-2H3,(H,37,43)(H,45,46)	LAKJQHPJDDWSBA-UHFFFAOYSA-N	335956	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- (dimethylamino)pyrimidin-5- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 183	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335956&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626381	384988113							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662006	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc(F)c(c2)C(=O)N2CCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C37H29ClF2N6O5/c38-28-7-4-8-31(32(28)40)46-20-30(42-43-46)36(49)45-18-15-25-24(22-11-14-29(39)27(19-22)35(48)44-16-1-2-17-44)5-3-6-26(25)33(45)34(47)41-23-12-9-21(10-13-23)37(50)51/h3-14,19-20,33H,1-2,15-18H2,(H,41,47)(H,50,51)	XYEHSKFIKWPKHQ-UHFFFAOYSA-N	335957	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- fluoro-3-(pyrrolidine-1- carbonyl)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 184	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335957&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348966	384988114							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662007	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccncc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H22ClFN6O4/c32-24-5-2-6-26(27(24)33)39-17-25(36-37-39)30(41)38-16-13-22-21(18-11-14-34-15-12-18)3-1-4-23(22)28(38)29(40)35-20-9-7-19(8-10-20)31(42)43/h1-12,14-15,17,28H,13,16H2,(H,35,40)(H,42,43)	LTIVYXGXQKAJJF-UHFFFAOYSA-N	335958	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (pyridin-4-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 186	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335958&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626255	384988115							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662008	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3C2=CCNCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN6O4/c32-24-5-2-6-26(27(24)33)39-17-25(36-37-39)30(41)38-16-13-22-21(18-11-14-34-15-12-18)3-1-4-23(22)28(38)29(40)35-20-9-7-19(8-10-20)31(42)43/h1-11,17,28,34H,12-16H2,(H,35,40)(H,42,43)	ICTKPTDRHQONJT-UHFFFAOYSA-N	335959	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (1,2,3,6-tetrahydropyridin-4- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 187	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335959	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335959&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348769	384988116							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662009	NC(=O)Cc1cccc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H26ClFN6O5/c35-26-8-3-9-28(30(26)36)42-18-27(39-40-42)33(45)41-15-14-24-23(21-5-1-4-19(16-21)17-29(37)43)6-2-7-25(24)31(41)32(44)38-22-12-10-20(11-13-22)34(46)47/h1-13,16,18,31H,14-15,17H2,(H2,37,43)(H,38,44)(H,46,47)	DQVCIPUEAIFNHL-UHFFFAOYSA-N	335960	4-(5-(3-(2-amino-2- oxoethyl)phenyl)-2-(1-(3- chloro-2-fluorophenyl)-1H- 1,2,3-triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 188	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335960&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348907	384988117							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662010	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc2N(C)C(=O)CCc2c1	InChI=1S/C35H35ClFN7O4/c1-41-28-11-10-22(19-21(28)9-12-31(41)45)38-34(46)33-25-5-3-7-29(42-16-13-23(48-2)14-17-42)24(25)15-18-43(33)35(47)27-20-44(40-39-27)30-8-4-6-26(36)32(30)37/h3-8,10-11,19-20,23,33H,9,12-18H2,1-2H3,(H,38,46)	BUBXPDDFAILUER-UHFFFAOYSA-N	335961	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 189	Coagulation factor XI	Homo sapiens	 411								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335961	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335961&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601819	384988118							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662011	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc2NC(=O)Cc2c1	InChI=1S/C33H31ClFN7O4/c1-46-21-10-13-40(14-11-21)27-6-2-4-23-22(27)12-15-41(31(23)32(44)36-20-8-9-25-19(16-20)17-29(43)37-25)33(45)26-18-42(39-38-26)28-7-3-5-24(34)30(28)35/h2-9,16,18,21,31H,10-15,17H2,1H3,(H,36,44)(H,37,43)	ITLFYSBJLLBJOI-UHFFFAOYSA-N	335962	2-(1-(3-Chloro-2-fluorophenyl)-1H-12,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-(2-oxoindolin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 190	Coagulation factor XI	Homo sapiens	 98.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335962	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335962&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601759	384988119							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662012	CC(=O)Nc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H22ClFN6O5/c1-15(37)31-21-6-2-4-19-18(21)12-13-35(25(19)26(38)32-17-10-8-16(9-11-17)28(40)41)27(39)22-14-36(34-33-22)23-7-3-5-20(29)24(23)30/h2-11,14,25H,12-13H2,1H3,(H,31,37)(H,32,38)(H,40,41)	DYDMJJDNJRSGGJ-UHFFFAOYSA-N	335963	4-(5-Acetamido-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 191	Coagulation factor XI	Homo sapiens	 13.4								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335963&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626383	384988120							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662013	CN1CCC(CC1)NC(=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN7O5/c1-40-15-12-21(13-16-40)36-30(43)24-5-2-4-23-22(24)14-17-41(29(23)31(44)37-20-10-8-19(9-11-20)33(46)47)32(45)26-18-42(39-38-26)27-7-3-6-25(34)28(27)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,43)(H,37,44)(H,46,47)	LGQQAPCYXLKLHW-UHFFFAOYSA-N	335964	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((1-methylpiperidin-4-yl)carbamoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt.::US9738655, Example 192	Coagulation factor XI	Homo sapiens	 9.97								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335964&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602250	384988121							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662014	OC(=O)c1ccc(NC(=O)C2N(CCc3c(NC(=O)NC4CCCC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H29ClFN7O5/c33-23-8-4-10-26(27(23)34)41-17-25(38-39-41)30(43)40-16-15-21-22(7-3-9-24(21)37-32(46)36-19-5-1-2-6-19)28(40)29(42)35-20-13-11-18(12-14-20)31(44)45/h3-4,7-14,17,19,28H,1-2,5-6,15-16H2,(H,35,42)(H,44,45)(H2,36,37,46)	LJVRVBNTOCCTEO-UHFFFAOYSA-N	335965	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(3-cyclopentylureido)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 193	Coagulation factor XI	Homo sapiens	 19.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335965	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335965&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601686	384988122							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662015	OC(=O)c1ccc(NC(=O)C2N(CCc3c(Cl)cccc23)C(=O)c2cn(nn2)C2CC=CC(Cl)=C2F)cc1	InChI=1S/C26H20Cl2FN5O4/c27-18-4-1-3-17-16(18)11-12-33(23(17)24(35)30-15-9-7-14(8-10-15)26(37)38)25(36)20-13-34(32-31-20)21-6-2-5-19(28)22(21)29/h1-5,7-10,13,21,23H,6,11-12H2,(H,30,35)(H,37,38)	WLTRHIYRFBTMJU-UHFFFAOYSA-N	335966	4-(5-Chloro-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 194	Coagulation factor XI	Homo sapiens	 57.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335966&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360915	384988123							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662016	OC(=O)c1ccc(NC(=O)C2N(CCc3c(F)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H18ClF2N5O4/c27-18-4-2-6-21(22(18)29)34-13-20(31-32-34)25(36)33-12-11-16-17(3-1-5-19(16)28)23(33)24(35)30-15-9-7-14(8-10-15)26(37)38/h1-10,13,23H,11-12H2,(H,30,35)(H,37,38)	PKTQTDFJRKLUQK-UHFFFAOYSA-N	335967	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 195	Coagulation factor XI	Homo sapiens	 40.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335967	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335967&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602022	384988124							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662017	O[C@H]1CCN(C1=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O6/c31-20-4-2-6-23(25(20)32)38-15-21(34-35-38)28(41)37-13-11-18-19(3-1-5-22(18)36-14-12-24(39)29(36)42)26(37)27(40)33-17-9-7-16(8-10-17)30(43)44/h1-10,15,24,26,39H,11-14H2,(H,33,40)(H,43,44)/t24-,26?/m0/s1	QEZNFQPAVIEUBG-QSAPEBAKSA-N	335968	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((S)-3-hydroxy-2-oxopyrrolidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 196	Coagulation factor XI	Homo sapiens	 7.10								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335968&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602162	384988125							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662018	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H26ClF4N7O5/c33-22-4-2-6-25(27(22)34)44-15-23(39-40-44)30(47)43-12-11-20-21(28(43)29(46)38-19-9-7-18(8-10-19)31(48)49)3-1-5-24(20)42-14-13-41(16-26(42)45)17-32(35,36)37/h1-10,15,28H,11-14,16-17H2,(H,38,46)(H,48,49)	CHOLKMVFUOCVEJ-UHFFFAOYSA-N	335969	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-oxo-4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 197	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335969&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602268	384988126							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662019	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18-19,29H,12-17H2,1H3,(H,34,39)(H,41,42)	HLDCZJMVJHEASJ-UHFFFAOYSA-N	335970	4-(2-(3-(3-chlorophenyl) isoxazole-5-carbonyl)-5- (4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 198	Coagulation factor XI	Homo sapiens	 49.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335970&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348948	384988127							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662020	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nc1C(F)(F)F)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClF3N6O4/c1-40-14-16-41(17-15-40)27-7-3-6-25-24(27)12-13-42(28(25)30(44)38-22-10-8-20(9-11-22)32(46)47)31(45)26-19-43(39-29(26)33(35,36)37)23-5-2-4-21(34)18-23/h2-11,18-19,28H,12-17H2,1H3,(H,38,44)(H,46,47)	GQXIFWCUUMUPDH-UHFFFAOYSA-N	335971	4-(2-(1-(3-chlorophenyl)- 3-(trifluoromethyl)-1H- pyrazole-4-carbonyl)-5- (4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 199	Coagulation factor XI	Homo sapiens	 2305								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335971&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348955	384988128							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662021	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClN6O4/c1-36-14-16-37(17-15-36)28-7-3-6-27-26(28)12-13-38(29(27)30(40)35-24-10-8-21(9-11-24)32(42)43)31(41)22-19-34-39(20-22)25-5-2-4-23(33)18-25/h2-11,18-20,29H,12-17H2,1H3,(H,35,40)(H,42,43)	LUIFJTITJHESQD-UHFFFAOYSA-N	335972	4-(2-(1-(3-chlorophenyl)- 1H-pyrazole-4-carbonyl)- 5-(4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 200	Coagulation factor XI	Homo sapiens	 41.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335972&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348951	384988129							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662022	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H30ClN7O4/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(28(25)29(40)33-22-10-8-20(9-11-22)31(42)43)30(41)26-19-39(35-34-26)23-5-2-4-21(32)18-23/h2-11,18-19,28H,12-17H2,1H3,(H,33,40)(H,42,43)	XMCZMUIHYCVFKG-UHFFFAOYSA-N	335973	4-(2-(1-(3-chlorophenyl)- 1H-1,2,3-triazole-4- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 201	Coagulation factor XI	Homo sapiens	 9.88								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335973&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348790	384988130							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662023	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN5O5/c1-37-14-16-38(17-15-37)26-7-3-4-22-21(26)12-13-39(29(22)30(40)35-20-10-8-19(9-11-20)32(42)43)31(41)27-18-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,27,29H,12-18H2,1H3,(H,35,40)(H,42,43)	VBRLSZRSHQMRBW-UHFFFAOYSA-N	335974	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 202	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335974&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348822	384988131							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662024	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)C2CC(=NO2)c2cccc(Cl)c2)cc1	InChI=1S/C36H38ClN5O5/c37-25-6-3-5-24(21-25)30-22-32(47-39-30)35(44)42-20-15-28-29(33(42)34(43)38-26-11-9-23(10-12-26)36(45)46)7-4-8-31(28)41-18-13-27(14-19-41)40-16-1-2-17-40/h3-12,21,27,32-33H,1-2,13-20,22H2,(H,38,43)(H,45,46)	OCAQZKQTRAMKPI-UHFFFAOYSA-N	335975	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4-(pyrrolidin- 1-yl)piperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 203::US9738655, Example 204	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335975&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348830	384988132							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662025	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)C2CC(=NO2)c2cccc(Cl)c2)cc1	InChI=1S/C36H38ClN5O5/c37-25-6-3-5-24(21-25)30-22-32(47-39-30)35(44)42-20-15-28-29(33(42)34(43)38-26-11-9-23(10-12-26)36(45)46)7-4-8-31(28)41-18-13-27(14-19-41)40-16-1-2-17-40/h3-12,21,27,32-33H,1-2,13-20,22H2,(H,38,43)(H,45,46)	OCAQZKQTRAMKPI-UHFFFAOYSA-N	335975	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4-(pyrrolidin- 1-yl)piperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 203::US9738655, Example 204	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335975&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348830	384988132							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662026	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClF2N5O5/c1-38-13-15-39(16-14-38)25-4-2-3-21-20(25)11-12-40(29(21)30(41)36-19-7-5-18(6-8-19)32(43)44)31(42)26-17-24(37-45-26)27-23(34)10-9-22(33)28(27)35/h2-10,26,29H,11-17H2,1H3,(H,36,41)(H,43,44)	SMIFYFPYEXCOIX-UHFFFAOYSA-N	335977	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 205	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335977&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348800	384988133							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662027	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2)cc1	InChI=1S/C35H34ClN7O5/c36-23-4-1-5-26(20-23)43-21-29(38-39-43)34(46)42-19-15-27-28(32(42)33(45)37-24-11-9-22(10-12-24)35(47)48)6-2-7-30(27)40-17-13-25(14-18-40)41-16-3-8-31(41)44/h1-2,4-7,9-12,20-21,25,32H,3,8,13-19H2,(H,37,45)(H,47,48)	HMYKACYTEVALQS-UHFFFAOYSA-N	335978	4-(2-(1-(3-chlorophenyl)- 1H-1,2,3-triazole-4- carbonyl)-5-(4-(2- oxopyrrolidin-1-yl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 206	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335978&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348862	384988134							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662028	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C36H35ClFN5O6/c37-27-6-1-5-26(32(27)38)28-20-30(49-40-28)35(46)43-19-15-24-25(33(43)34(45)39-22-11-9-21(10-12-22)36(47)48)4-2-7-29(24)41-17-13-23(14-18-41)42-16-3-8-31(42)44/h1-2,4-7,9-12,23,30,33H,3,8,13-20H2,(H,39,45)(H,47,48)/t30-,33+/m1/s1	BYIDDONUXSZNHZ-NDKRRWIDSA-N	335979	4-((S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4-(2- oxopyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 207::US9738655, Example 208	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335979&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348770	384988135							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662029	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C36H35ClFN5O6/c37-27-6-1-5-26(32(27)38)28-20-30(49-40-28)35(46)43-19-15-24-25(33(43)34(45)39-22-11-9-21(10-12-22)36(47)48)4-2-7-29(24)41-17-13-23(14-18-41)42-16-3-8-31(42)44/h1-2,4-7,9-12,23,30,33H,3,8,13-20H2,(H,39,45)(H,47,48)/t30-,33+/m1/s1	BYIDDONUXSZNHZ-NDKRRWIDSA-N	335979	4-((S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4-(2- oxopyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 207::US9738655, Example 208	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335979&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348770	384988135							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662030	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnnn1-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H29ClFN7O4/c1-37-14-16-38(17-15-37)24-6-2-4-22-21(24)12-13-39(28(22)29(41)35-20-10-8-19(9-11-20)31(43)44)30(42)26-18-34-36-40(26)25-7-3-5-23(32)27(25)33/h2-11,18,28H,12-17H2,1H3,(H,35,41)(H,43,44)	YGAQJTUPCIZKHJ-UHFFFAOYSA-N	335981	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-5-carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 209	Coagulation factor XI	Homo sapiens	 915								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335981&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348957	384988136							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662031	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN7O4/c36-27-6-4-8-30(31(27)37)44-21-28(39-40-44)34(46)43-20-15-25-26(32(43)33(45)38-23-11-9-22(10-12-23)35(47)48)5-3-7-29(25)42-18-13-24(14-19-42)41-16-1-2-17-41/h3-12,21,24,32H,1-2,13-20H2,(H,38,45)(H,47,48)	SQPALEBBCZQRAK-UHFFFAOYSA-N	335982	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (pyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 210	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335982&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348842	384988137							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662032	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H29ClFN7O4/c1-37-14-16-38(17-15-37)25-6-2-4-22-21(25)12-13-39(28(22)29(41)34-20-10-8-19(9-11-20)31(43)44)30(42)24-18-40(36-35-24)26-7-3-5-23(32)27(26)33/h2-11,18,28H,12-17H2,1H3,(H,34,41)(H,43,44)	POLUXRBRQBKZOB-UHFFFAOYSA-N	335984	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 211	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335984&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348915	384988139							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662033	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN7O4/c1-38-14-16-39(17-15-38)25-6-2-4-22-21(25)12-13-40(28(22)30(42)37-20-10-8-19(9-11-20)32(44)45)31(43)23-18-36-41(29(23)35)26-7-3-5-24(33)27(26)34/h2-11,18,28H,12-17,35H2,1H3,(H,37,42)(H,44,45)	NAHGIMDHYQSLEN-UHFFFAOYSA-N	335985	4-(2-(5-amino-1-(3-chloro- 2-fluorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 212	Coagulation factor XI	Homo sapiens	 20.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335985&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348847	384988140							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662034	Nc1c(cnn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2N2CCC(CC2)N2CCCC2)C1C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClFN7O4/c37-28-6-4-8-30(31(28)38)45-33(39)27(21-40-45)35(47)44-20-15-25-26(32(44)34(46)41-23-11-9-22(10-12-23)36(48)49)5-3-7-29(25)43-18-13-24(14-19-43)42-16-1-2-17-42/h3-12,21,24,32H,1-2,13-20,39H2,(H,41,46)(H,48,49)	ZZLZGWMCLXDEAX-UHFFFAOYSA-N	335987	4-(2-(5-amino-1-(3-chloro- 2-fluorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- (pyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 3TFA salt::US9738655, Example 213	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335987&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348876	384988142							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662035	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1O)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-37-14-16-38(17-15-37)25-6-2-4-22-21(25)12-13-39(28(22)29(41)36-20-10-8-19(9-11-20)32(44)45)30(42)23-18-35-40(31(23)43)26-7-3-5-24(33)27(26)34/h2-11,18,28,43H,12-17H2,1H3,(H,36,41)(H,44,45)	PPBVISRACBGNJU-UHFFFAOYSA-N	335988	4-(2-(1-(3-chloro-2- fluorophenyl)-5-hydroxy- 1H-pyrazole-4-carbonyl)-5- (4-methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt.::US9738655, Example 214	Coagulation factor XI	Homo sapiens	 713								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335988&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348760	384988143							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662036	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-45-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)30(41)35-20-10-8-19(9-11-20)32(43)44)31(42)25-18-40(37-36-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H,35,41)(H,43,44)	AVKKDSOYYJOTLE-UHFFFAOYSA-N	335989	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 215	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335989&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348785	384988144							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662037	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18,28-29H,12-17,19H2,1H3,(H,34,39)(H,41,42)	DXPRVTLHVRYGPT-UHFFFAOYSA-N	335990	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 216::US9738655, Example 217	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335990&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348945	384988145							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662038	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18,28-29H,12-17,19H2,1H3,(H,34,39)(H,41,42)	DXPRVTLHVRYGPT-UHFFFAOYSA-N	335990	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 216::US9738655, Example 217	Coagulation factor XI	Homo sapiens	 15.2								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335990&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348945	384988145							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662039	NC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H34ClFN8O4/c36-26-5-2-7-29(31(26)37)45-20-27(40-41-45)35(49)44-19-15-24-25(32(44)34(48)39-22-11-9-21(10-12-22)33(38)47)4-1-6-28(24)42-17-13-23(14-18-42)43-16-3-8-30(43)46/h1-2,4-7,9-12,20,23,32H,3,8,13-19H2,(H2,38,47)(H,39,48)	NGVXSPZNILPQBM-UHFFFAOYSA-N	335992	N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(2-oxopyrrolidin-1-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 218	Coagulation factor XI	Homo sapiens	 720								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335992&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602137	384988146							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662040	CCOC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C37H39ClFN7O4/c1-2-50-37(49)24-11-13-25(14-12-24)40-35(47)34-28-7-5-9-31(44-20-15-26(16-21-44)43-18-3-4-19-43)27(28)17-22-45(34)36(48)30-23-46(42-41-30)32-10-6-8-29(38)33(32)39/h5-14,23,26,34H,2-4,15-22H2,1H3,(H,40,47)	OGIRXZYFCSDAHF-UHFFFAOYSA-N	335993	Ethyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(pyrrolidin-1-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 219	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335993&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601687	384988147							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662041	Cn1cc2C(N(CCc2n1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C24H19ClFN7O4/c1-31-11-15-17(29-31)9-10-32(21(15)22(34)27-14-7-5-13(6-8-14)24(36)37)23(35)18-12-33(30-28-18)19-4-2-3-16(25)20(19)26/h2-8,11-12,21H,9-10H2,1H3,(H,27,34)(H,36,37)	PNBRHWUSMQXLGG-UHFFFAOYSA-N	335994	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-2-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 220	Coagulation factor XI	Homo sapiens	 769								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335994&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601273	384988148							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662042	Cc1nn(C)c2CCN(C(C(=O)Nc3ccc(cc3)C(O)=O)c12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C25H21ClFN7O4/c1-13-20-18(32(2)30-13)10-11-33(22(20)23(35)28-15-8-6-14(7-9-15)25(37)38)24(36)17-12-34(31-29-17)19-5-3-4-16(26)21(19)27/h3-9,12,22H,10-11H2,1-2H3,(H,28,35)(H,37,38)	LNKXXEMOPNVZGM-UHFFFAOYSA-N	335995	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,3-dimethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 221	Coagulation factor XI	Homo sapiens	 179								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335995&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602368	384988149							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662043	Cc1c2C(N(CCc2nn1C)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C25H21ClFN7O4/c1-13-20-17(30-32(13)2)10-11-33(22(20)23(35)28-15-8-6-14(7-9-15)25(37)38)24(36)18-12-34(31-29-18)19-5-3-4-16(26)21(19)27/h3-9,12,22H,10-11H2,1-2H3,(H,28,35)(H,37,38)	LPSATGNYPUSCRA-UHFFFAOYSA-N	335996	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-2,3-dimethyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 222	Coagulation factor XI	Homo sapiens	 30.0								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335996&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602225	384988150							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662044	CC(C)c1nnc2C(N(CCn12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C25H22ClFN8O4/c1-13(2)21-30-31-22-20(23(36)28-15-8-6-14(7-9-15)25(38)39)33(10-11-34(21)22)24(37)17-12-35(32-29-17)18-5-3-4-16(26)19(18)27/h3-9,12-13,20H,10-11H2,1-2H3,(H,28,36)(H,38,39)	UNPXKQNGNGYHMC-UHFFFAOYSA-N	335997	4-(7-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-3-isopropyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-8-carboxamido)benzoic acid::US9738655, Example 223	Coagulation factor XI	Homo sapiens	 2630								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335997&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348885	384988151							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662045	COC(C)(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClFN5O5/c1-36(2,48-3)24-14-17-41(18-15-24)29-8-4-6-27-26(29)16-19-42(32(27)33(44)40-25-12-10-22(11-13-25)35(46)47)34(45)23-20-39-43(21-23)30-9-5-7-28(37)31(30)38/h4-13,20-21,24,32H,14-19H2,1-3H3,(H,40,44)(H,46,47)	KOIPMQRRUHXKHA-UHFFFAOYSA-N	335998	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-methoxypropan-2-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 224	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335998&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602371	384988152							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662046	CC(CO)(CO)COC(C)(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C40H45ClFN5O7/c1-39(2,54-24-40(3,22-48)23-49)27-14-17-45(18-15-27)32-8-4-6-30-29(32)16-19-46(35(30)36(50)44-28-12-10-25(11-13-28)38(52)53)37(51)26-20-43-47(21-26)33-9-5-7-31(41)34(33)42/h4-13,20-21,27,35,48-49H,14-19,22-24H2,1-3H3,(H,44,50)(H,52,53)	LYLYQCQXDDERQN-UHFFFAOYSA-N	336000	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-(3-hydroxy-2-(hydroxymethyl)-2-methylpropoxy)propan-2-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 225	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336000&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626341	384988154							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662047	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C33H31ClFN7O5/c34-25-4-2-6-28(29(25)35)42-17-26(37-38-42)32(44)41-12-11-23-24(30(41)31(43)36-21-9-7-20(8-10-21)33(45)46)3-1-5-27(23)40-15-13-39(14-16-40)22-18-47-19-22/h1-10,17,22,30H,11-16,18-19H2,(H,36,43)(H,45,46)	OEFZJAZPDZGMHT-UHFFFAOYSA-N	336001	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 226	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336001&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602149	384988155							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662048	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C34H33ClFN5O6/c35-26-5-1-4-25(30(26)36)27-17-29(47-38-27)33(43)41-12-11-23-24(31(41)32(42)37-21-9-7-20(8-10-21)34(44)45)3-2-6-28(23)40-15-13-39(14-16-40)22-18-46-19-22/h1-10,22,29,31H,11-19H2,(H,37,42)(H,44,45)/t29-,31+/m1/s1	HSMSBYWOGCQATQ-VEEOACQBSA-N	336002	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 227	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336002&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602241	384988156							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662049	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C34H33ClFN5O6/c35-26-5-1-4-25(30(26)36)27-17-29(47-38-27)33(43)41-12-11-23-24(31(41)32(42)37-21-9-7-20(8-10-21)34(44)45)3-2-6-28(23)40-15-13-39(14-16-40)22-18-46-19-22/h1-10,22,29,31H,11-19H2,(H,37,42)(H,44,45)/t29-,31-/m1/s1	HSMSBYWOGCQATQ-BVRKHOPBSA-N	336003	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 228	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336003&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601520	384988157							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662050	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H28ClF4N7O4/c33-23-4-2-6-26(27(23)34)44-17-24(39-40-44)30(46)43-12-11-21-22(28(43)29(45)38-20-9-7-19(8-10-20)31(47)48)3-1-5-25(21)42-15-13-41(14-16-42)18-32(35,36)37/h1-10,17,28H,11-16,18H2,(H,38,45)(H,47,48)	HLCWXSMXMUHDBM-UHFFFAOYSA-N	336004	4-(2-(1-(3-Chloro-2 fluorophenyl) 1H 1,2,3 triazolo-4-carbonyl) 5 (4(2,2,2 trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 229	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336004&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626281	384988158							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662051	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)C2=NOC(C2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H30ClF4N5O5/c34-24-5-1-4-23(28(24)35)27-17-25(40-48-27)31(45)43-12-11-21-22(29(43)30(44)39-20-9-7-19(8-10-20)32(46)47)3-2-6-26(21)42-15-13-41(14-16-42)18-33(36,37)38/h1-10,27,29H,11-18H2,(H,39,44)(H,46,47)/t27?,29-/m0/s1	NCKGZOIZIIDSIQ-ACEFPKFPSA-N	336005	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 230	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336005&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138805702	384988159							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662052	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H30ClF4N5O5/c34-24-5-1-4-23(28(24)35)25-17-27(48-40-25)31(45)43-12-11-21-22(29(43)30(44)39-20-9-7-19(8-10-20)32(46)47)3-2-6-26(21)42-15-13-41(14-16-42)18-33(36,37)38/h1-10,27,29H,11-18H2,(H,39,44)(H,46,47)/t27-,29-/m1/s1	OFIYZOXNLSDWIA-XRKRLSELSA-N	336006	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 231	Coagulation factor XI	Homo sapiens	 136								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336006&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626343	384988160							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662053	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN5O6/c1-46-35(45)21-8-10-22(11-9-21)38-33(43)32-25-4-3-7-29(41-16-14-40(15-17-41)23-19-47-20-23)24(25)12-13-42(32)34(44)30-18-28(39-48-30)26-5-2-6-27(36)31(26)37/h2-11,23,30,32H,12-20H2,1H3,(H,38,43)/t30-,32+/m1/s1	WYNQUZLUOKMEBB-BHYZAODMSA-N	336007	Methyl 4-((S)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 232	Coagulation factor XI	Homo sapiens	 4132								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336007&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602131	384988161							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662054	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN5O6/c1-46-35(45)21-8-10-22(11-9-21)38-33(43)32-25-4-3-7-29(41-16-14-40(15-17-41)23-19-47-20-23)24(25)12-13-42(32)34(44)30-18-28(39-48-30)26-5-2-6-27(36)31(26)37/h2-11,23,30,32H,12-20H2,1H3,(H,38,43)/t30-,32-/m1/s1	WYNQUZLUOKMEBB-XLJNKUFUSA-N	336008	Methyl 4-((R)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 233	Coagulation factor XI	Homo sapiens	 5.45								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336008&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626342	384988162							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662055	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H34ClFN4O6/c36-27-5-1-4-26(31(27)37)28-17-30(47-39-28)34(43)41-16-13-24-25(32(41)33(42)38-23-9-7-21(8-10-23)35(44)45)3-2-6-29(24)40-14-11-20(12-15-40)22-18-46-19-22/h1-10,20,22,30,32H,11-19H2,(H,38,42)(H,44,45)/t30-,32+/m1/s1	QWULNBLKJBJATC-BHYZAODMSA-N	336009	4-((1S)-2-(3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 234	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336009&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626284	384988163							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662056	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccccc1F	InChI=1S/C32H31ClF2N4O4/c1-42-19-12-15-38(16-13-19)27-11-5-6-21-20(27)14-17-39(30(21)31(40)36-25-10-3-2-9-24(25)34)32(41)28-18-26(37-43-28)22-7-4-8-23(33)29(22)35/h2-11,19,28,30H,12-18H2,1H3,(H,36,40)/t28-,30+/m1/s1	FBKZJUBYSKDARQ-DGPALRBDSA-N	336010	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(2-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 235	Coagulation factor XI	Homo sapiens	 23.2								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336010&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348911	384988164							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662057	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccccc1F	InChI=1S/C32H31ClF2N4O4/c1-42-19-12-15-38(16-13-19)27-11-5-6-21-20(27)14-17-39(30(21)31(40)36-25-10-3-2-9-24(25)34)32(41)28-18-26(37-43-28)22-7-4-8-23(33)29(22)35/h2-11,19,28,30H,12-18H2,1H3,(H,36,40)/t28-,30-/m1/s1	FBKZJUBYSKDARQ-PQHLKRTFSA-N	336011	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(2-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 236	Coagulation factor XI	Homo sapiens	 454								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336011&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348975	384988165							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662058	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccc(F)c1	InChI=1S/C32H31ClF2N4O4/c1-42-21-11-14-38(15-12-21)27-10-4-7-23-22(27)13-16-39(30(23)31(40)36-20-6-2-5-19(34)17-20)32(41)28-18-26(37-43-28)24-8-3-9-25(33)29(24)35/h2-10,17,21,28,30H,11-16,18H2,1H3,(H,36,40)/t28-,30+/m1/s1	QVDOEOXJZQAZPB-DGPALRBDSA-N	336012	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(3-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 237	Coagulation factor XI	Homo sapiens	 15.3								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336012&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348869	384988166							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662059	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccc(F)c1	InChI=1S/C32H31ClF2N4O4/c1-42-21-11-14-38(15-12-21)27-10-4-7-23-22(27)13-16-39(30(23)31(40)36-20-6-2-5-19(34)17-20)32(41)28-18-26(37-43-28)24-8-3-9-25(33)29(24)35/h2-10,17,21,28,30H,11-16,18H2,1H3,(H,36,40)/t28-,30-/m1/s1	QVDOEOXJZQAZPB-PQHLKRTFSA-N	336013	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(3-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 238	Coagulation factor XI	Homo sapiens	 635								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336013&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348871	384988167							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662060	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C32H31ClF2N4O4/c1-42-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(34)9-11-20)32(41)28-18-26(37-43-28)24-5-2-6-25(33)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)/t28-,30+/m1/s1	XEUVRDLOIIIIHG-DGPALRBDSA-N	336014	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(4-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 239	Coagulation factor XI	Homo sapiens	 6.48								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336014&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348952	384988168							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662061	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C32H31ClF2N4O4/c1-42-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(34)9-11-20)32(41)28-18-26(37-43-28)24-5-2-6-25(33)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)/t28-,30-/m1/s1	XEUVRDLOIIIIHG-PQHLKRTFSA-N	336015	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(4-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 240	Coagulation factor XI	Homo sapiens	 175								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336015&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348765	384988169							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662062	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccnc1	InChI=1S/C31H31ClFN5O4/c1-41-20-10-14-37(15-11-20)26-9-3-6-22-21(26)12-16-38(29(22)30(39)35-19-5-4-13-34-18-19)31(40)27-17-25(36-42-27)23-7-2-8-24(32)28(23)33/h2-9,13,18,20,27,29H,10-12,14-17H2,1H3,(H,35,39)/t27-,29+/m1/s1	BKEBYDDMOGLBNQ-PXJZQJOASA-N	336016	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-N- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 241	Coagulation factor XI	Homo sapiens	 8.78								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336016&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348835	384988170							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662063	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccnc1	InChI=1S/C31H31ClFN5O4/c1-41-20-10-14-37(15-11-20)26-9-3-6-22-21(26)12-16-38(29(22)30(39)35-19-5-4-13-34-18-19)31(40)27-17-25(36-42-27)23-7-2-8-24(32)28(23)33/h2-9,13,18,20,27,29H,10-12,14-17H2,1H3,(H,35,39)/t27-,29-/m1/s1	BKEBYDDMOGLBNQ-XRKRLSELSA-N	336017	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-N- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 242	Coagulation factor XI	Homo sapiens	 188								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336017&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348810	384988171							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662064	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1F)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-19-10-13-39(14-11-19)27-7-3-4-21-20(27)12-15-40(30(21)31(41)37-25-9-8-18(33(43)44)16-24(25)35)32(42)28-17-26(38-46-28)22-5-2-6-23(34)29(22)36/h2-9,16,19,28,30H,10-15,17H2,1H3,(H,37,41)(H,43,44)/t28-,30+/m1/s1	BRVVKZBEEFTKFV-DGPALRBDSA-N	336018	4-((S)-2-((R)-3-(3- chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide)-3- fluorobenzoic acid, TFA salt::US9738655, Example 243	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336018&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360916	384988172							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662065	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1F)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-19-10-13-39(14-11-19)27-7-3-4-21-20(27)12-15-40(30(21)31(41)37-25-9-8-18(33(43)44)16-24(25)35)32(42)28-17-26(38-46-28)22-5-2-6-23(34)29(22)36/h2-9,16,19,28,30H,10-15,17H2,1H3,(H,37,41)(H,43,44)/t28-,30-/m1/s1	BRVVKZBEEFTKFV-PQHLKRTFSA-N	336019	4-((R)-2-((R)-3-(3- chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamido)-3- fluorobenzoic acid, TFA salt::US9738655, Example 244	Coagulation factor XI	Homo sapiens	 38.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336019&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348926	384988173							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662066	Cn1ncnc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H22ClFN8O4/c1-37-26(32-15-33-37)20-5-2-4-19-18(20)12-13-38(25(19)27(40)34-17-10-8-16(9-11-17)29(42)43)28(41)22-14-39(36-35-22)23-7-3-6-21(30)24(23)31/h2-11,14-15,25H,12-13H2,1H3,(H,34,40)(H,42,43)	RMAYSVYLVSTKER-UHFFFAOYSA-N	336020	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(1-methyl-1H-1,2,4-triazol-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 245	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336020&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602031	384988174							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662067	Cn1cnc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H23ClFN7O4/c1-37-14-23(33-16-37)20-4-2-5-21-19(20)12-13-38(27(21)28(40)34-18-10-8-17(9-11-18)30(42)43)29(41)24-15-39(36-35-24)25-7-3-6-22(31)26(25)32/h2-11,14-16,27H,12-13H2,1H3,(H,34,40)(H,42,43)	YIYZFYYPRWABJD-UHFFFAOYSA-N	336021	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(1-methyl-1H-imidazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 246	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336021&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602346	384988175							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662068	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-n2cnnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C29H22ClFN6O5/c30-21-5-1-4-20(25(21)31)22-13-24(42-35-22)28(39)37-12-11-18-19(3-2-6-23(18)36-14-32-33-15-36)26(37)27(38)34-17-9-7-16(8-10-17)29(40)41/h1-10,14-15,24,26H,11-13H2,(H,34,38)(H,40,41)/t24-,26+/m1/s1	VZRPGIGGABVQRY-RSXGOPAZSA-N	336022	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 247	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336022&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602032	384988176							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662069	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-n2cnnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C29H22ClFN6O5/c30-21-5-1-4-20(25(21)31)22-13-24(42-35-22)28(39)37-12-11-18-19(3-2-6-23(18)36-14-32-33-15-36)26(37)27(38)34-17-9-7-16(8-10-17)29(40)41/h1-10,14-15,24,26H,11-13H2,(H,34,38)(H,40,41)/t24-,26-/m1/s1	VZRPGIGGABVQRY-AOYPEHQESA-N	336023	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 248	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336023&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602179	384988177							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662070	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-n2cnnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C28H20ClFN8O4/c29-20-4-2-6-23(24(20)30)38-13-21(34-35-38)27(40)37-12-11-18-19(3-1-5-22(18)36-14-31-32-15-36)25(37)26(39)33-17-9-7-16(8-10-17)28(41)42/h1-10,13-15,25H,11-12H2,(H,33,39)(H,41,42)	DVVGYZRXNJAFET-UHFFFAOYSA-N	336024	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 249	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336024&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602366	384988178							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662071	Cc1ncn(n1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O5/c1-16-33-15-38(35-16)24-7-3-4-20-19(24)12-13-37(27(20)28(39)34-18-10-8-17(9-11-18)30(41)42)29(40)25-14-23(36-43-25)21-5-2-6-22(31)26(21)32/h2-11,15,25,27H,12-14H2,1H3,(H,34,39)(H,41,42)/t25-,27+/m1/s1	DKXUHQBHEBTMRA-VPUSJEBWSA-N	336025	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-1H-1,2,4-triazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 250	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336025&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602048	384988179							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662072	Cc1ncn(n1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O5/c1-16-33-15-38(35-16)24-7-3-4-20-19(24)12-13-37(27(20)28(39)34-18-10-8-17(9-11-18)30(41)42)29(40)25-14-23(36-43-25)21-5-2-6-22(31)26(21)32/h2-11,15,25,27H,12-14H2,1H3,(H,34,39)(H,41,42)/t25-,27-/m1/s1	DKXUHQBHEBTMRA-XNMGPUDCSA-N	336026	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-1H-1,2,4-triazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 251	Coagulation factor XI	Homo sapiens	 14.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336026&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602070	384988180							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662073	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(30(25)31(41)37-22-10-8-20(9-11-22)33(43)44)32(42)21-18-36-40(19-21)28-7-3-5-26(34)29(28)35/h2-11,18-19,23,30H,12-17H2,1H3,(H,37,41)(H,43,44)	RWHNCKXIRHTDDM-UHFFFAOYSA-N	336027	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 252	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336027&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348805	384988181							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662074	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-19-29(37-38-41(19)27-8-4-6-25(34)28(27)35)32(43)40-18-15-23-24(5-3-7-26(23)39-16-13-22(46-2)14-17-39)30(40)31(42)36-21-11-9-20(10-12-21)33(44)45/h3-12,22,30H,13-18H2,1-2H3,(H,36,42)(H,44,45)	DWRSBCWFVOSCSL-UHFFFAOYSA-N	336028	4-(2-(1-(3-chloro-2- fluorophenyl)-5-methyl-1H- 1,2,3-triazole-4-cabonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 253	Coagulation factor XI	Homo sapiens	 11.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336028&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348977	384988182							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662075	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClF2N6O5/c1-46-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(28(22)30(42)36-19-7-5-18(6-8-19)32(44)45)31(43)25-17-41(38-37-25)29-24(34)10-9-23(33)27(29)35/h2-10,17,20,28H,11-16H2,1H3,(H,36,42)(H,44,45)	BSVVTWVVLQCLSV-UHFFFAOYSA-N	336029	4-(2-(1-(3-chloro-2,6- difluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 254	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336029&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348855	384988183							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662076	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-46-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(31(25)32(42)37-22-10-8-20(9-11-22)34(44)45)33(43)21-18-29(41)40(19-21)28-7-3-5-26(35)30(28)36/h2-11,21,23,31H,12-19H2,1H3,(H,37,42)(H,44,45)	FVMSTJUBRSUZEY-UHFFFAOYSA-N	336030	4-(2-(1-(3-chloro-2- fluorophenyl)-5-oxopyrrolidine- 3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 255::US9738655, Example 260	Coagulation factor XI	Homo sapiens	 7.13								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336030&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348888	384988184							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662077	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,37,41)(H,43,44)	STEFBFVBPIATQL-UHFFFAOYSA-N	336031	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 256::US9738655, Example 257	Coagulation factor XI	Homo sapiens	 12.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336031&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348852	384988185							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662078	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,37,41)(H,43,44)	STEFBFVBPIATQL-UHFFFAOYSA-N	336031	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 256::US9738655, Example 257	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336031&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348852	384988185							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662079	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H37ClN4O5/c1-44-27-13-17-37(18-14-27)30-7-3-6-29-28(30)15-19-39(31(29)32(40)36-25-10-8-22(9-11-25)34(42)43)33(41)23-12-16-38(21-23)26-5-2-4-24(35)20-26/h2-11,20,23,27,31H,12-19,21H2,1H3,(H,36,40)(H,42,43)	SDSUGQWNKGNWPZ-UHFFFAOYSA-N	336033	4-(2-(1-(3-chlorophenyl) pyrrolidine-3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 258::US9738655, Example 261	Coagulation factor XI	Homo sapiens	 127								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336033&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348789	384988186							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662080	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN5O5/c1-20-26(19-37-41(20)29-8-4-6-27(35)30(29)36)33(43)40-18-15-24-25(5-3-7-28(24)39-16-13-23(46-2)14-17-39)31(40)32(42)38-22-11-9-21(10-12-22)34(44)45/h3-12,19,23,31H,13-18H2,1-2H3,(H,38,42)(H,44,45)	UCDVYJZKTAJIGN-UHFFFAOYSA-N	336034	4-(2-(1-(3-chloro-2- fluorophenyl)-5-methyl-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 259	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336034&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348864	384988187							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662081	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-46-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(31(25)32(42)37-22-10-8-20(9-11-22)34(44)45)33(43)21-18-29(41)40(19-21)28-7-3-5-26(35)30(28)36/h2-11,21,23,31H,12-19H2,1H3,(H,37,42)(H,44,45)	FVMSTJUBRSUZEY-UHFFFAOYSA-N	336030	4-(2-(1-(3-chloro-2- fluorophenyl)-5-oxopyrrolidine- 3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 255::US9738655, Example 260	Coagulation factor XI	Homo sapiens	 2463								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336030&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348888	384988184							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662082	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H37ClN4O5/c1-44-27-13-17-37(18-14-27)30-7-3-6-29-28(30)15-19-39(31(29)32(40)36-25-10-8-22(9-11-25)34(42)43)33(41)23-12-16-38(21-23)26-5-2-4-24(35)20-26/h2-11,20,23,27,31H,12-19,21H2,1H3,(H,36,40)(H,42,43)	SDSUGQWNKGNWPZ-UHFFFAOYSA-N	336033	4-(2-(1-(3-chlorophenyl) pyrrolidine-3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 258::US9738655, Example 261	Coagulation factor XI	Homo sapiens	 948								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336033&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348789	384988186							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662083	CC(C)(O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H36ClFN4O6/c1-35(2,46)21-13-16-40(17-14-21)28-8-4-5-24-23(28)15-18-41(31(24)32(42)38-22-11-9-20(10-12-22)34(44)45)33(43)29-19-27(39-47-29)25-6-3-7-26(36)30(25)37/h3-12,21,29,31,46H,13-19H2,1-2H3,(H,38,42)(H,44,45)	CBUOZCLOWILCLC-UHFFFAOYSA-N	336040	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(2-hydroxypropan-2- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 262::US9738655, Example 263	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336040&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348803	384988191							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662084	CC(C)(O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H36ClFN4O6/c1-35(2,46)21-13-16-40(17-14-21)28-8-4-5-24-23(28)15-18-41(31(24)32(42)38-22-11-9-20(10-12-22)34(44)45)33(43)29-19-27(39-47-29)25-6-3-7-26(36)30(25)37/h3-12,21,29,31,46H,13-19H2,1-2H3,(H,38,42)(H,44,45)	CBUOZCLOWILCLC-UHFFFAOYSA-N	336040	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(2-hydroxypropan-2- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 262::US9738655, Example 263	Coagulation factor XI	Homo sapiens	 11.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336040&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348803	384988191							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662085	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nc1O)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O6/c1-46-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)31(42)36-20-10-8-19(9-11-20)33(44)45)32(43)24-18-40(37-30(24)41)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,42)(H,37,41)(H,44,45)	JHRMBOAVPWDUPH-UHFFFAOYSA-N	336042	4-(2-(1-(3-chloro-2- fluorophenyl)-3-hydroxy-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 264	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336042&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348797	384988192							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662086	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,17,20,30H,11-16H2,1H3,(H,37,41)(H,43,44)	DPNLDCMWYAQGGL-UHFFFAOYSA-N	336043	4-(2-(3-(3-chloro-2,6- difluorophenyl)isoxazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 265	Coagulation factor XI	Homo sapiens	 13.2								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336043&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348968	384988193							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662087	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1(C)CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-34(19-27(38-46-34)25-6-3-7-26(35)29(25)36)33(44)40-18-15-23-24(5-4-8-28(23)39-16-13-22(45-2)14-17-39)30(40)31(41)37-21-11-9-20(10-12-21)32(42)43/h3-12,22,30H,13-19H2,1-2H3,(H,37,41)(H,42,43)	FQAXKURWFFUWDN-UHFFFAOYSA-N	336044	4-(2-(3-(3-chloro-2- fluorophenyl)-5-methyl-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 266::US9738655, Example 267	Coagulation factor XI	Homo sapiens	 420								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336044&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348791	384988194							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662088	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1(C)CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-34(19-27(38-46-34)25-6-3-7-26(35)29(25)36)33(44)40-18-15-23-24(5-4-8-28(23)39-16-13-22(45-2)14-17-39)30(40)31(41)37-21-11-9-20(10-12-21)32(42)43/h3-12,22,30H,13-19H2,1-2H3,(H,37,41)(H,42,43)	FQAXKURWFFUWDN-UHFFFAOYSA-N	336044	4-(2-(3-(3-chloro-2- fluorophenyl)-5-methyl-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 266::US9738655, Example 267	Coagulation factor XI	Homo sapiens	 103								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336044&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348791	384988194							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662089	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,18,21,30H,12-17H2,1H3,(H,36,40)(H,42,43)	FYOLOKHABDOZTA-UHFFFAOYSA-N	336046	4-(2-(3-(3-chloro-2- fluorophenyl)isoxazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 268	Coagulation factor XI	Homo sapiens	 1428								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336046&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348848	384988195							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662090	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(ns1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O5S/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,18,21,30H,12-17H2,1H3,(H,36,40)(H,42,43)	ZBMLIFNYLFHWTC-UHFFFAOYSA-N	336047	4-(2-(3-(3-chloro-2- fluorophenyl)isothiazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 269	Coagulation factor XI	Homo sapiens	 33.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336047&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348829	384988196							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662091	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnc(s1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O5S/c1-44-21-12-15-38(16-13-21)26-7-3-4-23-22(26)14-17-39(29(23)30(40)37-20-10-8-19(9-11-20)33(42)43)32(41)27-18-36-31(45-27)24-5-2-6-25(34)28(24)35/h2-11,18,21,29H,12-17H2,1H3,(H,37,40)(H,42,43)	VPZJMGJFKCWLAF-UHFFFAOYSA-N	336048	4-(2-(2-(3-chloro-2- fluorophenyl)thiazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 270	Coagulation factor XI	Homo sapiens	 20.4								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336048&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348782	384988197							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662092	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)	FBWNGNXFIOJJRU-UHFFFAOYSA-N	336049	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 271	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336049&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348773	384988198							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662093	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m1/s1	FBWNGNXFIOJJRU-SSEXGKCCSA-N	336050	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 272	Coagulation factor XI	Homo sapiens	 976								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336050&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348867	384988199							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662094	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m0/s1	FBWNGNXFIOJJRU-PMERELPUSA-N	336051	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid, TFA salt::US9738655, Example 273	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336051&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360909	384988200							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662095	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)	ZHBIFHSCHDUCTJ-UHFFFAOYSA-N	336052	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 274	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336052&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348843	384988201							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662096	COc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H21ClFN5O5/c1-39-22-7-2-4-18-17(22)12-13-33(24(18)25(35)30-16-10-8-15(9-11-16)27(37)38)26(36)20-14-34(32-31-20)21-6-3-5-19(28)23(21)29/h2-11,14,24H,12-13H2,1H3,(H,30,35)(H,37,38)	LBKUAODILILVMN-UHFFFAOYSA-N	336053	4-(2-(1-(3-chloro-2- fluoroplienyl)-1H-1,2,3-triazole- 4-carbonyl)-5-methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 275	Coagulation factor XI	Homo sapiens	 10.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336053&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360851	384988202							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662097	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN5O6/c1-40(2)33(44)20-13-16-41(17-14-20)28-8-4-5-24-23(28)15-18-42(31(24)32(43)38-22-11-9-21(10-12-22)35(46)47)34(45)29-19-27(39-48-29)25-6-3-7-26(36)30(25)37/h3-12,20,29,31H,13-19H2,1-2H3,(H,38,43)(H,46,47)	KSKNDDJIIWDYJR-UHFFFAOYSA-N	336054	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(dimethylcarbamoyl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 278::US9738655, Example 279	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336054&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348906	384988203							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662098	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN5O6/c1-40(2)33(44)20-13-16-41(17-14-20)28-8-4-5-24-23(28)15-18-42(31(24)32(43)38-22-11-9-21(10-12-22)35(46)47)34(45)29-19-27(39-48-29)25-6-3-7-26(36)30(25)37/h3-12,20,29,31H,13-19H2,1-2H3,(H,38,43)(H,46,47)	KSKNDDJIIWDYJR-UHFFFAOYSA-N	336054	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(dimethylcarbamoyl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 278::US9738655, Example 279	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336054&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348906	384988203							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662099	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Coagulation factor XI	Homo sapiens	 36.5								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662100	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Coagulation factor XI	Homo sapiens	 12.8								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662101	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662102	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Coagulation factor XI	Homo sapiens	 8.27								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662103	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H28ClFN6O5/c1-37-14-15-38(17-27(37)41)25-6-2-4-22-21(25)12-13-40(29(22)30(42)36-20-10-8-19(9-11-20)32(44)45)31(43)24-16-39(18-35-24)26-7-3-5-23(33)28(26)34/h2-11,16,18,29H,12-15,17H2,1H3,(H,36,42)(H,44,45)	HZAQQZFPWMLEIS-UHFFFAOYSA-N	336061	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 284	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336061&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348764	384988206							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662104	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)/t29-/m0/s1	OERFGGVKNYUNRK-LJAQVGFWSA-N	336062	(S)-4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 285	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336062&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348858	384988207							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662105	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)/t29-/m1/s1	OERFGGVKNYUNRK-GDLZYMKVSA-N	336063	(R)-4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 286	Coagulation factor XI	Homo sapiens	 266								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336063&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348884	384988208							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662106	CN1CCN(CC1=O)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m0/s1	ZHBIFHSCHDUCTJ-NDEPHWFRSA-N	336064	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperizin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 287	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336064&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360859	384988209							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662107	CN1CCN(CC1=O)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m1/s1	ZHBIFHSCHDUCTJ-MUUNZHRXSA-N	336065	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 288	Coagulation factor XI	Homo sapiens	 155								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336065&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348969	384988210							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662108	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN4O7/c32-22-5-1-4-21(27(22)33)23-15-25(44-35-23)30(40)37-12-11-19-20(3-2-6-24(19)36-13-14-43-16-26(36)38)28(37)29(39)34-18-9-7-17(8-10-18)31(41)42/h1-10,25,28H,11-16H2,(H,34,39)(H,41,42)/t25-,28+/m1/s1	HUJNCDQHFCQWPY-NAKRPHOHSA-N	336066	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (3-oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,::US9738655, Example 289	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336066&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348866	384988211							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662109	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN4O7/c32-22-5-1-4-21(27(22)33)23-15-25(44-35-23)30(40)37-12-11-19-20(3-2-6-24(19)36-13-14-43-16-26(36)38)28(37)29(39)34-18-9-7-17(8-10-18)31(41)42/h1-10,25,28H,11-16H2,(H,34,39)(H,41,42)/t25-,28-/m1/s1	HUJNCDQHFCQWPY-LEAFIULHSA-N	336067	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (3-oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 290	Coagulation factor XI	Homo sapiens	 13.4								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336067&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360801	384988212							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662110	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCCCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H30ClFN4O5/c33-24-8-4-7-23(28(24)34)25-18-27(43-36-25)31(40)38-17-14-21-22(6-5-9-26(21)37-15-2-1-3-16-37)29(38)30(39)35-20-12-10-19(11-13-20)32(41)42/h4-13,27,29H,1-3,14-18H2,(H,35,39)(H,41,42)/t27-,29+/m1/s1	DZKVUSJHEHTSJV-PXJZQJOASA-N	336068	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 291	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336068&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348895	384988213							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662111	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCCCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H30ClFN4O5/c33-24-8-4-7-23(28(24)34)25-18-27(43-36-25)31(40)38-17-14-21-22(6-5-9-26(21)37-15-2-1-3-16-37)29(38)30(39)35-20-12-10-19(11-13-20)32(41)42/h4-13,27,29H,1-3,14-18H2,(H,35,39)(H,41,42)/t27-,29-/m1/s1	DZKVUSJHEHTSJV-XRKRLSELSA-N	336069	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid, TFA salt::US9738655, Example 292	Coagulation factor XI	Homo sapiens	 154								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336069&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360773	384988214							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662112	COc1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H23ClFN3O6/c1-38-22-7-3-4-18-17(22)12-13-33(25(18)26(34)31-16-10-8-15(9-11-16)28(36)37)27(35)23-14-21(32-39-23)19-5-2-6-20(29)24(19)30/h2-11,23,25H,12-14H2,1H3,(H,31,34)(H,36,37)/t23-,25+/m1/s1	JMRJXBGKNVHKIB-NOZRDPDXSA-N	336070	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid::US9738655, Example 293	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336070&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360914	384988215							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662113	COc1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H23ClFN3O6/c1-38-22-7-3-4-18-17(22)12-13-33(25(18)26(34)31-16-10-8-15(9-11-16)28(36)37)27(35)23-14-21(32-39-23)19-5-2-6-20(29)24(19)30/h2-11,23,25H,12-14H2,1H3,(H,31,34)(H,36,37)/t23-,25-/m1/s1	JMRJXBGKNVHKIB-ILBGXUMGSA-N	336071	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 294	Coagulation factor XI	Homo sapiens	 73.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336071&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348787	384988216							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662114	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN4O6/c32-23-5-1-4-22(27(23)33)24-17-26(43-35-24)30(39)37-12-11-20-21(3-2-6-25(20)36-13-15-42-16-14-36)28(37)29(38)34-19-9-7-18(8-10-19)31(40)41/h1-10,26,28H,11-17H2,(H,34,38)(H,40,41)/t26-,28+/m1/s1	OUHGEEOLVXEYAO-IAPPQJPRSA-N	336072	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- morpholino-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 295	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336072&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348932	384988217							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662115	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN4O6/c32-23-5-1-4-22(27(23)33)24-17-26(43-35-24)30(39)37-12-11-20-21(3-2-6-25(20)36-13-15-42-16-14-36)28(37)29(38)34-19-9-7-18(8-10-19)31(40)41/h1-10,26,28H,11-17H2,(H,34,38)(H,40,41)/t26-,28-/m1/s1	OUHGEEOLVXEYAO-IXCJQBJRSA-N	336073	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- morpholino-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 296	Coagulation factor XI	Homo sapiens	 24.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336073&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121360852	384988218							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662116	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)c(Cl)ccc1C(F)(F)F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF4N4O6/c1-48-20-11-14-42(15-12-20)26-4-2-3-22-21(26)13-16-43(30(22)31(44)40-19-7-5-18(6-8-19)33(46)47)32(45)27-17-25(41-49-27)28-23(34(37,38)39)9-10-24(35)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,40,44)(H,46,47)	YCGVFCIHVNNBFQ-UHFFFAOYSA-N	336074	4-(2-(3-(3-chloro-2-fluoro-6- (trifluoromethyl)phenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 297::US9738655, Example 298	Coagulation factor XI	Homo sapiens	 46.3								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336074&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348831	384988219							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662117	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)c(Cl)ccc1C(F)(F)F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF4N4O6/c1-48-20-11-14-42(15-12-20)26-4-2-3-22-21(26)13-16-43(30(22)31(44)40-19-7-5-18(6-8-19)33(46)47)32(45)27-17-25(41-49-27)28-23(34(37,38)39)9-10-24(35)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,40,44)(H,46,47)	YCGVFCIHVNNBFQ-UHFFFAOYSA-N	336074	4-(2-(3-(3-chloro-2-fluoro-6- (trifluoromethyl)phenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 297::US9738655, Example 298	Coagulation factor XI	Homo sapiens	 64.8								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336074&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348831	384988219							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662118	CO[C@@H]1CCN(C1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c1-43-20-12-14-37(17-20)26-7-3-4-22-21(26)13-15-38(29(22)30(39)35-19-10-8-18(9-11-19)32(41)42)31(40)27-16-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,20,27,29H,12-17H2,1H3,(H,35,39)(H,41,42)/t20-,27-,29-/m1/s1	HRMKSRKSQRTIIL-VXLYDYDQSA-N	336076	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- ((R)-3-methoxypyrrolidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 299	Coagulation factor XI	Homo sapiens	 62.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336076&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348839	384988220							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662119	CO[C@@H]1CCN(C1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c1-43-20-12-14-37(17-20)26-7-3-4-22-21(26)13-15-38(29(22)30(39)35-19-10-8-18(9-11-19)32(41)42)31(40)27-16-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,20,27,29H,12-17H2,1H3,(H,35,39)(H,41,42)/t20-,27-,29+/m1/s1	HRMKSRKSQRTIIL-LEFTWQHSSA-N	336077	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- ((R)-3-methoxypyrrolidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 300	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336077&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348794	384988221							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662120	OC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c33-24-5-1-4-23(28(24)34)25-17-27(44-36-25)31(41)38-16-13-21-22(3-2-6-26(21)37-14-11-20(39)12-15-37)29(38)30(40)35-19-9-7-18(8-10-19)32(42)43/h1-10,20,27,29,39H,11-17H2,(H,35,40)(H,42,43)/t27-,29+/m1/s1	YTMXOUJHZITLIA-PXJZQJOASA-N	336078	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-hydroxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 301	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336078&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348833	384988222							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662121	OC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c33-24-5-1-4-23(28(24)34)25-17-27(44-36-25)31(41)38-16-13-21-22(3-2-6-26(21)37-14-11-20(39)12-15-37)29(38)30(40)35-19-9-7-18(8-10-19)32(42)43/h1-10,20,27,29,39H,11-17H2,(H,35,40)(H,42,43)/t27-,29-/m1/s1	YTMXOUJHZITLIA-XRKRLSELSA-N	336079	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-hydroxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 302	Coagulation factor XI	Homo sapiens	 81.7								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336079&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348938	384988223							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662122	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Coagulation factor XI	Homo sapiens	 659								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662123	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Coagulation factor XI	Homo sapiens	 24.2								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662124	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662125	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H36ClFN4O5/c1-45-24-13-17-38(18-14-24)28-6-2-4-26-25(28)15-19-40(31(26)32(41)37-23-10-8-21(9-11-23)34(43)44)33(42)22-12-16-39(20-22)29-7-3-5-27(35)30(29)36/h2-11,22,24,31H,12-20H2,1H3,(H,37,41)(H,43,44)	XXEHXWAALBKPOQ-UHFFFAOYSA-N	336083	4-(2-(1-(3-Chloro-2-fluorophenyl)pyrrolidine-3-carbonyl) 5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 307::US9738655, Example 308	Coagulation factor XI	Homo sapiens	 165								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336083&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601967	384988225							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662126	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H36ClFN4O5/c1-45-24-13-17-38(18-14-24)28-6-2-4-26-25(28)15-19-40(31(26)32(41)37-23-10-8-21(9-11-23)34(43)44)33(42)22-12-16-39(20-22)29-7-3-5-27(35)30(29)36/h2-11,22,24,31H,12-20H2,1H3,(H,37,41)(H,43,44)	XXEHXWAALBKPOQ-UHFFFAOYSA-N	336083	4-(2-(1-(3-Chloro-2-fluorophenyl)pyrrolidine-3-carbonyl) 5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 307::US9738655, Example 308	Coagulation factor XI	Homo sapiens	 6.03								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336083&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601967	384988225							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662127	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)	OERFGGVKNYUNRK-UHFFFAOYSA-N	336085	4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 309	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336085&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348841	384988226							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662128	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1coc(n1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(29(23)30(40)36-20-10-8-19(9-11-20)33(42)43)32(41)26-18-45-31(37-26)24-5-2-6-25(34)28(24)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,40)(H,42,43)	DSJQQMSCVFIBAC-UHFFFAOYSA-N	336086	4-(2-(2-(3-chloro-2- fluorophenyl)oxazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline- 1-carboxamido)benzoic acid, TFA salt::US9738655, Example 310	Coagulation factor XI	Homo sapiens	 82.0								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336086&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348778	384988227							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662129	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(n[nH]1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O			336087	4-(2-(3-(3-chlorophenyl)-1H- pyrazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 311::US9738655, Example 316	Coagulation factor XI	Homo sapiens	 18.4								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336087&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752707	384988228							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662130	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClF2N5O5/c1-46-21-11-14-39(15-12-21)27-4-2-3-23-22(27)13-16-41(29(23)31(42)38-20-7-5-19(6-8-20)33(44)45)32(43)26-17-40(18-37-26)30-25(35)10-9-24(34)28(30)36/h2-10,17-18,21,29H,11-16H2,1H3,(H,38,42)(H,44,45)	NUPTVFLTOJMODJ-UHFFFAOYSA-N	336088	4-(2-(1-(3-chloro-2,6- difluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 312	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336088&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348774	384988229							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662131	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1ccncc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H33N7O5/c1-44-23-11-16-37(17-12-23)27-4-2-3-25-24(27)13-18-38(28(25)30(40)36-21-7-5-20(6-8-21)32(42)43)31(41)26-19-35-39(29(26)33)22-9-14-34-15-10-22/h2-10,14-15,19,23,28H,11-13,16-18,33H2,1H3,(H,36,40)(H,42,43)	MIVMVOVFTPYYTQ-UHFFFAOYSA-N	336089	4-(2-(5-amino-1-(pyridin-4-yl)- 1H-pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 313	Coagulation factor XI	Homo sapiens	 4823								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336089&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348806	384988230							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662132	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-45-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)30(41)35-20-10-8-19(9-11-20)32(43)44)31(42)25-18-40(37-36-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H,35,41)(H,43,44)/t29-/m0/s1	AVKKDSOYYJOTLE-LJAQVGFWSA-N	336090	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 314	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336090&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348916	384988231							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662133	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(30(25)31(41)37-22-10-8-20(9-11-22)33(43)44)32(42)21-18-36-40(19-21)28-7-3-5-26(34)29(28)35/h2-11,18-19,23,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m0/s1	RWHNCKXIRHTDDM-PMERELPUSA-N	336091	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 315	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336091&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348804	384988232							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662134	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(n[nH]1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O			336087	4-(2-(3-(3-chlorophenyl)-1H- pyrazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 311::US9738655, Example 316	Coagulation factor XI	Homo sapiens	 42.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336087&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752707	384988228							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662135	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN7O5/c1-41(2)33(46)20-13-16-42(17-14-20)27-7-3-5-24-23(27)15-18-43(30(24)32(45)40-22-11-9-21(10-12-22)35(48)49)34(47)25-19-39-44(31(25)38)28-8-4-6-26(36)29(28)37/h3-12,19-20,30H,13-18,38H2,1-2H3,(H,40,45)(H,48,49)	LWVFYGGVTSBNPF-UHFFFAOYSA-N	336093	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(dimethylcarbamoyl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 317	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336093&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602265	384988233							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662136	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN7O5/c1-38-14-15-39(17-26(38)42)24-6-2-4-21-20(24)12-13-40(28(21)30(43)37-19-10-8-18(9-11-19)32(45)46)31(44)22-16-36-41(29(22)35)25-7-3-5-23(33)27(25)34/h2-11,16,28H,12-15,17,35H2,1H3,(H,37,43)(H,45,46)	KXECQFQEVMSQTL-UHFFFAOYSA-N	336094	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-methyl-3-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 318	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336094&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601538	384988234							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662137	CN(C)CCOC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H39ClFN7O5/c1-42(2)19-20-50-24-13-16-43(17-14-24)29-7-3-5-26-25(29)15-18-44(32(26)34(46)41-23-11-9-22(10-12-23)36(48)49)35(47)27-21-40-45(33(27)39)30-8-4-6-28(37)31(30)38/h3-12,21,24,32H,13-20,39H2,1-2H3,(H,41,46)(H,48,49)	RLBBCCQWYWHBBU-UHFFFAOYSA-N	336095	4-(2-(3-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-(dimethylamino)ethoxy)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 319	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336095&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602078	384988235							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662138	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H32ClN5O4/c1-38-14-16-39(17-15-38)30-7-3-6-29-28(30)12-13-40(31(29)32(41)37-27-10-8-22(9-11-27)34(43)44)33(42)25-18-24(20-36-21-25)23-4-2-5-26(35)19-23/h2-11,18-21,31H,12-17H2,1H3,(H,37,41)(H,43,44)	HPPADHZZFREPQU-UHFFFAOYSA-N	336096	4-(2-(5-(3-Chlorophenyl)nicotinoyl)-5-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 320	Coagulation factor XI	Homo sapiens	 158								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336096&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602034	384988236							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662139	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1ccccc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33N5O4/c1-37-16-18-38(19-17-37)30-9-5-8-29-28(30)14-15-39(31(29)32(40)36-27-12-10-24(11-13-27)34(42)43)33(41)26-20-25(21-35-22-26)23-6-3-2-4-7-23/h2-13,20-22,31H,14-19H2,1H3,(H,36,40)(H,42,43)	LOCAZELFDYLNGC-UHFFFAOYSA-N	336097	4-(5-(4-Methylpiperazin-1-yl)-2-(5-phenylnicotinoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 321::US9738655, Example 326	Coagulation factor XI	Homo sapiens	 236								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336097&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601369	384988237							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662140	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1=NC=C[N](=C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H32ClFN5O5/c1-46-23-12-16-39(17-13-23)28-6-2-4-25-24(28)14-18-41(31(25)32(42)38-22-10-8-21(9-11-22)34(44)45)33(43)27-20-40(19-15-37-27)29-7-3-5-26(35)30(29)36/h2-11,15,19-20,23,31H,12-14,16-18H2,1H3,(H,38,42)(H,44,45)	OLVDIBOPUAHCNU-UHFFFAOYSA-N	336098	4-(2-(4-(3-Chloro-2-fluorophenyl)picolinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 322	Coagulation factor XI	Homo sapiens	 8.21								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336098&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			138752708	384988238							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662141	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-25-12-15-40(16-13-25)30-7-3-5-28-27(30)14-17-41(32(28)33(42)39-24-10-8-21(9-11-24)35(44)45)34(43)23-18-22(19-38-20-23)26-4-2-6-29(36)31(26)37/h2-11,18-20,25,32H,12-17H2,1H3,(H,39,42)(H,44,45)	YTLXZIUVYLFAJM-UHFFFAOYSA-N	336099	4-(2-(5-(3-Chloro-2-fluorophenyl)nicotinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 323	Coagulation factor XI	Homo sapiens	 5.28								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336099&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601670	384988239							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662142	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1ccnc(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-24-13-17-40(18-14-24)30-7-3-4-26-25(30)15-19-41(32(26)33(42)39-23-10-8-21(9-11-23)35(44)45)34(43)22-12-16-38-29(20-22)27-5-2-6-28(36)31(27)37/h2-12,16,20,24,32H,13-15,17-19H2,1H3,(H,39,42)(H,44,45)	IDTDQUJKOQHEEX-UHFFFAOYSA-N	336100	4-(2-(2-(3-Chloro-2-fluorophenyl)isonicotinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 324	Coagulation factor XI	Homo sapiens	 37.1								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336100&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602159	384988240							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662143	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cccc(n1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-23-15-18-40(19-16-23)30-10-3-5-25-24(30)17-20-41(32(25)33(42)38-22-13-11-21(12-14-22)35(44)45)34(43)29-9-4-8-28(39-29)26-6-2-7-27(36)31(26)37/h2-14,23,32H,15-20H2,1H3,(H,38,42)(H,44,45)	MOWBZALNHWFSAX-UHFFFAOYSA-N	336101	4-(2-(6-(3-Chloro-2-fluorophenyl)picolinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 325	Coagulation factor XI	Homo sapiens	 2403								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336101&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601512	384988241							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662144	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1ccccc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33N5O4/c1-37-16-18-38(19-17-37)30-9-5-8-29-28(30)14-15-39(31(29)32(40)36-27-12-10-24(11-13-27)34(42)43)33(41)26-20-25(21-35-22-26)23-6-3-2-4-7-23/h2-13,20-22,31H,14-19H2,1H3,(H,36,40)(H,42,43)	LOCAZELFDYLNGC-UHFFFAOYSA-N	336097	4-(5-(4-Methylpiperazin-1-yl)-2-(5-phenylnicotinoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 321::US9738655, Example 326	Coagulation factor XI	Homo sapiens	 330								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336097&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601369	384988237							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662145	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1ccnc(C)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H34N6O5/c1-21-18-25(10-14-34-21)39-20-23(19-35-39)32(41)38-17-13-27-28(4-3-5-29(27)37-15-11-26(44-2)12-16-37)30(38)31(40)36-24-8-6-22(7-9-24)33(42)43/h3-10,14,18-20,26,30H,11-13,15-17H2,1-2H3,(H,36,40)(H,42,43)	UKMKWFZGYUGHDQ-UHFFFAOYSA-N	336103	4-(5-(4-Methoxypiperidin-1-yl)-2-(1-(2-methylpyridin-4-yl)-1H-pyrazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 327	Coagulation factor XI	Homo sapiens	 816								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336103&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602027	384988242							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662146	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cc(Cl)ccn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClN6O5/c1-44-24-10-14-37(15-11-24)27-4-2-3-26-25(27)12-16-38(29(26)30(40)36-23-7-5-20(6-8-23)32(42)43)31(41)21-18-35-39(19-21)28-17-22(33)9-13-34-28/h2-9,13,17-19,24,29H,10-12,14-16H2,1H3,(H,36,40)(H,42,43)	UTRAREPQGBRVSK-UHFFFAOYSA-N	336104	4-(2-(1-(5-chloropyridin-3- yl)-1H-pyrazole-4-carbonyl)- 5-(4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 328	Coagulation factor XI	Homo sapiens	 1966								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336104&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121357627	384988243							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662147	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClN5O5/c1-44-26-12-15-37(16-13-26)29-7-3-6-28-27(29)14-17-38(30(28)31(40)36-24-10-8-21(9-11-24)33(42)43)32(41)22-19-35-39(20-22)25-5-2-4-23(34)18-25/h2-11,18-20,26,30H,12-17H2,1H3,(H,36,40)(H,42,43)	RESLNCPFDIUSRS-UHFFFAOYSA-N	336105	4-(2-(1-(3-chlorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 329	Coagulation factor XI	Homo sapiens	 26.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336105&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626288	384988244							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662148	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccnc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32N6O5/c1-43-25-11-15-36(16-12-25)28-6-2-5-27-26(28)13-17-37(29(27)30(39)35-23-9-7-21(8-10-23)32(41)42)31(40)22-18-34-38(20-22)24-4-3-14-33-19-24/h2-10,14,18-20,25,29H,11-13,15-17H2,1H3,(H,35,39)(H,41,42)	CXGWBRHGBOMOMU-UHFFFAOYSA-N	336106	4-(5-(4-methoxypiperidin-1- yl)-2-(1-(pyridin-3-yl)-1H- pyrazolc-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 330	Coagulation factor XI	Homo sapiens	 3513								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336106&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626289	384988245							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662149	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1ccc2nonc2c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31N7O6/c1-45-24-11-14-38(15-12-24)29-4-2-3-26-25(29)13-16-39(30(26)31(41)35-22-7-5-20(6-8-22)33(43)44)32(42)21-18-34-40(19-21)23-9-10-27-28(17-23)37-46-36-27/h2-10,17-19,24,30H,11-16H2,1H3,(H,35,41)(H,43,44)	LPIYTZNUEQITRK-UHFFFAOYSA-N	336107	4-(2-(1-(benzo[c][1,2,5] oxadiazol-5-yl)-1H-pyrazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 331	Coagulation factor XI	Homo sapiens	 7052								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336107&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			121348853	384988246							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662150	CC(=C)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H23ClFN5O4/c1-16(2)19-5-3-6-21-20(19)13-14-35(26(21)27(37)32-18-11-9-17(10-12-18)29(39)40)28(38)23-15-36(34-33-23)24-8-4-7-22(30)25(24)31/h3-12,15,26H,1,13-14H2,2H3,(H,32,37)(H,39,40)	JCVXAUSYJPWAPW-UHFFFAOYSA-N	336108	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(prop-1-en-2-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 333	Coagulation factor XI	Homo sapiens	 18.2								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336108&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601361	384988247							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662151	Nc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C26H20ClFN6O4/c27-18-4-2-6-21(22(18)28)34-13-20(31-32-34)25(36)33-12-11-16-17(3-1-5-19(16)29)23(33)24(35)30-15-9-7-14(8-10-15)26(37)38/h1-10,13,23H,11-12,29H2,(H,30,35)(H,37,38)	XWNDSMYHTNPVSM-UHFFFAOYSA-N	336109	4-(5-Amino-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 334	Coagulation factor XI	Homo sapiens	 10.6								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336109&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117602158	384988248							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662152	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C32H31ClFN7O4/c1-45-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(43)36-20-10-8-19(9-11-20)30(35)42)32(44)25-18-41(38-37-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H2,35,42)(H,36,43)	QYVCEYOGBUMRBR-UHFFFAOYSA-N	336110	N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 335	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336110&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117601484	384988249							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662153	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31+/m1/s1	PULGOHDYZKUKTQ-MVSFAKPFSA-N	336111	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 336	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336111&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626262	384988250							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662154	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31-/m1/s1	PULGOHDYZKUKTQ-GRKNLSHJSA-N	336112	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 337	Coagulation factor XI	Homo sapiens	 27.9								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336112&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626318	384988251							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662155	Cc1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClFN7O5/c1-18-37-38-28-17-40(14-15-41(18)28)26-7-3-4-22-21(26)12-13-42(30(22)31(43)36-20-10-8-19(9-11-20)33(45)46)32(44)27-16-25(39-47-27)23-5-2-6-24(34)29(23)35/h2-11,27,30H,12-17H2,1H3,(H,36,43)(H,45,46)/t27-,30+/m1/s1	QNQFMFYHIZXXRE-OFSOJUDTSA-N	336113	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 340	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336113&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626347	384988252							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662156	Cc1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClFN7O5/c1-18-37-38-28-17-40(14-15-41(18)28)26-7-3-4-22-21(26)12-13-42(30(22)31(43)36-20-10-8-19(9-11-20)33(45)46)32(44)27-16-25(39-47-27)23-5-2-6-24(34)29(23)35/h2-11,27,30H,12-17H2,1H3,(H,36,43)(H,45,46)/t27-,30-/m1/s1	QNQFMFYHIZXXRE-POURPWNDSA-N	336114	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 341	Coagulation factor XI	Homo sapiens	<5.00								US Patent		10.7270/Q2BG2R3R		aid1797038	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1357&target=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336114&enzyme=Coagulation+factor+XI&column=ki&startPg=0&Increment=50&submit=Search			117626234	384988253							1	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV	1XX9,2F83,2J8J,2J8L,4NA7,4NA8,5EOD,5EOK,5I25,6I58,7QOT	Coagulation factor XI	FA11_HUMAN	P03951	D3DP64 Q4W5C2 Q9Y495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662157	OC(=O)c1ccc(NC(=O)C2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)	HRLKIYSEPAYSAH-UHFFFAOYSA-N	335746	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 1	Plasma kallikrein	Human	 20.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335746	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335746&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298144	384987904							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662158	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)/t23-/m0/s1	HRLKIYSEPAYSAH-QHCPKHFHSA-N	335748	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 3::US9738655, Example 4	Plasma kallikrein	Human	 13.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602305	384987906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662159	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3ccccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H19ClFN5O4/c27-19-6-3-7-21(22(19)28)33-14-20(30-31-33)25(35)32-13-12-15-4-1-2-5-18(15)23(32)24(34)29-17-10-8-16(9-11-17)26(36)37/h1-11,14,23H,12-13H2,(H,29,34)(H,36,37)/t23-/m0/s1	HRLKIYSEPAYSAH-QHCPKHFHSA-N	335748	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 3::US9738655, Example 4	Plasma kallikrein	Human	 6.38								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335748	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335748&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602305	384987906							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662160	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3ccccc23)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C27H21ClFN3O5/c28-20-7-3-6-19(23(20)29)21-14-22(37-31-21)26(34)32-13-12-15-4-1-2-5-18(15)24(32)25(33)30-17-10-8-16(9-11-17)27(35)36/h1-11,22,24H,12-14H2,(H,30,33)(H,35,36)/t22-,24-/m1/s1	YPBHIZULGJULIC-ISKFKSNPSA-N	335750	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 5	Plasma kallikrein	Human	 1384								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335750	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335750&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602560	384987907							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662161	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)	QBESKCQOPGRWTA-UHFFFAOYSA-N	335751	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 6	Plasma kallikrein	Human	 2.40								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335751	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335751&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298354	384987908							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662162	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C38H35ClFN7O5/c1-22-33(43-44-47(22)31-9-5-8-30(39)32(31)40)37(50)46-20-18-28-27(23-10-12-24(13-11-23)35(48)41-19-21-45(2)3)6-4-7-29(28)34(46)36(49)42-26-16-14-25(15-17-26)38(51)52/h4-17,34H,18-21H2,1-3H3,(H,41,48)(H,42,49)(H,51,52)	WHXXBNXPFFJZMV-UHFFFAOYSA-N	335752	4-(2-(1-(3-Chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 7	Plasma kallikrein	Human	 29.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335752	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335752&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298355	384987909							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662163	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C38H34ClFN6O5/c1-44(2)20-18-41-35(47)24-11-9-23(10-12-24)28-5-3-6-30-29(28)17-19-45(34(30)36(48)43-27-15-13-25(14-16-27)38(50)51)37(49)26-21-42-46(22-26)32-8-4-7-31(39)33(32)40/h3-16,21-22,34H,17-20H2,1-2H3,(H,41,47)(H,43,48)(H,50,51)	ASWKOTUOPISDTN-UHFFFAOYSA-N	335753	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 8	Plasma kallikrein	Human	 3.37								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335753	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335753&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298356	384987910							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662164	CN(C)C(=O)c1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H30ClFN6O5/c1-20-31(40-41-44(20)29-9-5-8-28(37)30(29)38)35(47)43-19-18-26-25(21-10-12-22(13-11-21)34(46)42(2)3)6-4-7-27(26)32(43)33(45)39-24-16-14-23(15-17-24)36(48)49/h4-17,32H,18-19H2,1-3H3,(H,39,45)(H,48,49)	UTWSISMNNOGZOP-UHFFFAOYSA-N	335754	4-(2-(1-(3-Chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylcarbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 9	Plasma kallikrein	Human	 72.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335754	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335754&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86298357	384987911							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662165	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)/t33-/m0/s1	QBESKCQOPGRWTA-XIFFEERXSA-N	335755	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 10	Plasma kallikrein	Human	 1.08								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335755	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335755&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295514	384987912							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662166	CN(C)CCNC(=O)c1ccc(cc1)-c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C37H33ClFN7O5/c1-44(2)20-18-40-34(47)23-11-9-22(10-12-23)26-5-3-6-28-27(26)17-19-45(33(28)35(48)41-25-15-13-24(14-16-25)37(50)51)36(49)30-21-46(43-42-30)31-8-4-7-29(38)32(31)39/h3-16,21,33H,17-20H2,1-2H3,(H,40,47)(H,41,48)(H,50,51)/t33-/m1/s1	QBESKCQOPGRWTA-MGBGTMOVSA-N	335756	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid TFA salt::US9738655, Example 11	Plasma kallikrein	Human	 1056								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335756	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335756&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295305	384987913							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662167	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)	WNUYVQYWNLTYDS-UHFFFAOYSA-N	335757	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 12	Plasma kallikrein	Human	 9.88								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335757	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335757&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295306	384987914							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662168	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)/t27-/m1/s1	WNUYVQYWNLTYDS-HHHXNRCGSA-N	335758	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 13	Plasma kallikrein	Human	 427								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335758	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335758&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626242	384987915							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662169	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H21ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-10,13-16,27H,11-12H2,(H,35,40)(H,42,43)/t27-/m0/s1	WNUYVQYWNLTYDS-MHZLTWQESA-N	335759	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 14	Plasma kallikrein	Human	 6.27								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335759	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335759&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601612	384987916							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662170	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc(nc2)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H21ClFN7O4/c33-25-5-2-6-27(28(25)34)41-17-26(38-39-41)31(43)40-14-13-23-22(19-9-12-21(15-35)36-16-19)3-1-4-24(23)29(40)30(42)37-20-10-7-18(8-11-20)32(44)45/h1-12,16-17,29H,13-14H2,(H,37,42)(H,44,45)/t29-/m1/s1	HETUUWMBFBHOTJ-GDLZYMKVSA-N	335760	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-cyanopyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 15	Plasma kallikrein	Human	 219								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335760	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335760&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295307	384987917							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662171	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2ccc(nc2)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H21ClFN7O4/c33-25-5-2-6-27(28(25)34)41-17-26(38-39-41)31(43)40-14-13-23-22(19-9-12-21(15-35)36-16-19)3-1-4-24(23)29(40)30(42)37-20-10-7-18(8-11-20)32(44)45/h1-12,16-17,29H,13-14H2,(H,37,42)(H,44,45)/t29-/m0/s1	HETUUWMBFBHOTJ-LJAQVGFWSA-N	335761	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-cyanopyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 16	Plasma kallikrein	Human	 4.55								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335761	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335761&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601910	384987918							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662172	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN5O5/c32-24-6-2-5-23(27(24)33)25-13-26(43-37-25)30(40)38-12-11-21-20(18-14-34-16-35-15-18)3-1-4-22(21)28(38)29(39)36-19-9-7-17(8-10-19)31(41)42/h1-10,14-16,26,28H,11-13H2,(H,36,39)(H,41,42)/t26-,28+/m1/s1	DZCHJSRSEJTLGM-IAPPQJPRSA-N	335762	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 17	Plasma kallikrein	Human	 3.00								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335762	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335762&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295308	384987919							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662173	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN5O5/c32-24-6-2-5-23(27(24)33)25-13-26(43-37-25)30(40)38-12-11-21-20(18-14-34-16-35-15-18)3-1-4-22(21)28(38)29(39)36-19-9-7-17(8-10-19)31(41)42/h1-10,14-16,26,28H,11-13H2,(H,36,39)(H,41,42)/t26-,28-/m1/s1	DZCHJSRSEJTLGM-IXCJQBJRSA-N	335763	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 18	Plasma kallikrein	Human	 892								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335763	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335763&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602165	384987920							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662174	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN5O6/c1-37-31(42)26-13-10-19(17-38-26)21-4-2-5-23-22(21)14-15-41(30(23)32(43)39-20-11-8-18(9-12-20)34(45)46)33(44)28-16-27(40-47-28)24-6-3-7-25(35)29(24)36/h2-13,17,28,30H,14-16H2,1H3,(H,37,42)(H,39,43)(H,45,46)/t28-,30+/m1/s1	RZCBNXHMENKKFK-DGPALRBDSA-N	335764	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 19	Plasma kallikrein	Human	 1.51								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335764	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335764&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601679	384987921							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662175	CNC(=O)c1ccc(cn1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN5O6/c1-37-31(42)26-13-10-19(17-38-26)21-4-2-5-23-22(21)14-15-41(30(23)32(43)39-20-11-8-18(9-12-20)34(45)46)33(44)28-16-27(40-47-28)24-6-3-7-25(35)29(24)36/h2-13,17,28,30H,14-16H2,1H3,(H,37,42)(H,39,43)(H,45,46)/t28-,30-/m1/s1	RZCBNXHMENKKFK-PQHLKRTFSA-N	335765	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 20	Plasma kallikrein	Human	 840								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335765	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335765&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602054	384987922							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662176	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H23ClF2N4O5/c33-25-6-2-5-24(28(25)35)26-14-27(44-38-26)31(41)39-12-11-22-21(18-13-19(34)16-36-15-18)3-1-4-23(22)29(39)30(40)37-20-9-7-17(8-10-20)32(42)43/h1-10,13,15-16,27,29H,11-12,14H2,(H,37,40)(H,42,43)/t27-,29+/m1/s1	WWPQQFMLZRWSKU-PXJZQJOASA-N	335766	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-fluoropyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 21	Plasma kallikrein	Human	 9.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335766	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335766&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602235	384987923							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662177	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H23ClF2N4O5/c33-25-6-2-5-24(28(25)35)26-14-27(44-38-26)31(41)39-12-11-22-21(18-13-19(34)16-36-15-18)3-1-4-23(22)29(39)30(40)37-20-9-7-17(8-10-20)32(42)43/h1-10,13,15-16,27,29H,11-12,14H2,(H,37,40)(H,42,43)/t27-,29-/m1/s1	WWPQQFMLZRWSKU-XRKRLSELSA-N	335767	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-fluoropyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 22	Plasma kallikrein	Human	 869								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335767	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335767&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601893	384987924							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662178	COc1cncc(c1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN4O6/c1-44-21-14-19(16-36-17-21)22-4-2-5-24-23(22)12-13-39(30(24)31(40)37-20-10-8-18(9-11-20)33(42)43)32(41)28-15-27(38-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,37,40)(H,42,43)/t28-,30+/m1/s1	DQPLJHAOKDIZJN-DGPALRBDSA-N	335768	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-methoxypyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 23	Plasma kallikrein	Human	 17.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335768	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335768&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602040	384987925							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662179	COc1cncc(c1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H26ClFN4O6/c1-44-21-14-19(16-36-17-21)22-4-2-5-24-23(22)12-13-39(30(24)31(40)37-20-10-8-18(9-11-20)33(42)43)32(41)28-15-27(38-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,37,40)(H,42,43)/t28-,30-/m1/s1	DQPLJHAOKDIZJN-PQHLKRTFSA-N	335769	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(5-methoxypyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 24	Plasma kallikrein	Human	 396								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335769	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335769&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601496	384987926							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662180	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-11,14-17,28H,12-13H2,1H3,(H,36,41)/t28-/m1/s1	WUUCSGOLHNCBKX-MUUNZHRXSA-N	335770	(R)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 25	Plasma kallikrein	Human	>4340								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335770	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335770&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295515	384987927							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662181	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H23ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-11,14-17,28H,12-13H2,1H3,(H,36,41)/t28-/m0/s1	WUUCSGOLHNCBKX-NDEPHWFRSA-N	335771	(S)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 26	Plasma kallikrein	Human	 62.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335771	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335771&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626327	384987928							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662182	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(=O)OC	InChI=1S/C34H27ClFN7O5/c1-37-31(44)26-14-11-20(17-38-26)22-5-3-6-24-23(22)15-16-42(30(24)32(45)39-21-12-9-19(10-13-21)34(47)48-2)33(46)27-18-43(41-40-27)28-8-4-7-25(35)29(28)36/h3-14,17-18,30H,15-16H2,1-2H3,(H,37,44)(H,39,45)/t30-/m0/s1	CSJGZBYRICNEJG-PMERELPUSA-N	335772	(S)-Methyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, TFA salt::US9738655, Example 27	Plasma kallikrein	Human	 46.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335772	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335772&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626355	384987929							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662183	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O5/c1-43-32(42)18-8-10-20(11-9-18)37-30(40)29-23-5-2-4-21(19-15-35-17-36-16-19)22(23)12-13-39(29)31(41)27-14-26(38-44-27)24-6-3-7-25(33)28(24)34/h2-11,15-17,27,29H,12-14H2,1H3,(H,37,40)/t27-,29+/m1/s1	FAARZNRHKXNPTK-PXJZQJOASA-N	335773	Methyl 4-((S)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 28	Plasma kallikrein	Human	 55.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335773	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335773&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601981	384987930							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662184	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O5/c1-43-32(42)18-8-10-20(11-9-18)37-30(40)29-23-5-2-4-21(19-15-35-17-36-16-19)22(23)12-13-39(29)31(41)27-14-26(38-44-27)24-6-3-7-25(33)28(24)34/h2-11,15-17,27,29H,12-14H2,1H3,(H,37,40)/t27-,29-/m1/s1	FAARZNRHKXNPTK-XRKRLSELSA-N	335774	Methyl 4-((R)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate::US9738655, Example 29	Plasma kallikrein	Human	 1200								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335774	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335774&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602065	384987931							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662185	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(N)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H26ClFN6O5/c1-44-31(43)17-8-10-19(11-9-17)38-29(41)28-22-5-2-4-20(18-15-36-32(35)37-16-18)21(22)12-13-40(28)30(42)26-14-25(39-45-26)23-6-3-7-24(33)27(23)34/h2-11,15-16,26,28H,12-14H2,1H3,(H,38,41)(H2,35,36,37)/t26-,28-/m1/s1	PKWKUSFGPORMHY-IXCJQBJRSA-N	335775	4-(5-(2-aminopyrimidin-5- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 30	Plasma kallikrein	Human	 15.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335775	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335775&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752685	384987932							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662186	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(OC)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O6/c1-44-32(43)18-9-11-20(12-10-18)38-30(41)29-23-6-3-5-21(19-16-36-33(45-2)37-17-19)22(23)13-14-40(29)31(42)27-15-26(39-46-27)24-7-4-8-25(34)28(24)35/h3-12,16-17,27,29H,13-15H2,1-2H3,(H,38,41)/t27-,29-/m1/s1	BHULQGCNQYHAQM-XRKRLSELSA-N	335776	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methoxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 31	Plasma kallikrein	Human	 19.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335776	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335776&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752686	384987933							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662187	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(nc2)C#N)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H24ClFN6O5/c1-45-33(44)18-8-10-20(11-9-18)39-31(42)30-23-5-2-4-21(19-16-37-28(15-36)38-17-19)22(23)12-13-41(30)32(43)27-14-26(40-46-27)24-6-3-7-25(34)29(24)35/h2-11,16-17,27,30H,12-14H2,1H3,(H,39,42)/t27-,30-/m1/s1	FDSLGCZUIUTCAB-POURPWNDSA-N	335777	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- cyanopyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 32	Plasma kallikrein	Human	 17.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335777	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335777&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752687	384987934							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662188	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cccnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H26ClFN4O5/c1-43-33(42)19-10-12-21(13-11-19)37-31(40)30-24-7-2-6-22(20-5-4-15-36-18-20)23(24)14-16-39(30)32(41)28-17-27(38-44-28)25-8-3-9-26(34)29(25)35/h2-13,15,18,28,30H,14,16-17H2,1H3,(H,37,40)/t28-,30-/m1/s1	VMYPYDBRMJCEQI-PQHLKRTFSA-N	335778	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 33	Plasma kallikrein	Human	 9.54								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335778	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335778&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752688	384987935							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662189	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cnc(O)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H25ClFN5O6/c1-44-31(42)17-8-10-19(11-9-17)37-29(40)28-22-5-2-4-20(18-15-35-32(43)36-16-18)21(22)12-13-39(28)30(41)26-14-25(38-45-26)23-6-3-7-24(33)27(23)34/h2-11,15-16,26,28H,12-14H2,1H3,(H,37,40)(H,35,36,43)/t26-,28-/m1/s1	DNGPLVNRQZAENL-IXCJQBJRSA-N	335779	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- hydroxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 34	Plasma kallikrein	Human	 0.460								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335779	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335779&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752689	384987936							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662190	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(F)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H25ClF2N4O5/c1-44-33(43)18-8-10-21(11-9-18)38-31(41)30-24-5-2-4-22(19-14-20(35)17-37-16-19)23(24)12-13-40(30)32(42)28-15-27(39-45-28)25-6-3-7-26(34)29(25)36/h2-11,14,16-17,28,30H,12-13,15H2,1H3,(H,38,41)/t28-,30-/m1/s1	ITJJRCDKHPPSSS-PQHLKRTFSA-N	335780	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- fluoropyridin-3-yl)- 1.2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 35	Plasma kallikrein	Human	 22.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335780	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335780&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752690	384987937							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662191	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(OC)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C34H28ClFN4O6/c1-44-22-15-20(17-37-18-22)23-5-3-6-25-24(23)13-14-40(31(25)32(41)38-21-11-9-19(10-12-21)34(43)45-2)33(42)29-16-28(39-46-29)26-7-4-8-27(35)30(26)36/h3-12,15,17-18,29,31H,13-14,16H2,1-2H3,(H,38,41)/t29-,31-/m1/s1	RLHOWYGHDLUQRW-BVRKHOPBSA-N	335781	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- methoxypyridin-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 36	Plasma kallikrein	Human	 26.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335781	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335781&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752691	384987938							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662192	CNC(=O)c1cncc(c1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(=O)OC	InChI=1S/C35H29ClFN5O6/c1-38-32(43)21-15-20(17-39-18-21)23-5-3-6-25-24(23)13-14-42(31(25)33(44)40-22-11-9-19(10-12-22)35(46)47-2)34(45)29-16-28(41-48-29)26-7-4-8-27(36)30(26)37/h3-12,15,17-18,29,31H,13-14,16H2,1-2H3,(H,38,43)(H,40,44)/t29-,31-/m1/s1	BRCVBPCFQZEAOB-BVRKHOPBSA-N	335782	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(5- (methylcarbamoyl)pyridin- 3-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 37	Plasma kallikrein	Human	 12.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335782	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335782&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752692	384987939							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662193	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cncc(N)c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O5/c1-44-33(43)18-8-10-21(11-9-18)38-31(41)30-24-5-2-4-22(19-14-20(36)17-37-16-19)23(24)12-13-40(30)32(42)28-15-27(39-45-28)25-6-3-7-26(34)29(25)35/h2-11,14,16-17,28,30H,12-13,15,36H2,1H3,(H,38,41)/t28-,30-/m1/s1	XPDXBPGISHRRGJ-PQHLKRTFSA-N	335783	4-(5-(2-aminopyridin-4- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 38	Plasma kallikrein	Human	 3.51								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335783	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335783&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752693	384987940							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662194	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc(N)nc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H27ClFN5O5/c1-44-33(43)18-8-11-20(12-9-18)38-31(41)30-23-5-2-4-21(19-10-13-28(36)37-17-19)22(23)14-15-40(30)32(42)27-16-26(39-45-27)24-6-3-7-25(34)29(24)35/h2-13,17,27,30H,14-16H2,1H3,(H2,36,37)(H,38,41)/t27-,30-/m1/s1	BCGVTAKTYPSRQS-POURPWNDSA-N	335784	4-(5-(6-aminopyridin-3- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 39	Plasma kallikrein	Human	 2.63								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335784	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335784&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752694	384987941							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662195	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccc3CNCCc3c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C37H32ClFN4O5/c1-47-37(46)21-10-12-25(13-11-21)41-35(44)34-28-5-2-4-26(23-8-9-24-20-40-16-14-22(24)18-23)27(28)15-17-43(34)36(45)32-19-31(42-48-32)29-6-3-7-30(38)33(29)39/h2-13,18,32,34,40H,14-17,19-20H2,1H3,(H,41,44)/t32-,34-/m1/s1	FENPKALJPSEIAL-ZFEZZJPFSA-N	335785	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)- 1,1',2,2',3,3',4,4'- octahydro-[5,6'- biisoquinoline]-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 40	Plasma kallikrein	Human	 2.81								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335785	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335785&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752695	384987942							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662196	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2cn[nH]c2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1			335786	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (1H-pyrazol-4-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 41	Plasma kallikrein	Human	 7.68								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335786	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335786&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752696	384987943							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662197	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccnn2C)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H27ClFN5O5/c1-38-26(13-15-35-38)21-5-3-6-22-20(21)14-16-39(29(22)30(40)36-19-11-9-18(10-12-19)32(42)43-2)31(41)27-17-25(37-44-27)23-7-4-8-24(33)28(23)34/h3-13,15,27,29H,14,16-17H2,1-2H3,(H,36,40)/t27-,29-/m1/s1	HPQUBGDPTRWPBQ-XRKRLSELSA-N	335787	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-pyrazol-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 42	Plasma kallikrein	Human	 13.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335787	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335787&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752697	384987944							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662198	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-c2ccn(C)n2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H27ClFN5O5/c1-38-15-14-25(36-38)21-5-3-6-22-20(21)13-16-39(29(22)30(40)35-19-11-9-18(10-12-19)32(42)43-2)31(41)27-17-26(37-44-27)23-7-4-8-24(33)28(23)34/h3-12,14-15,27,29H,13,16-17H2,1-2H3,(H,35,40)/t27-,29-/m1/s1	BRRKPQDJNOUSDE-XRKRLSELSA-N	335788	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-pyrazol-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 43	Plasma kallikrein	Human	 16.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335788	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335788&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752698	384987945							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662199	CNC(=O)c1ccc(cn1)-c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H25ClFN7O5/c1-36-30(43)25-13-10-19(16-37-25)21-4-2-5-23-22(21)14-15-41(29(23)31(44)38-20-11-8-18(9-12-20)33(46)47)32(45)26-17-42(40-39-26)27-7-3-6-24(34)28(27)35/h2-13,16-17,29H,14-15H2,1H3,(H,36,43)(H,38,44)(H,46,47)/t29-/m0/s1	MNYQVTQMJHBGTD-LJAQVGFWSA-N	335789	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 44	Plasma kallikrein	Human	 3.28								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335789	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335789&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295516	384987946							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662200	CNC(=O)c1ccc(cn1)-c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H25ClFN7O5/c1-36-30(43)25-13-10-19(16-37-25)21-4-2-5-23-22(21)14-15-41(29(23)31(44)38-20-11-8-18(9-12-20)33(46)47)32(45)26-17-42(40-39-26)27-7-3-6-24(34)28(27)35/h2-13,16-17,29H,14-15H2,1H3,(H,36,43)(H,38,44)(H,46,47)/t29-/m1/s1	MNYQVTQMJHBGTD-GDLZYMKVSA-N	335790	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 45	Plasma kallikrein	Human	 364								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335790	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335790&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602009	384987947							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662201	Nc1c(cnn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H23ClFN7O4/c32-24-5-2-6-25(26(24)33)40-28(34)23(15-37-40)30(42)39-12-11-21-20(18-13-35-16-36-14-18)3-1-4-22(21)27(39)29(41)38-19-9-7-17(8-10-19)31(43)44/h1-10,13-16,27H,11-12,34H2,(H,38,41)(H,43,44)	DYZTYGBGDOZFGS-UHFFFAOYSA-N	335791	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 46	Plasma kallikrein	Human	 50.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335791	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335791&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602105	384987948							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662202	CNC(=O)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H27ClFN7O5/c1-38-31(44)26-13-10-19(16-39-26)21-4-2-5-23-22(21)14-15-42(29(23)32(45)41-20-11-8-18(9-12-20)34(47)48)33(46)24-17-40-43(30(24)37)27-7-3-6-25(35)28(27)36/h2-13,16-17,29H,14-15,37H2,1H3,(H,38,44)(H,41,45)(H,47,48)	JWUMGKLUPFRBEL-UHFFFAOYSA-N	335792	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 47	Plasma kallikrein	Human	 20.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335792	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335792&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295517	384987949							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662203	CNC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN7O4/c1-35-20-12-15-39(16-13-20)26-6-2-4-23-22(26)14-17-40(29(23)30(42)36-21-10-8-19(9-11-21)32(44)45)31(43)25-18-41(38-37-25)27-7-3-5-24(33)28(27)34/h2-11,18,20,29,35H,12-17H2,1H3,(H,36,42)(H,44,45)/t29-/m1/s1	TZOHATLRQAUOQP-GDLZYMKVSA-N	335793	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 48	Plasma kallikrein	Human	 452								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335793	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335793&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			130346376	384987950							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662204	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H33ClFN7O4/c1-39(2)22-13-16-40(17-14-22)27-7-3-5-24-23(27)15-18-41(30(24)31(43)36-21-11-9-20(10-12-21)33(45)46)32(44)26-19-42(38-37-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H,36,43)(H,45,46)/t30-/m0/s1	IRADZYNYESBTAE-PMERELPUSA-N	335794	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 49	Plasma kallikrein	Human	 1.39								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335794	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335794&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348905	384987951							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662205	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)	FBPUIWCXHWSFDU-UHFFFAOYSA-N	335795	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 50	Plasma kallikrein	Human	 4.94								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335795	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335795&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348819	384987952							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662206	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m1/s1	FBPUIWCXHWSFDU-WJOKGBTCSA-N	335796	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 51	Plasma kallikrein	Human	 340								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335796	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335796&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348873	384987953							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662207	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)24-13-16-40(17-14-24)28-7-3-5-26-25(28)15-18-41(31(26)32(43)38-23-11-9-21(10-12-23)34(45)46)33(44)22-19-37-42(20-22)29-8-4-6-27(35)30(29)36/h3-12,19-20,24,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m0/s1	FBPUIWCXHWSFDU-HKBQPEDESA-N	335797	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 52	Plasma kallikrein	Human	 1.79								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335797	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335797&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348857	384987954							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662208	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)	TUTDFHYFDVWALK-UHFFFAOYSA-N	335799	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 53	Plasma kallikrein	Human	 1.21								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335799	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335799&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348865	384987956							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662209	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m1/s1	TUTDFHYFDVWALK-WJOKGBTCSA-N	335800	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 54	Plasma kallikrein	Human	 50.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335800	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335800&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348863	384987957							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662210	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN6O4/c1-39(2)23-13-16-40(17-14-23)28-7-3-5-25-24(28)15-18-42(31(25)32(43)38-22-11-9-21(10-12-22)34(45)46)33(44)27-19-41(20-37-27)29-8-4-6-26(35)30(29)36/h3-12,19-20,23,31H,13-18H2,1-2H3,(H,38,43)(H,45,46)/t31-/m0/s1	TUTDFHYFDVWALK-HKBQPEDESA-N	335801	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylamino)piperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  bis-TFA salt::US9738655, Example 55	Plasma kallikrein	Human	 0.920								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335801	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335801&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348942	384987958							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662211	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)	MGKYNQMITPWKCX-UHFFFAOYSA-N	335802	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 56	Plasma kallikrein	Human	 5.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335802&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295725	384987959							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662212	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)/t30-/m1/s1	MGKYNQMITPWKCX-SSEXGKCCSA-N	335803	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 57	Plasma kallikrein	Human	 276								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335803	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335803&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348973	384987960							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662213	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN7O5/c1-40(2)32(45)20-13-16-41(17-14-20)27-7-3-5-24-23(27)15-18-42(30(24)31(44)37-22-11-9-21(10-12-22)34(47)48)33(46)26-19-43(39-38-26)28-8-4-6-25(35)29(28)36/h3-12,19-20,30H,13-18H2,1-2H3,(H,37,44)(H,47,48)/t30-/m0/s1	MGKYNQMITPWKCX-PMERELPUSA-N	335804	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 58	Plasma kallikrein	Human	 3.24								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335804	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335804&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348922	384987961							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662214	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)	OSEVVJFCRIBXMR-UHFFFAOYSA-N	335805	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 59	Plasma kallikrein	Human	 10.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335805	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335805&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295726	384987962							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662215	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m1/s1	OSEVVJFCRIBXMR-WJOKGBTCSA-N	335806	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 60	Plasma kallikrein	Human	 698								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335806	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335806&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348889	384987963							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662216	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-26-25(28)15-18-42(31(26)32(44)39-24-11-9-22(10-12-24)35(47)48)34(46)23-19-38-43(20-23)29-8-4-6-27(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m0/s1	OSEVVJFCRIBXMR-HKBQPEDESA-N	335807	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 61	Plasma kallikrein	Human	 5.89								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335807	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335807&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348844	384987964							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662217	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-25-24(28)15-18-43(31(25)32(44)39-23-11-9-22(10-12-23)35(47)48)34(46)27-19-42(20-38-27)29-8-4-6-26(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m1/s1	DUQMUTYXYZUOHC-WJOKGBTCSA-N	335808	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 62	Plasma kallikrein	Human	 399								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335808	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335808&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348950	384987965							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662218	CN(C)C(=O)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H34ClFN6O5/c1-40(2)33(45)21-13-16-41(17-14-21)28-7-3-5-25-24(28)15-18-43(31(25)32(44)39-23-11-9-22(10-12-23)35(47)48)34(46)27-19-42(20-38-27)29-8-4-6-26(36)30(29)37/h3-12,19-21,31H,13-18H2,1-2H3,(H,39,44)(H,47,48)/t31-/m0/s1	DUQMUTYXYZUOHC-HKBQPEDESA-N	335809	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- (dimethylcarbamoyl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 63	Plasma kallikrein	Human	 2.71								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335809	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335809&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348854	384987966							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662219	CC(C)c1nnc2CN(CCn12)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)	NNFFYYPCMGFLPV-UHFFFAOYSA-N	335810	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 64	Plasma kallikrein	Human	 4.70								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335810	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335810&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295727	384987967							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662220	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)/t30-/m1/s1	NNFFYYPCMGFLPV-SSEXGKCCSA-N	335811	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboximido)benzoic acid,  TFA salt::US9738655, Example 65	Plasma kallikrein	Human	 260								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335811	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335811&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348941	384987968							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662221	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClFN9O4/c1-19(2)31-40-39-28-18-42(15-16-43(28)31)26-7-3-5-23-22(26)13-14-44(30(23)32(46)37-21-11-9-20(10-12-21)34(48)49)33(47)25-17-45(41-38-25)27-8-4-6-24(35)29(27)36/h3-12,17,19,30H,13-16,18H2,1-2H3,(H,37,46)(H,48,49)/t30-/m0/s1	NNFFYYPCMGFLPV-PMERELPUSA-N	335812	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- isopropyl-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 66	Plasma kallikrein	Human	 2.57								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335812	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335812&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348923	384987969							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662222	CC1(O)CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-32(45)13-16-38(17-14-32)25-6-2-4-22-21(25)12-15-39(28(22)29(41)35-20-10-8-19(9-11-20)31(43)44)30(42)24-18-40(37-36-24)26-7-3-5-23(33)27(26)34/h2-11,18,28,45H,12-17H2,1H3,(H,35,41)(H,43,44)	FIWQHMLLHCSPLW-UHFFFAOYSA-N	335813	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- hydroxy-4-methylpiperidin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 67	Plasma kallikrein	Human	 7.17								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335813	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335813&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			86295728	384987970							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662223	CC1(O)CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-33(45)13-16-38(17-14-33)26-6-2-4-24-23(26)12-15-39(29(24)30(41)37-22-10-8-20(9-11-22)32(43)44)31(42)21-18-36-40(19-21)27-7-3-5-25(34)28(27)35/h2-11,18-19,29,45H,12-17H2,1H3,(H,37,41)(H,43,44)	VEDPYHVUKWTDSO-UHFFFAOYSA-N	335814	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-hydroxy-4- methylpiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 68	Plasma kallikrein	Human	 22.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335814	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335814&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348850	384987971							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662224	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCOCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H24ClFN6O6/c31-21-4-2-6-24(26(21)32)38-15-22(34-35-38)29(41)37-12-11-19-20(3-1-5-23(19)36-13-14-44-16-25(36)39)27(37)28(40)33-18-9-7-17(8-10-18)30(42)43/h1-10,15,27H,11-14,16H2,(H,33,40)(H,42,43)	XTLAPAGGJSLEHW-UHFFFAOYSA-N	335815	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 69	Plasma kallikrein	Human	 9.92								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335815	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335815&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348814	384987972							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662225	CN1CCN(c2cccc3C(N(CCc23)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C(=O)CC1	InChI=1S/C33H30ClFN6O5/c1-38-14-13-28(42)39(17-16-38)26-6-2-4-24-23(26)12-15-40(30(24)31(43)37-22-10-8-20(9-11-22)33(45)46)32(44)21-18-36-41(19-21)27-7-3-5-25(34)29(27)35/h2-11,18-19,30H,12-17H2,1H3,(H,37,43)(H,45,46)	XQFKNIZFWNFDAV-UHFFFAOYSA-N	335816	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-methyl-7-oxo- 1,4-diazepan-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 70	Plasma kallikrein	Human	 11.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335816	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335816&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348891	384987973							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662226	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClF2N4O6/c1-47-22-11-14-39(15-12-22)27-4-2-3-24-23(27)13-16-40(30(24)32(43)38-21-7-5-19(6-8-21)34(45)46)33(44)20-17-28(42)41(18-20)31-26(36)10-9-25(35)29(31)37/h2-10,20,22,30H,11-18H2,1H3,(H,38,43)(H,45,46)	MOURHNDDHSTRPL-UHFFFAOYSA-N	335817	4-(2-(1-(3-chloro-2,6- difluorophenyl)-5- oxopyrrolidine-3-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 71	Plasma kallikrein	Human	>6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335817	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335817&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348809	384987974							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662227	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H33ClFN7O5/c36-26-5-2-7-29(31(26)37)44-20-27(39-40-44)34(47)43-19-15-24-25(32(43)33(46)38-22-11-9-21(10-12-22)35(48)49)4-1-6-28(24)41-17-13-23(14-18-41)42-16-3-8-30(42)45/h1-2,4-7,9-12,20,23,32H,3,8,13-19H2,(H,38,46)(H,48,49)	WQWGGABJZOMIBL-UHFFFAOYSA-N	335819	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4-(2- oxopyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 72	Plasma kallikrein	Human	 13.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335819	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335819&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348920	384987976							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662228	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCS(=O)(=O)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H26ClFN6O6S/c31-22-4-2-6-25(26(22)32)38-17-23(34-35-38)29(40)37-12-11-20-21(3-1-5-24(20)36-13-15-45(43,44)16-14-36)27(37)28(39)33-19-9-7-18(8-10-19)30(41)42/h1-10,17,27H,11-16H2,(H,33,39)(H,41,42)	TZMZVJYUKWQYBS-UHFFFAOYSA-N	335820	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1,1- dioxidothiomorpholino)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 73	Plasma kallikrein	Human	 4.18								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335820	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335820&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348816	384987977							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662229	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H34ClFN6O5/c37-28-5-2-7-30(32(28)38)44-21-23(20-39-44)35(47)43-19-15-26-27(33(43)34(46)40-24-11-9-22(10-12-24)36(48)49)4-1-6-29(26)41-17-13-25(14-18-41)42-16-3-8-31(42)45/h1-2,4-7,9-12,20-21,25,33H,3,8,13-19H2,(H,40,46)(H,48,49)	DUMHALQWYMKJRI-UHFFFAOYSA-N	335821	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4-(2- oxopyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 74	Plasma kallikrein	Human	 27.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335821	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335821&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348817	384987978							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662230	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H31ClFN5O6/c36-26-4-2-6-28(30(26)37)42-20-22(19-38-42)33(45)41-16-12-24-25(31(41)32(44)39-23-9-7-21(8-10-23)34(46)47)3-1-5-27(24)40-17-14-35(15-18-40)13-11-29(43)48-35/h1-10,19-20,31H,11-18H2,(H,39,44)(H,46,47)	KCJXOPXQHIVGOD-UHFFFAOYSA-N	335822	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(2-oxo-1-oxa-8- azaspiro[4.5]-decan-8-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 75	Plasma kallikrein	Human	 25.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335822	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335822&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348802	384987979							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662231	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C34H30ClFN6O6/c35-24-4-2-6-27(29(24)36)42-19-25(38-39-42)32(45)41-16-12-22-23(30(41)31(44)37-21-9-7-20(8-10-21)33(46)47)3-1-5-26(22)40-17-14-34(15-18-40)13-11-28(43)48-34/h1-10,19,30H,11-18H2,(H,37,44)(H,46,47)	XPKQMZKAEDLRFG-UHFFFAOYSA-N	335823	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2-oxo- 1-oxa-8-azaspiro[4.5]decan-8- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboximido)benzoic acid,  TFA::US9738655, Example 76	Plasma kallikrein	Human	 15.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335823	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335823&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348949	384987980							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662232	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC3(CCC(=O)O3)CC2)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H31ClFN5O6/c36-25-4-2-6-28(30(25)37)41-19-26(38-20-41)33(45)42-16-12-23-24(31(42)32(44)39-22-9-7-21(8-10-22)34(46)47)3-1-5-27(23)40-17-14-35(15-18-40)13-11-29(43)48-35/h1-10,19-20,31H,11-18H2,(H,39,44)(H,46,47)	ZCFREWNYRKHFJI-UHFFFAOYSA-N	335824	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole- 4-carbonyl)-5-(2-oxo-1-oxa-8- azaspiro[4.5]decan-8-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 77	Plasma kallikrein	Human	 7.96								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335824	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335824&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348904	384987981							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662233	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN6O4/c32-23-7-5-9-26(27(23)33)39-18-24(35-36-39)30(41)38-17-14-21-22(6-4-8-25(21)37-15-2-1-3-16-37)28(38)29(40)34-20-12-10-19(11-13-20)31(42)43/h4-13,18,28H,1-3,14-17H2,(H,34,40)(H,42,43)	MMIGYNHOZGOKSR-UHFFFAOYSA-N	335825	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 78	Plasma kallikrein	Human	 36.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335825	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335825&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348881	384987982							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662234	CN1CCN(C(=O)C1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(26(41)17-37)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m1/s1	IJPZYJYAKOUZKY-MUUNZHRXSA-N	335826	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methyl-2-oxopiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 79	Plasma kallikrein	Human	 719								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335826	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335826&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348893	384987983							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662235	CN1CCN(C(=O)C1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(26(41)17-37)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m0/s1	IJPZYJYAKOUZKY-NDEPHWFRSA-N	335849	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methyl-2-oxopiprazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  HCl::US9738655, Example 80	Plasma kallikrein	Human	 6.37								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335849	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335849&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348974	384988006							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662236	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN6O5/c32-22-6-4-8-25(27(22)33)39-17-23(35-36-39)30(42)38-16-14-20-21(5-3-7-24(20)37-15-2-1-9-26(37)40)28(38)29(41)34-19-12-10-18(11-13-19)31(43)44/h3-8,10-13,17,28H,1-2,9,14-16H2,(H,34,41)(H,43,44)	YKRLXMNVDVQBIC-UHFFFAOYSA-N	335850	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- oxopiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 81	Plasma kallikrein	Human	 20.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335850	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335850&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348836	384988007							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662237	CCOC1CN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c1-2-44-20-15-37(16-20)25-7-3-5-22-21(25)13-14-38(28(22)29(40)34-19-11-9-18(10-12-19)31(42)43)30(41)24-17-39(36-35-24)26-8-4-6-23(32)27(26)33/h3-12,17,20,28H,2,13-16H2,1H3,(H,34,40)(H,42,43)	MQJWOKRUYVLVHD-UHFFFAOYSA-N	335851	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- ethoxyazetidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 82	Plasma kallikrein	Human	 23.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335851	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335851&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348875	384988008							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662238	COC1CN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H26ClFN6O5/c1-43-19-14-36(15-19)24-6-2-4-21-20(24)12-13-37(27(21)28(39)33-18-10-8-17(9-11-18)30(41)42)29(40)23-16-38(35-34-23)25-7-3-5-22(31)26(25)32/h2-11,16,19,27H,12-15H2,1H3,(H,33,39)(H,41,42)	MYNRGUFJJDMWTG-UHFFFAOYSA-N	335852	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- methoxyazetidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 83	Plasma kallikrein	Human	 12.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335852	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335852&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348960	384988009							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662239	CO[C@@H]1CCN(C1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c1-44-20-12-14-37(16-20)25-6-2-4-22-21(25)13-15-38(28(22)29(40)34-19-10-8-18(9-11-19)31(42)43)30(41)24-17-39(36-35-24)26-7-3-5-23(32)27(26)33/h2-11,17,20,28H,12-16H2,1H3,(H,34,40)(H,42,43)/t20-,28?/m1/s1	SJPWVCKRLGPILA-HFLPEKOISA-N	335853	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-((R)-3- methoxypyrrolidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 84	Plasma kallikrein	Human	 15.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335853	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335853&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348879	384988010							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662240	OC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H28ClFN6O5/c32-23-4-2-6-26(27(23)33)39-17-24(35-36-39)30(42)38-16-13-21-22(3-1-5-25(21)37-14-11-20(40)12-15-37)28(38)29(41)34-19-9-7-18(8-10-19)31(43)44/h1-10,17,20,28,40H,11-16H2,(H,34,41)(H,43,44)	PJWXABPIRATKKW-UHFFFAOYSA-N	335854	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- hydroxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,  TFA salt::US9738655, Example 85	Plasma kallikrein	Human	 5.29								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335854	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335854&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348777	384988011							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662241	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-24-4-2-6-26(27(24)33)38-18-20(17-34-38)30(40)37-12-11-22-23(3-1-5-25(22)36-13-15-43-16-14-36)28(37)29(39)35-21-9-7-19(8-10-21)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m1/s1	AZMXBQFTTJWWIS-MUUNZHRXSA-N	335857	(R)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 88	Plasma kallikrein	Human	 2085								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335857	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335857&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601721	384988014							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662242	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-24-4-2-6-26(27(24)33)38-18-20(17-34-38)30(40)37-12-11-22-23(3-1-5-25(22)36-13-15-43-16-14-36)28(37)29(39)35-21-9-7-19(8-10-21)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m0/s1	AZMXBQFTTJWWIS-NDEPHWFRSA-N	335858	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 89	Plasma kallikrein	Human	 11.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335858	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335858&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601534	384988015							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662243	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C30H26ClFN6O5/c31-22-4-2-6-25(26(22)32)38-17-23(34-35-38)29(40)37-12-11-20-21(3-1-5-24(20)36-13-15-43-16-14-36)27(37)28(39)33-19-9-7-18(8-10-19)30(41)42/h1-10,17,27H,11-16H2,(H,33,39)(H,41,42)/t27-/m0/s1	UCSKYPRDSCVAMS-MHZLTWQESA-N	335859	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 90	Plasma kallikrein	Human	 5.37								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335859	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335859&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601974	384988016							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662244	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H27ClFN5O5/c32-23-4-2-6-26(27(23)33)37-17-24(34-18-37)30(40)38-12-11-21-22(3-1-5-25(21)36-13-15-43-16-14-36)28(38)29(39)35-20-9-7-19(8-10-20)31(41)42/h1-10,17-18,28H,11-16H2,(H,35,39)(H,41,42)/t28-/m0/s1	DVLBZAYUFSXDAP-NDEPHWFRSA-N	335860	(S)-4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-morpholino-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 91	Plasma kallikrein	Human	 3.84								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335860	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335860&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602090	384988017							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662245	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(cn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H34ClFN6O5/c37-27-5-2-7-30(32(27)38)42-20-28(39-21-42)35(47)44-19-15-25-26(33(44)34(46)40-23-11-9-22(10-12-23)36(48)49)4-1-6-29(25)41-17-13-24(14-18-41)43-16-3-8-31(43)45/h1-2,4-7,9-12,20-21,24,33H,3,8,13-19H2,(H,40,46)(H,48,49)	OHZPVCRHBZYZJT-UHFFFAOYSA-N	335861	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-(4-(2-oxopyrrolidin-1-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 92	Plasma kallikrein	Human	 5.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335861	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335861&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602164	384988018							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662246	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncco1	InChI=1S/C36H35ClFN7O3/c1-42(2)26-13-17-43(18-14-26)30-7-3-5-28-27(30)15-19-44(36(47)24-21-40-45(22-24)31-8-4-6-29(37)32(31)38)33(28)34(46)41-25-11-9-23(10-12-25)35-39-16-20-48-35/h3-12,16,20-22,26,33H,13-15,17-19H2,1-2H3,(H,41,46)	DJUCOOVKTPLJLE-UHFFFAOYSA-N	335862	2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-N-(4-(oxazol-2-yl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 93	Plasma kallikrein	Human	 9.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335862	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335862&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602110	384988019							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662247	CCn1nnc(n1)-c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N(C)C)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H38ClFN10O2/c1-4-48-42-34(41-43-48)23-11-13-25(14-12-23)40-35(49)33-28-7-5-9-30(45-18-15-26(16-19-45)44(2)3)27(28)17-20-46(33)36(50)24-21-39-47(22-24)31-10-6-8-29(37)32(31)38/h5-14,21-22,26,33H,4,15-20H2,1-3H3,(H,40,49)	RKJMKFUCSWGOSU-UHFFFAOYSA-N	335863	2-(1-(3-chloro 2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-(2-ethyl-2H-tetrazol-5- yl)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 94	Plasma kallikrein	Human	 10.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335863&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348887	384988020							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662248	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(OCC2CCCO2)cc1	InChI=1S/C38H42ClFN6O4/c1-43(2)27-15-18-44(19-16-27)33-9-3-7-31-30(33)17-20-45(38(48)25-22-41-46(23-25)34-10-4-8-32(39)35(34)40)36(31)37(47)42-26-11-13-28(14-12-26)50-24-29-6-5-21-49-29/h3-4,7-14,22-23,27,29,36H,5-6,15-21,24H2,1-2H3,(H,42,47)	RKRFJYCLJSOKBN-UHFFFAOYSA-N	335864	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-((tetrahydrofuran-2- yl)methoxy)phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 95	Plasma kallikrein	Human	 16.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335864	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335864&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348781	384988021							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662249	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(OC(F)F)cc1	InChI=1S/C34H34ClF3N6O3/c1-41(2)23-13-16-42(17-14-23)28-7-3-5-26-25(28)15-18-43(31(26)32(45)40-22-9-11-24(12-10-22)47-34(37)38)33(46)21-19-39-44(20-21)29-8-4-6-27(35)30(29)36/h3-12,19-20,23,31,34H,13-18H2,1-2H3,(H,40,45)	AUTKGNDQORIBBN-UHFFFAOYSA-N	335865	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-N-(4- (difluoromethoxy)phenyl)-5-(4- (dimethylamino)piperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 96	Plasma kallikrein	Human	 34.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335865&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348838	384988022							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662250	COc1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N(C)C)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)cc1	InChI=1S/C34H36ClFN6O3/c1-39(2)24-14-17-40(18-15-24)29-8-4-6-27-26(29)16-19-41(32(27)33(43)38-23-10-12-25(45-3)13-11-23)34(44)22-20-37-42(21-22)30-9-5-7-28(35)31(30)36/h4-13,20-21,24,32H,14-19H2,1-3H3,(H,38,43)	BYWCUUZBTKXTQC-UHFFFAOYSA-N	335866	2-(1-(3-chloro-2-fluorophenyl)- 1H-pyrazole-4-carbonyl)-5-(4- (dimethylamino)piperidin-1-yl)- N-(4-methoxyphenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 97	Plasma kallikrein	Human	 21.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335866	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335866&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348861	384988023							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662251	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1noc(C)n1	InChI=1S/C35H35ClFN9O3/c1-21-38-33(41-49-21)22-10-12-23(13-11-22)39-34(47)32-26-6-4-8-29(44-17-14-24(15-18-44)43(2)3)25(26)16-19-45(32)35(48)28-20-46(42-40-28)30-9-5-7-27(36)31(30)37/h4-13,20,24,32H,14-19H2,1-3H3,(H,39,47)	PGRXFTCYMWPHKW-UHFFFAOYSA-N	335867	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino) piperidin-1-yl)-N-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 98	Plasma kallikrein	Human	 5.20								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335867&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601898	384988024							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662252	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)	NMESXYFWTSUGKH-UHFFFAOYSA-N	335868	N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 99	Plasma kallikrein	Human	 2.74								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335868	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335868&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602100	384988025							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662253	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)/t30-/m1/s1	NMESXYFWTSUGKH-SSEXGKCCSA-N	335869	(R)-N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 100	Plasma kallikrein	Human	 494								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335869	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335869&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601365	384988026							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662254	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C33H34ClFN8O3/c1-40(2)22-13-16-41(17-14-22)27-7-3-5-24-23(27)15-18-42(30(24)32(45)37-21-11-9-20(10-12-21)31(36)44)33(46)26-19-43(39-38-26)28-8-4-6-25(34)29(28)35/h3-12,19,22,30H,13-18H2,1-2H3,(H2,36,44)(H,37,45)/t30-/m0/s1	NMESXYFWTSUGKH-PMERELPUSA-N	335870	(S)-N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 101	Plasma kallikrein	Human	 1.75								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335870	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335870&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601517	384988027							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662255	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335871	N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 102	Plasma kallikrein	Human	 1.39								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335871&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601936	384988028							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662256	CN(C)C1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335872	(R)-N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 103	Plasma kallikrein	Human	 34.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335872&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601934	384988029							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662257	CN(C)C1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1cn[nH]c1			335873	(S)-N-(4-(1H-Pyrazol-4-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 104	Plasma kallikrein	Human	 0.960								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335873&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602077	384988030							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662258	CN(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1nnn[nH]1			335874	N-(4-(1H-Tetrazol-5-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, bis-TFA salt::US9738655, Example 105	Plasma kallikrein	Human	 1.69								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335874&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601367	384988031							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662259	CN1CCC2(CCN(CC2)c2cccc3C(N(CCc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C1=O	InChI=1S/C35H33ClFN7O5/c1-41-17-13-35(34(41)49)14-18-42(19-15-35)27-6-2-4-24-23(27)12-16-43(30(24)31(45)38-22-10-8-21(9-11-22)33(47)48)32(46)26-20-44(40-39-26)28-7-3-5-25(36)29(28)37/h2-11,20,30H,12-19H2,1H3,(H,38,45)(H,47,48)	LDBRXJJCOCLPDO-UHFFFAOYSA-N	335875	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-methyl-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 106	Plasma kallikrein	Human	 7.58								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335875	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335875&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602434	384988032							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662260	CN1CCC2(CCN(CC2)c2cccc3C(N(CCc23)C(=O)c2cnn(c2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)C1=O	InChI=1S/C36H34ClFN6O5/c1-41-17-13-36(35(41)49)14-18-42(19-15-36)28-6-2-4-26-25(28)12-16-43(31(26)32(45)40-24-10-8-22(9-11-24)34(47)48)33(46)23-20-39-44(21-23)29-7-3-5-27(37)30(29)38/h2-11,20-21,31H,12-19H2,1H3,(H,40,45)(H,47,48)	IVMRSEGVRIIAGV-UHFFFAOYSA-N	335876	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(2-methyl-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 107	Plasma kallikrein	Human	 12.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335876	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335876&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602252	384988033							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662261	OC(=O)c1ccc(NC(=O)C2N(CCc3c(cccc23)C#N)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C27H18ClFN6O4/c28-20-5-2-6-22(23(20)29)35-14-21(32-33-35)26(37)34-12-11-18-16(13-30)3-1-4-19(18)24(34)25(36)31-17-9-7-15(8-10-17)27(38)39/h1-10,14,24H,11-12H2,(H,31,36)(H,38,39)	RMICWTGTVHFVQN-UHFFFAOYSA-N	335877	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-cyano-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 108	Plasma kallikrein	Human	 50.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335877	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335877&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602058	384988034							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662262	NCc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H22ClFN6O4/c28-20-5-2-6-22(23(20)29)35-14-21(32-33-35)26(37)34-12-11-18-16(13-30)3-1-4-19(18)24(34)25(36)31-17-9-7-15(8-10-17)27(38)39/h1-10,14,24H,11-13,30H2,(H,31,36)(H,38,39)	YTULCQGNUIGFGU-UHFFFAOYSA-N	335878	4-(5-(Aminomethyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 109	Plasma kallikrein	Human	 2.29								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335878&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602249	384988035							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662263	OC(=O)c1ccc(NC(=O)C2N(CCc3c(Br)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H18BrClFN5O4/c27-18-4-1-3-17-16(18)11-12-33(23(17)24(35)30-15-9-7-14(8-10-15)26(37)38)25(36)20-13-34(32-31-20)21-6-2-5-19(28)22(21)29/h1-10,13,23H,11-12H2,(H,30,35)(H,37,38)	FTJKBBGXMSWJLV-UHFFFAOYSA-N	335879	4-(5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 110	Plasma kallikrein	Human	 23.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335879	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335879&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601996	384988036							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662264	OCCNc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H24ClFN6O5/c29-20-4-2-6-23(24(20)30)36-15-22(33-34-36)27(39)35-13-11-18-19(3-1-5-21(18)31-12-14-37)25(35)26(38)32-17-9-7-16(8-10-17)28(40)41/h1-10,15,25,31,37H,11-14H2,(H,32,38)(H,40,41)	NYQZRXFSTDWBHC-UHFFFAOYSA-N	335880	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((2-hydroxyethyl)amino)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 111	Plasma kallikrein	Human	 5.60								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335880&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602499	384988037							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662265	OC(=O)c1ccc(NC(=O)C2N(CCc3c(OC4CCNCC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN6O5/c32-23-4-2-5-25(27(23)33)39-17-24(36-37-39)30(41)38-16-13-21-22(3-1-6-26(21)44-20-11-14-34-15-12-20)28(38)29(40)35-19-9-7-18(8-10-19)31(42)43/h1-10,17,20,28,34H,11-16H2,(H,35,40)(H,42,43)	DRTJXWBTRVZLSH-UHFFFAOYSA-N	335881	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(piperidin-4-yloxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 112	Plasma kallikrein	Human	 3.16								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335881&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602076	384988038							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662266	OCCCOc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H25ClFN5O6/c30-21-5-2-6-23(25(21)31)36-16-22(33-34-36)28(39)35-13-12-19-20(4-1-7-24(19)42-15-3-14-37)26(35)27(38)32-18-10-8-17(9-11-18)29(40)41/h1-2,4-11,16,26,37H,3,12-15H2,(H,32,38)(H,40,41)	ZKEMSABRIROBTJ-UHFFFAOYSA-N	335882	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 113	Plasma kallikrein	Human	 11.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335882&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752699	384988039							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662267	OCCCOc1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H27ClFN3O7/c31-22-6-1-5-21(26(22)32)23-16-25(42-34-23)29(38)35-13-12-19-20(4-2-7-24(19)41-15-3-14-36)27(35)28(37)33-18-10-8-17(9-11-18)30(39)40/h1-2,4-11,25,27,36H,3,12-16H2,(H,33,37)(H,39,40)/t25-,27+/m1/s1	GQEFKPHQGKFWAI-VPUSJEBWSA-N	335883	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, and 4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(2-methoxyethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 114	Plasma kallikrein	Human	 15.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335883&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752700	384988040							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662268	OCCCOc1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H27ClFN3O7/c31-22-6-1-5-21(26(22)32)23-16-25(42-34-23)29(38)35-13-12-19-20(4-2-7-24(19)41-15-3-14-36)27(35)28(37)33-18-10-8-17(9-11-18)30(39)40/h1-2,4-11,25,27,36H,3,12-16H2,(H,33,37)(H,39,40)/t25-,27-/m1/s1	GQEFKPHQGKFWAI-XNMGPUDCSA-N	335884	US9738655, Example 115	Plasma kallikrein	Human	 61.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335884	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335884&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752701	384988041							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662269	CCOC(=O)Cc1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc(nc2)C(=O)NC)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C36H31ClFN7O5/c1-3-50-31(46)18-21-10-13-23(14-11-21)41-35(48)33-26-7-4-6-24(22-12-15-28(40-19-22)34(47)39-2)25(26)16-17-44(33)36(49)29-20-45(43-42-29)30-9-5-8-27(37)32(30)38/h4-15,19-20,33H,3,16-18H2,1-2H3,(H,39,47)(H,41,48)	RSPKBHVBCVXNMS-UHFFFAOYSA-N	335885	Ethyl 2-(4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)phenyl)acetate, TFA salt::US9738655, Example 116	Plasma kallikrein	Human	 128								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335885	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335885&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626246	384988042							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662270	CNC(=O)c1ccc(cn1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CC(O)=O)cc1	InChI=1S/C34H27ClFN7O5/c1-37-32(46)26-13-10-20(17-38-26)22-4-2-5-24-23(22)14-15-42(31(24)33(47)39-21-11-8-19(9-12-21)16-29(44)45)34(48)27-18-43(41-40-27)28-7-3-6-25(35)30(28)36/h2-13,17-18,31H,14-16H2,1H3,(H,37,46)(H,39,47)(H,44,45)	PCKDHIDIRRZJKO-UHFFFAOYSA-N	335886	2-(4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(6-(methylcarbamoyl)pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)phenyl)acetic acid, TFA salt::US9738655, Example 117	Plasma kallikrein	Human	 16.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335886	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335886&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626270	384988043					C03768		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662271	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccccc1	InChI=1S/C31H30ClFN6O3/c1-42-21-13-16-37(17-14-21)26-11-5-9-23-22(26)15-18-38(29(23)30(40)34-20-7-3-2-4-8-20)31(41)25-19-39(36-35-25)27-12-6-10-24(32)28(27)33/h2-12,19,21,29H,13-18H2,1H3,(H,34,40)	OYJMUKCJZWQNIM-UHFFFAOYSA-N	335887	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 118	Plasma kallikrein	Human	 250								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335887	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335887&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602103	384988044							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662272	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(Br)cccc2C1C(=O)Nc1ccccc1	InChI=1S/C25H18BrClFN5O2/c26-18-9-4-8-17-16(18)12-13-32(23(17)24(34)29-15-6-2-1-3-7-15)25(35)20-14-33(31-30-20)21-11-5-10-19(27)22(21)28/h1-11,14,23H,12-13H2,(H,29,34)	YQDIROVALXIHCO-UHFFFAOYSA-N	335888	5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 119	Plasma kallikrein	Human	 1104								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335888	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335888&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601337	384988045							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662273	OCc1ccc(NC(=O)C2N(CCc3c(Br)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H20BrClFN5O3/c27-19-4-1-3-18-17(19)11-12-33(24(18)25(36)30-16-9-7-15(14-35)8-10-16)26(37)21-13-34(32-31-21)22-6-2-5-20(28)23(22)29/h1-10,13,24,35H,11-12,14H2,(H,30,36)	UVSSXHYWEKOUGV-UHFFFAOYSA-N	335889	5-Bromo-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 120	Plasma kallikrein	Human	 517								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335889&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626330	384988046							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662274	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CO)cc1	InChI=1S/C32H32ClFN6O4/c1-44-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-39(30(24)31(42)35-21-10-8-20(19-41)9-11-21)32(43)26-18-40(37-36-26)28-7-3-5-25(33)29(28)34/h2-11,18,22,30,41H,12-17,19H2,1H3,(H,35,42)/t30-/m1/s1	IKSYNZROZSKPEA-SSEXGKCCSA-N	335890	(R)-2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 121	Plasma kallikrein	Human	 7896								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335890	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335890&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601941	384988047							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662275	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(CO)cc1	InChI=1S/C32H32ClFN6O4/c1-44-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-39(30(24)31(42)35-21-10-8-20(19-41)9-11-21)32(43)26-18-40(37-36-26)28-7-3-5-25(33)29(28)34/h2-11,18,22,30,41H,12-17,19H2,1H3,(H,35,42)/t30-/m0/s1	IKSYNZROZSKPEA-PMERELPUSA-N	335891	(S)-2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-N-(4-(hydroxymethyl)phenyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide::US9738655, Example 122	Plasma kallikrein	Human	 99.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335891	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335891&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601458	384988048							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662276	OC(=O)c1ccc(NC(=O)C2N(CCc3c(OC4COC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C29H23ClFN5O6/c30-21-4-2-5-23(25(21)31)36-13-22(33-34-36)28(38)35-12-11-19-20(3-1-6-24(19)42-18-14-41-15-18)26(35)27(37)32-17-9-7-16(8-10-17)29(39)40/h1-10,13,18,26H,11-12,14-15H2,(H,32,37)(H,39,40)	AMHCONOGPXXSHI-UHFFFAOYSA-N	335892	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(oxetan-3-yloxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 123	Plasma kallikrein	Human	 21.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335892	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335892&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602453	384988049							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662277	CC1(COc2cccc3C(N(CCc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)C(=O)Nc2ccc(cc2)C(O)=O)COC1	InChI=1S/C31H27ClFN5O6/c1-31(15-43-16-31)17-44-25-7-2-4-21-20(25)12-13-37(27(21)28(39)34-19-10-8-18(9-11-19)30(41)42)29(40)23-14-38(36-35-23)24-6-3-5-22(32)26(24)33/h2-11,14,27H,12-13,15-17H2,1H3,(H,34,39)(H,41,42)	LEGCVLXVQJXNEL-UHFFFAOYSA-N	335893	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((3-methyloxetan-3-yl)methoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 124	Plasma kallikrein	Human	 36.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335893&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626334	384988050							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662278	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc2ncccc2c1	InChI=1S/C32H22ClFN8O2/c33-25-7-2-8-28(29(25)34)42-17-27(39-40-42)32(44)41-13-11-23-22(20-15-35-18-36-16-20)5-1-6-24(23)30(41)31(43)38-21-9-10-26-19(14-21)4-3-12-37-26/h1-10,12,14-18,30H,11,13H2,(H,38,43)/t30-/m1/s1	AOJOJDICJYHDFM-SSEXGKCCSA-N	335894	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-N-(quinolin-6-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 125	Plasma kallikrein	Human	 54.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335894	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335894&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121357622	384988051							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662279	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335895	N-(4-(1H-imidazol-2-yl)phenyl)-2-(1- (3-chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahy-droisoquinoline-1- carboxamide, TFA salt::US9738655, Example 126	Plasma kallikrein	Human	 94.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335895	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335895&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348927	384988052							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662280	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1cc[nH]n1			335896	N-(4-(1H-pyrazol-3-yl)phenyl)-2-(1-(3- chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 127	Plasma kallikrein	Human	 196								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335896	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335896&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348768	384988053							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662281	COC(=O)c1ccc2cc(NC(=O)C3N(CCc4c3cccc4-c3cncnc3)C(=O)c3cn(nn3)-c3cccc(Cl)c3F)ccc2n1	InChI=1S/C34H24ClFN8O4/c1-48-34(47)27-10-8-19-14-21(9-11-26(19)40-27)39-32(45)31-24-5-2-4-22(20-15-37-18-38-16-20)23(24)12-13-43(31)33(46)28-17-44(42-41-28)29-7-3-6-25(35)30(29)36/h2-11,14-18,31H,12-13H2,1H3,(H,39,45)	KIPVHPIVDXTMIZ-UHFFFAOYSA-N	335897	US9738655, Example 128::methyl 6-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) quinoline-2-carboxylate, TFA salt	Plasma kallikrein	Human	 65.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335897	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335897&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348964	384988054							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662282	OC(=O)c1ccc2cc(NC(=O)C3N(CCc4c3cccc4-c3cncnc3)C(=O)c3cn(nn3)-c3cccc(Cl)c3F)ccc2n1	InChI=1S/C33H22ClFN8O4/c34-24-5-2-6-28(29(24)35)43-16-27(40-41-43)32(45)42-12-11-22-21(19-14-36-17-37-15-19)3-1-4-23(22)30(42)31(44)38-20-8-10-25-18(13-20)7-9-26(39-25)33(46)47/h1-10,13-17,30H,11-12H2,(H,38,44)(H,46,47)	CBWGFRXFDKEMRZ-UHFFFAOYSA-N	335898	6-(2-(1-(3-chloro-2-fluorophenyl)-1H- 1,2,3-triazole-4-carbonyl)-5- (pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) quinoline-2-carboxylic acid, TFA salt::US9738655, Example 129	Plasma kallikrein	Human	 34.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335898	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335898&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348962	384988055							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662283	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc2cnccc2c1	InChI=1S/C32H22ClFN8O2/c33-26-5-2-6-28(29(26)34)42-17-27(39-40-42)32(44)41-12-10-24-23(21-15-36-18-37-16-21)3-1-4-25(24)30(41)31(43)38-22-8-7-20-14-35-11-9-19(20)13-22/h1-9,11,13-18,30H,10,12H2,(H,38,43)	JNENWLQOWWWAGJ-UHFFFAOYSA-N	335899	2-(1-(3-chloro-2-fluorophenyl)-1H- 1,2,3-triazol-4-carbonyl)-N- (isoquinolin-6-yl)-5-(pyrimidin-5-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 130	Plasma kallikrein	Human	 126								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335899	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335899&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348762	384988056							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662284	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncn[nH]1			335900	N-(4-(1H-1,2,4-triazol-5-yl)phenyl)-2- (1-(3-chloro-2-fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(pyrimidin-5- yl)-1,2,3,4-tetrahydroisoquinoline-1- carboxamide, TFA salt::US9738655, Example 131	Plasma kallikrein	Human	 60.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335900&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348776	384988057							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662285	COC(=O)[C@@H]1CC[C@@H](CC1)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C31H29ClFN7O4/c1-44-31(43)18-8-10-20(11-9-18)36-29(41)28-23-5-2-4-21(19-14-34-17-35-15-19)22(23)12-13-39(28)30(42)25-16-40(38-37-25)26-7-3-6-24(32)27(26)33/h2-7,14-18,20,28H,8-13H2,1H3,(H,36,41)/t18-,20+,28?	KRPMWHOIXWBEJN-NWNQRXDVSA-N	335901	(1R,4R)-methyl 4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) cyclohexanecarboxylate::US9738655, Example 132	Plasma kallikrein	Human	 1624								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335901	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335901&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348820	384988058							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662286	OC(=O)[C@@H]1CC[C@@H](CC1)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C30H27ClFN7O4/c31-23-5-2-6-25(26(23)32)39-15-24(36-37-39)29(41)38-12-11-21-20(18-13-33-16-34-14-18)3-1-4-22(21)27(38)28(40)35-19-9-7-17(8-10-19)30(42)43/h1-6,13-17,19,27H,7-12H2,(H,35,40)(H,42,43)/t17-,19+,27?	BKPBNEGPJBNSTD-MEXJIUHXSA-N	335902	(1R,4R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole-4- carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4- tetrahydroisoquinoline-1-carboxamido) cyclohexanecarboxylic acid::US9738655, Example 133	Plasma kallikrein	Human	 750								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335902&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348874	384988059							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662287	Fc1c(Cl)cccc1C1=NO[C@H](C1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335903	(1S)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt, and (1R)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 134	Plasma kallikrein	Human	 24.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335903&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602084	384988060							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662288	Fc1c(Cl)cccc1C1=NO[C@H](C1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335904	US9738655, Example 135	Plasma kallikrein	Human	 399								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335904	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335904&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601929	384988061							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662289	Cc1c(ncn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335905	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA salt::US9738655, Example 136	Plasma kallikrein	Human	 157								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335905	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335905&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601342	384988062							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662290	Fc1c(Cl)cccc1-n1cnc(c1)C(=O)N1CCc2c(cccc2-c2cncnc2)C1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335906	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-imidazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA::US9738655, Example 137	Plasma kallikrein	Human	 53.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335906	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335906&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601909	384988063							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662291	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335907	(S)-N-(4-(H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt, and (R)-N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 138	Plasma kallikrein	Human	 25.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335907	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335907&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602016	384988064							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662292	Fc1c(Cl)cccc1-n1cc(nn1)C(=O)N1CCc2c(cccc2-c2cncnc2)[C@@H]1C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335910	US9738655, Example 139	Plasma kallikrein	Human	 16.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335910	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335910&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601485	384988067							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662293	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335911	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA salt::US9738655, Example 140	Plasma kallikrein	Human	 2371								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335911	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335911&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601331	384988068							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662294	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)-c1ncc[nH]1			335912	N-(4-(1H-Imidazol-2-yl)phenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, 2 TFA::US9738655, Example 141	Plasma kallikrein	Human	 161								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335912	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335912&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601344	384988069							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662295	COC(=O)C12CCC(CC1)(CC2)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C33H31ClFN7O4/c1-46-31(45)32-9-12-33(13-10-32,14-11-32)38-29(43)28-23-5-2-4-21(20-16-36-19-37-17-20)22(23)8-15-41(28)30(44)25-18-42(40-39-25)26-7-3-6-24(34)27(26)35/h2-7,16-19,28H,8-15H2,1H3,(H,38,43)	XUSXNGCEKZUXPA-UHFFFAOYSA-N	335913	Methyl 4-(2-{[1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylate, TFA salt::US9738655, Example 142	Plasma kallikrein	Human	 426								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335913	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335913&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626226	384988070							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662296	OC(=O)C12CCC(CC1)(CC2)NC(=O)C1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)	PAUFAVZBDGYZEP-UHFFFAOYSA-N	335914	4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA::US9738655, Example 143	Plasma kallikrein	Human	 237								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335914	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626271	384988071							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662297	OC(=O)C12CCC(CC1)(CC2)NC(=O)[C@H]1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)/t27-,31?,32?/m0/s1	PAUFAVZBDGYZEP-ZHGDCFTFSA-N	335915	4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA (enantiomer A), and 4-(2-{[1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]carbonyl}-5-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-amido)bicyclo[2.2.2]octane-1-carboxylic acid, 1 TFA (enantiomer B)::US9738655, Example 144	Plasma kallikrein	Human	 330								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335915	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335915&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752702	384988072							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662298	OC(=O)C12CCC(CC1)(CC2)NC(=O)[C@@H]1N(CCc2c1cccc2-c1cncnc1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C32H29ClFN7O4/c33-23-5-2-6-25(26(23)34)41-17-24(38-39-41)29(43)40-14-7-21-20(19-15-35-18-36-16-19)3-1-4-22(21)27(40)28(42)37-32-11-8-31(9-12-32,10-13-32)30(44)45/h1-6,15-18,27H,7-14H2,(H,37,42)(H,44,45)/t27-,31?,32?/m1/s1	PAUFAVZBDGYZEP-XJRVHGQPSA-N	335916	US9738655, Example 145	Plasma kallikrein	Human	 252								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335916	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335916&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752703	384988073							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662299	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1sc(nc1C)-c1cccnc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H33N5O5S/c1-20-29(44-31(35-20)22-5-4-15-34-19-22)32(40)38-18-14-25-26(6-3-7-27(25)37-16-12-24(43-2)13-17-37)28(38)30(39)36-23-10-8-21(9-11-23)33(41)42/h3-11,15,19,24,28H,12-14,16-18H2,1-2H3,(H,36,39)(H,41,42)	LLLXEIXZHFLWRN-UHFFFAOYSA-N	335917	4-(5-(4-methoxypiperidin-1- yl)-2-(4-methyl-2-(pyridin-3- yl)thiazole-5-carbonyl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 146	Plasma kallikrein	Human	 2000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335917	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335917&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626275	384988074							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662300	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(C)n(c1C)-c1ccc(Cl)cc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClN4O5/c1-22-21-31(23(2)41(22)27-13-9-25(37)10-14-27)35(43)40-20-17-29-30(5-4-6-32(29)39-18-15-28(46-3)16-19-39)33(40)34(42)38-26-11-7-24(8-12-26)36(44)45/h4-14,21,28,33H,15-20H2,1-3H3,(H,38,42)(H,44,45)	JUDGQBWJCBBMPL-UHFFFAOYSA-N	335918	4-(2-(1-(4-chlorophenyl)-2,5- dimethyl-1H-pyrrole-3- carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 147	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335918	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335918&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626253	384988075							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662301	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1ccccc1Cl)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClN4O6/c1-43-22-13-16-37(17-14-22)28-8-4-6-24-23(28)15-18-38(30(24)31(39)35-21-11-9-20(10-12-21)33(41)42)32(40)29-19-27(36-44-29)25-5-2-3-7-26(25)34/h2-12,19,22,30H,13-18H2,1H3,(H,35,39)(H,41,42)	FBWHUCZKOUXAFK-UHFFFAOYSA-N	335919	4-(2-(3-(2-chlorophenyl) isoxazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 148	Plasma kallikrein	Human	 1250								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335919	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335919&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626257	384988076							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662302	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1C(F)(F)F)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF3N5O5/c1-48-24-12-15-41(16-13-24)28-7-3-6-26-25(28)14-17-42(29(26)31(44)40-22-10-8-20(9-11-22)33(46)47)32(45)27-19-39-43(30(27)34(36,37)38)23-5-2-4-21(35)18-23/h2-11,18-19,24,29H,12-17H2,1H3,(H,40,44)(H,46,47)	UOAJSVQRAORWBH-UHFFFAOYSA-N	335921	4-(2-(1-(3-chlorophenyl)-5- (trifluoromethyl)-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 150	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335921	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335921&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348851	384988078							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662303	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1=O)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H35ClN4O6/c1-45-25-12-16-37(17-13-25)29-7-3-6-27-26(29)14-19-39(30(27)31(40)36-23-10-8-21(9-11-23)34(43)44)33(42)28-15-18-38(32(28)41)24-5-2-4-22(35)20-24/h2-11,20,25,28,30H,12-19H2,1H3,(H,36,40)(H,43,44)	HBNGEEKQCFDTBF-UHFFFAOYSA-N	336115	4-(2-(1-(3-chlorophenyl)-2- oxopyrrolidine-3-carbonyl)- 5-(4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 151	Plasma kallikrein	Human	 816								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626259	384988254							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662304	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(F)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31FN4O6/c1-43-24-12-15-37(16-13-24)28-7-3-6-26-25(28)14-17-38(30(26)31(39)35-23-10-8-20(9-11-23)33(41)42)32(40)29-19-27(36-44-29)21-4-2-5-22(34)18-21/h2-11,18-19,24,30H,12-17H2,1H3,(H,35,39)(H,41,42)	CZQIYQUQRWMSNN-UHFFFAOYSA-N	335922	4-(2-(3-(3-fluorophenyl) isoxazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 152	Plasma kallikrein	Human	 2516								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335922	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335922&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626254	384988079							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662305	COc1ncccc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H24ClFN6O5/c1-45-30-23(7-4-15-35-30)20-5-2-6-22-21(20)14-16-39(28(22)29(41)36-19-12-10-18(11-13-19)32(43)44)31(42)25-17-40(38-37-25)26-9-3-8-24(33)27(26)34/h2-13,15,17,28H,14,16H2,1H3,(H,36,41)(H,43,44)	IGZAIPQOJHCWHB-UHFFFAOYSA-N	335924	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methoxypyridin-3-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 153	Plasma kallikrein	Human	 62.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335924	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335924&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626316	384988081							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662306	CN(C)Cc1ccc(cc1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H30ClFN6O4/c1-41(2)19-21-9-11-22(12-10-21)25-5-3-6-27-26(25)17-18-42(32(27)33(44)38-24-15-13-23(14-16-24)35(46)47)34(45)29-20-43(40-39-29)30-8-4-7-28(36)31(30)37/h3-16,20,32H,17-19H2,1-2H3,(H,38,44)(H,46,47)	ZVZJRSQLHVSFCT-UHFFFAOYSA-N	335925	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- ((dimethylamino)methyl) phenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 154	Plasma kallikrein	Human	 5.26								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335925	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335925&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626305	384988082							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662307	NS(=O)(=O)c1cccc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H24ClFN6O6S/c33-25-8-3-9-27(28(25)34)40-17-26(37-38-40)31(42)39-15-14-23-22(19-4-1-5-21(16-19)47(35,45)46)6-2-7-24(23)29(39)30(41)36-20-12-10-18(11-13-20)32(43)44/h1-13,16-17,29H,14-15H2,(H,36,41)(H,43,44)(H2,35,45,46)	WIFGOOCSSHFCOL-UHFFFAOYSA-N	335926	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(3- sulfamoylphenyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 155	Plasma kallikrein	Human	 23.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335926	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335926&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626308	384988083							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662308	Cn1ncc2cc(ccc12)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-28-13-10-20(16-21(28)17-37-41)23-4-2-5-25-24(23)14-15-42(31(25)32(44)38-22-11-8-19(9-12-22)34(46)47)33(45)27-18-43(40-39-27)29-7-3-6-26(35)30(29)36/h2-13,16-18,31H,14-15H2,1H3,(H,38,44)(H,46,47)	PEYSPUAISONHGJ-UHFFFAOYSA-N	335927	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1- methyl-1H-indazol-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 156	Plasma kallikrein	Human	 30.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335927	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335927&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626313	384988084							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662309	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3OCOc3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C33H23ClFN5O6/c34-24-5-2-6-26(29(24)35)40-16-25(37-38-40)32(42)39-14-13-22-21(19-9-12-27-28(15-19)46-17-45-27)3-1-4-23(22)30(39)31(41)36-20-10-7-18(8-11-20)33(43)44/h1-12,15-16,30H,13-14,17H2,(H,36,41)(H,43,44)	YMKJYIGERWZMBD-UHFFFAOYSA-N	335928	4-(5-(benzo[d][1,3]dioxol-5- yl)-2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 157	Plasma kallikrein	Human	 29.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335928	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335928&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626227	384988085							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662310	COc1nc(CO)ncc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H25ClFN7O6/c1-47-30-22(14-35-26(16-42)37-30)19-4-2-5-21-20(19)12-13-40(28(21)29(43)36-18-10-8-17(9-11-18)32(45)46)31(44)24-15-41(39-38-24)25-7-3-6-23(33)27(25)34/h2-11,14-15,28,42H,12-13,16H2,1H3,(H,36,43)(H,45,46)	KEIUQGAQXZMPMF-UHFFFAOYSA-N	335929	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2,4- dimethoxypyrimidin-5-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 158	Plasma kallikrein	Human	 140								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335929&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752704	384988086							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662311	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cnoc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C29H20ClFN6O5/c30-22-5-2-6-24(25(22)31)37-14-23(34-35-37)28(39)36-12-11-20-19(17-13-32-42-15-17)3-1-4-21(20)26(36)27(38)33-18-9-7-16(8-10-18)29(40)41/h1-10,13-15,26H,11-12H2,(H,33,38)(H,40,41)	KNHSJHYZPJNHQS-UHFFFAOYSA-N	335930	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5- (isoxazol-4-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 159	Plasma kallikrein	Human	 21.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335930&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626229	384988087							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662312	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2cccc3cc[nH]c23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335931	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- indol-7-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 160	Plasma kallikrein	Human	 117								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335931&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626230	384988088							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662313	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-c2ccc3cn[nH]c3c2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1			335932	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(1H- indazol-6-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 161	Plasma kallikrein	Human	 2.46								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335932	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335932&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626374	384988089							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662314	Cn1cc2ccc(cc2n1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H25ClFN7O4/c1-41-17-21-9-8-20(16-27(21)39-41)23-4-2-5-25-24(23)14-15-42(31(25)32(44)37-22-12-10-19(11-13-22)34(46)47)33(45)28-18-43(40-38-28)29-7-3-6-26(35)30(29)36/h2-13,16-18,31H,14-15H2,1H3,(H,37,44)(H,46,47)	KHUVYEDRWCEEIA-UHFFFAOYSA-N	335933	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(2- methyl-2H-indazol-6-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 162	Plasma kallikrein	Human	 49.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335933&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626372	384988090							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662315	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc2N(C)C(=O)CCc2c1	InChI=1S/C35H35ClFN7O4/c1-41-28-11-10-22(19-21(28)9-12-31(41)45)38-34(46)33-25-5-3-7-29(42-16-13-23(48-2)14-17-42)24(25)15-18-43(33)35(47)27-20-44(40-39-27)30-8-4-6-26(36)32(30)37/h3-8,10-11,19-20,23,33H,9,12-18H2,1-2H3,(H,38,46)	BUBXPDDFAILUER-UHFFFAOYSA-N	335961	2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 189	Plasma kallikrein	Human	 540								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335961	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335961&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601819	384988118							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662316	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc2NC(=O)Cc2c1	InChI=1S/C33H31ClFN7O4/c1-46-21-10-13-40(14-11-21)27-6-2-4-23-22(27)12-15-41(31(23)32(44)36-20-8-9-25-19(16-20)17-29(43)37-25)33(45)26-18-42(39-38-26)28-7-3-5-24(34)30(28)35/h2-9,16,18,21,31H,10-15,17H2,1H3,(H,36,44)(H,37,43)	ITLFYSBJLLBJOI-UHFFFAOYSA-N	335962	2-(1-(3-Chloro-2-fluorophenyl)-1H-12,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-N-(2-oxoindolin-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 190	Plasma kallikrein	Human	 163								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335962	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335962&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601759	384988119							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662317	CC(=O)Nc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H22ClFN6O5/c1-15(37)31-21-6-2-4-19-18(21)12-13-35(25(19)26(38)32-17-10-8-16(9-11-17)28(40)41)27(39)22-14-36(34-33-22)23-7-3-5-20(29)24(23)30/h2-11,14,25H,12-13H2,1H3,(H,31,37)(H,32,38)(H,40,41)	DYDMJJDNJRSGGJ-UHFFFAOYSA-N	335963	4-(5-Acetamido-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 191	Plasma kallikrein	Human	 12.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335963&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626383	384988120							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662318	CN1CCC(CC1)NC(=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN7O5/c1-40-15-12-21(13-16-40)36-30(43)24-5-2-4-23-22(24)14-17-41(29(23)31(44)37-20-10-8-19(9-11-20)33(46)47)32(45)26-18-42(39-38-26)27-7-3-6-25(34)28(27)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,43)(H,37,44)(H,46,47)	LGQQAPCYXLKLHW-UHFFFAOYSA-N	335964	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((1-methylpiperidin-4-yl)carbamoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt.::US9738655, Example 192	Plasma kallikrein	Human	 55.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335964&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602250	384988121							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662319	OC(=O)c1ccc(NC(=O)C2N(CCc3c(NC(=O)NC4CCCC4)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H29ClFN7O5/c33-23-8-4-10-26(27(23)34)41-17-25(38-39-41)30(43)40-16-15-21-22(7-3-9-24(21)37-32(46)36-19-5-1-2-6-19)28(40)29(42)35-20-13-11-18(12-14-20)31(44)45/h3-4,7-14,17,19,28H,1-2,5-6,15-16H2,(H,35,42)(H,44,45)(H2,36,37,46)	LJVRVBNTOCCTEO-UHFFFAOYSA-N	335965	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(3-cyclopentylureido)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 193	Plasma kallikrein	Human	 2.34								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335965	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335965&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601686	384988122							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662320	OC(=O)c1ccc(NC(=O)C2N(CCc3c(Cl)cccc23)C(=O)c2cn(nn2)C2CC=CC(Cl)=C2F)cc1	InChI=1S/C26H20Cl2FN5O4/c27-18-4-1-3-17-16(18)11-12-33(23(17)24(35)30-15-9-7-14(8-10-15)26(37)38)25(36)20-13-34(32-31-20)21-6-2-5-19(28)22(21)29/h1-5,7-10,13,21,23H,6,11-12H2,(H,30,35)(H,37,38)	WLTRHIYRFBTMJU-UHFFFAOYSA-N	335966	4-(5-Chloro-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 194	Plasma kallikrein	Human	 41.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335966&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360915	384988123							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662321	OC(=O)c1ccc(NC(=O)C2N(CCc3c(F)cccc23)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C26H18ClF2N5O4/c27-18-4-2-6-21(22(18)29)34-13-20(31-32-34)25(36)33-12-11-16-17(3-1-5-19(16)28)23(33)24(35)30-15-9-7-14(8-10-15)26(37)38/h1-10,13,23H,11-12H2,(H,30,35)(H,37,38)	PKTQTDFJRKLUQK-UHFFFAOYSA-N	335967	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 195	Plasma kallikrein	Human	 30.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335967	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335967&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602022	384988124							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662322	O[C@H]1CCN(C1=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O6/c31-20-4-2-6-23(25(20)32)38-15-21(34-35-38)28(41)37-13-11-18-19(3-1-5-22(18)36-14-12-24(39)29(36)42)26(37)27(40)33-17-9-7-16(8-10-17)30(43)44/h1-10,15,24,26,39H,11-14H2,(H,33,40)(H,43,44)/t24-,26?/m0/s1	QEZNFQPAVIEUBG-QSAPEBAKSA-N	335968	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-((S)-3-hydroxy-2-oxopyrrolidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 196	Plasma kallikrein	Human	 11.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335968&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602162	384988125							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662323	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H26ClF4N7O5/c33-22-4-2-6-25(27(22)34)44-15-23(39-40-44)30(47)43-12-11-20-21(28(43)29(46)38-19-9-7-18(8-10-19)31(48)49)3-1-5-24(20)42-14-13-41(16-26(42)45)17-32(35,36)37/h1-10,15,28H,11-14,16-17H2,(H,38,46)(H,48,49)	CHOLKMVFUOCVEJ-UHFFFAOYSA-N	335969	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(2-oxo-4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 197	Plasma kallikrein	Human	 10.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602268	384988126							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662324	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18-19,29H,12-17H2,1H3,(H,34,39)(H,41,42)	HLDCZJMVJHEASJ-UHFFFAOYSA-N	335970	4-(2-(3-(3-chlorophenyl) isoxazole-5-carbonyl)-5- (4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 198	Plasma kallikrein	Human	 122								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335970&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348948	384988127							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662325	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nc1C(F)(F)F)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClF3N6O4/c1-40-14-16-41(17-15-40)27-7-3-6-25-24(27)12-13-42(28(25)30(44)38-22-10-8-20(9-11-22)32(46)47)31(45)26-19-43(39-29(26)33(35,36)37)23-5-2-4-21(34)18-23/h2-11,18-19,28H,12-17H2,1H3,(H,38,44)(H,46,47)	GQXIFWCUUMUPDH-UHFFFAOYSA-N	335971	4-(2-(1-(3-chlorophenyl)- 3-(trifluoromethyl)-1H- pyrazole-4-carbonyl)-5- (4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 199	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335971&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348955	384988128							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662326	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClN6O4/c1-36-14-16-37(17-15-36)28-7-3-6-27-26(28)12-13-38(29(27)30(40)35-24-10-8-21(9-11-24)32(42)43)31(41)22-19-34-39(20-22)25-5-2-4-23(33)18-25/h2-11,18-20,29H,12-17H2,1H3,(H,35,40)(H,42,43)	LUIFJTITJHESQD-UHFFFAOYSA-N	335972	4-(2-(1-(3-chlorophenyl)- 1H-pyrazole-4-carbonyl)- 5-(4-methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 200	Plasma kallikrein	Human	 10.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348951	384988129							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662327	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H30ClN7O4/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(28(25)29(40)33-22-10-8-20(9-11-22)31(42)43)30(41)26-19-39(35-34-26)23-5-2-4-21(32)18-23/h2-11,18-19,28H,12-17H2,1H3,(H,33,40)(H,42,43)	XMCZMUIHYCVFKG-UHFFFAOYSA-N	335973	4-(2-(1-(3-chlorophenyl)- 1H-1,2,3-triazole-4- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 201	Plasma kallikrein	Human	 4.21								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348790	384988130							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662328	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN5O5/c1-37-14-16-38(17-15-37)26-7-3-4-22-21(26)12-13-39(29(22)30(40)35-20-10-8-19(9-11-20)32(42)43)31(41)27-18-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,27,29H,12-18H2,1H3,(H,35,40)(H,42,43)	VBRLSZRSHQMRBW-UHFFFAOYSA-N	335974	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 202	Plasma kallikrein	Human	 1.11								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348822	384988131							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662329	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)C2CC(=NO2)c2cccc(Cl)c2)cc1	InChI=1S/C36H38ClN5O5/c37-25-6-3-5-24(21-25)30-22-32(47-39-30)35(44)42-20-15-28-29(33(42)34(43)38-26-11-9-23(10-12-26)36(45)46)7-4-8-31(28)41-18-13-27(14-19-41)40-16-1-2-17-40/h3-12,21,27,32-33H,1-2,13-20,22H2,(H,38,43)(H,45,46)	OCAQZKQTRAMKPI-UHFFFAOYSA-N	335975	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4-(pyrrolidin- 1-yl)piperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 203::US9738655, Example 204	Plasma kallikrein	Human	 1.29								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348830	384988132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662330	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)C2CC(=NO2)c2cccc(Cl)c2)cc1	InChI=1S/C36H38ClN5O5/c37-25-6-3-5-24(21-25)30-22-32(47-39-30)35(44)42-20-15-28-29(33(42)34(43)38-26-11-9-23(10-12-26)36(45)46)7-4-8-31(28)41-18-13-27(14-19-41)40-16-1-2-17-40/h3-12,21,27,32-33H,1-2,13-20,22H2,(H,38,43)(H,45,46)	OCAQZKQTRAMKPI-UHFFFAOYSA-N	335975	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4-(pyrrolidin- 1-yl)piperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 203::US9738655, Example 204	Plasma kallikrein	Human	 11.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348830	384988132							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662331	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClF2N5O5/c1-38-13-15-39(16-14-38)25-4-2-3-21-20(25)11-12-40(29(21)30(41)36-19-7-5-18(6-8-19)32(43)44)31(42)26-17-24(37-45-26)27-23(34)10-9-22(33)28(27)35/h2-10,26,29H,11-17H2,1H3,(H,36,41)(H,43,44)	SMIFYFPYEXCOIX-UHFFFAOYSA-N	335977	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 205	Plasma kallikrein	Human	 0.640								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348800	384988133							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662332	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)c2cn(nn2)-c2cccc(Cl)c2)cc1	InChI=1S/C35H34ClN7O5/c36-23-4-1-5-26(20-23)43-21-29(38-39-43)34(46)42-19-15-27-28(32(42)33(45)37-24-11-9-22(10-12-24)35(47)48)6-2-7-30(27)40-17-13-25(14-18-40)41-16-3-8-31(41)44/h1-2,4-7,9-12,20-21,25,32H,3,8,13-19H2,(H,37,45)(H,47,48)	HMYKACYTEVALQS-UHFFFAOYSA-N	335978	4-(2-(1-(3-chlorophenyl)- 1H-1,2,3-triazole-4- carbonyl)-5-(4-(2- oxopyrrolidin-1-yl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 206	Plasma kallikrein	Human	 68.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335978&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348862	384988134							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662333	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C36H35ClFN5O6/c37-27-6-1-5-26(32(27)38)28-20-30(49-40-28)35(46)43-19-15-24-25(33(43)34(45)39-22-11-9-21(10-12-22)36(47)48)4-2-7-29(24)41-17-13-23(14-18-41)42-16-3-8-31(42)44/h1-2,4-7,9-12,23,30,33H,3,8,13-20H2,(H,39,45)(H,47,48)/t30-,33+/m1/s1	BYIDDONUXSZNHZ-NDKRRWIDSA-N	335979	4-((S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4-(2- oxopyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 207::US9738655, Example 208	Plasma kallikrein	Human	 30.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348770	384988135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662334	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C36H35ClFN5O6/c37-27-6-1-5-26(32(27)38)28-20-30(49-40-28)35(46)43-19-15-24-25(33(43)34(45)39-22-11-9-21(10-12-22)36(47)48)4-2-7-29(24)41-17-13-23(14-18-41)42-16-3-8-31(42)44/h1-2,4-7,9-12,23,30,33H,3,8,13-20H2,(H,39,45)(H,47,48)/t30-,33+/m1/s1	BYIDDONUXSZNHZ-NDKRRWIDSA-N	335979	4-((S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4-(2- oxopyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 207::US9738655, Example 208	Plasma kallikrein	Human	 447								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348770	384988135							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662335	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnnn1-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H29ClFN7O4/c1-37-14-16-38(17-15-37)24-6-2-4-22-21(24)12-13-39(28(22)29(41)35-20-10-8-19(9-11-20)31(43)44)30(42)26-18-34-36-40(26)25-7-3-5-23(32)27(25)33/h2-11,18,28H,12-17H2,1H3,(H,35,41)(H,43,44)	YGAQJTUPCIZKHJ-UHFFFAOYSA-N	335981	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-5-carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 209	Plasma kallikrein	Human	 491								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348957	384988136							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662336	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN7O4/c36-27-6-4-8-30(31(27)37)44-21-28(39-40-44)34(46)43-20-15-25-26(32(43)33(45)38-23-11-9-22(10-12-23)35(47)48)5-3-7-29(25)42-18-13-24(14-19-42)41-16-1-2-17-41/h3-12,21,24,32H,1-2,13-20H2,(H,38,45)(H,47,48)	SQPALEBBCZQRAK-UHFFFAOYSA-N	335982	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- (pyrrolidin-1-yl)piperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 210	Plasma kallikrein	Human	 1.34								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348842	384988137							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662337	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H29ClFN7O4/c1-37-14-16-38(17-15-37)25-6-2-4-22-21(25)12-13-39(28(22)29(41)34-20-10-8-19(9-11-20)31(43)44)30(42)24-18-40(36-35-24)26-7-3-5-23(32)27(26)33/h2-11,18,28H,12-17H2,1H3,(H,34,41)(H,43,44)	POLUXRBRQBKZOB-UHFFFAOYSA-N	335984	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 211	Plasma kallikrein	Human	 0.520								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348915	384988139							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662338	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClFN7O4/c1-38-14-16-39(17-15-38)25-6-2-4-22-21(25)12-13-40(28(22)30(42)37-20-10-8-19(9-11-20)32(44)45)31(43)23-18-36-41(29(23)35)26-7-3-5-24(33)27(26)34/h2-11,18,28H,12-17,35H2,1H3,(H,37,42)(H,44,45)	NAHGIMDHYQSLEN-UHFFFAOYSA-N	335985	4-(2-(5-amino-1-(3-chloro- 2-fluorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- methylpiperazin-1- yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 212	Plasma kallikrein	Human	 2.89								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348847	384988140							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662339	Nc1c(cnn1-c1cccc(Cl)c1F)C(=O)N1CCc2c(cccc2N2CCC(CC2)N2CCCC2)C1C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClFN7O4/c37-28-6-4-8-30(31(28)38)45-33(39)27(21-40-45)35(47)44-20-15-25-26(32(44)34(46)41-23-11-9-22(10-12-23)36(48)49)5-3-7-29(25)43-18-13-24(14-19-43)42-16-1-2-17-42/h3-12,21,24,32H,1-2,13-20,39H2,(H,41,46)(H,48,49)	ZZLZGWMCLXDEAX-UHFFFAOYSA-N	335987	4-(2-(5-amino-1-(3-chloro- 2-fluorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- (pyrrolidin-1- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 3TFA salt::US9738655, Example 213	Plasma kallikrein	Human	 12.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348876	384988142							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662340	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-45-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)30(41)35-20-10-8-19(9-11-20)32(43)44)31(42)25-18-40(37-36-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H,35,41)(H,43,44)	AVKKDSOYYJOTLE-UHFFFAOYSA-N	335989	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 215	Plasma kallikrein	Human	 20.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348785	384988144							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662341	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18,28-29H,12-17,19H2,1H3,(H,34,39)(H,41,42)	DXPRVTLHVRYGPT-UHFFFAOYSA-N	335990	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 216::US9738655, Example 217	Plasma kallikrein	Human	 0.360								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348945	384988145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662342	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32ClN5O5/c1-36-14-16-37(17-15-36)27-7-3-6-25-24(27)12-13-38(29(25)30(39)34-23-10-8-20(9-11-23)32(41)42)31(40)28-19-26(35-43-28)21-4-2-5-22(33)18-21/h2-11,18,28-29H,12-17,19H2,1H3,(H,34,39)(H,41,42)	DXPRVTLHVRYGPT-UHFFFAOYSA-N	335990	4-(2-(3-(3-chlorophenyl)- 4,5-dihydroisoxazole-5- carbonyl)-5-(4- methylpiperazin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 216::US9738655, Example 217	Plasma kallikrein	Human	 3.12								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348945	384988145							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662343	CCOC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCC(CC2)N2CCCC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C37H39ClFN7O4/c1-2-50-37(49)24-11-13-25(14-12-24)40-35(47)34-28-7-5-9-31(44-20-15-26(16-21-44)43-18-3-4-19-43)27(28)17-22-45(34)36(48)30-23-46(42-41-30)32-10-6-8-29(38)33(32)39/h5-14,23,26,34H,2-4,15-22H2,1H3,(H,40,47)	OGIRXZYFCSDAHF-UHFFFAOYSA-N	335993	Ethyl 4-(2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(pyrrolidin-1-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 219	Plasma kallikrein	Human	 1.96								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601687	384988147							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662344	Cn1cc2C(N(CCc2n1)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C24H19ClFN7O4/c1-31-11-15-17(29-31)9-10-32(21(15)22(34)27-14-7-5-13(6-8-14)24(36)37)23(35)18-12-33(30-28-18)19-4-2-3-16(25)20(19)26/h2-8,11-12,21H,9-10H2,1H3,(H,27,34)(H,36,37)	PNBRHWUSMQXLGG-UHFFFAOYSA-N	335994	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-2-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 220	Plasma kallikrein	Human	 179								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601273	384988148							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662345	Cc1nn(C)c2CCN(C(C(=O)Nc3ccc(cc3)C(O)=O)c12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F	InChI=1S/C25H21ClFN7O4/c1-13-20-18(32(2)30-13)10-11-33(22(20)23(35)28-15-8-6-14(7-9-15)25(37)38)24(36)17-12-34(31-29-17)19-5-3-4-16(26)21(19)27/h3-9,12,22H,10-11H2,1-2H3,(H,28,35)(H,37,38)	LNKXXEMOPNVZGM-UHFFFAOYSA-N	335995	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,3-dimethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 221	Plasma kallikrein	Human	 9.56								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602368	384988149							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662346	Cc1c2C(N(CCc2nn1C)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C25H21ClFN7O4/c1-13-20-17(30-32(13)2)10-11-33(22(20)23(35)28-15-8-6-14(7-9-15)25(37)38)24(36)18-12-34(31-29-18)19-5-3-4-16(26)21(19)27/h3-9,12,22H,10-11H2,1-2H3,(H,28,35)(H,37,38)	LPSATGNYPUSCRA-UHFFFAOYSA-N	335996	4-(5-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-2,3-dimethyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-4-carboxamido)benzoic acid::US9738655, Example 222	Plasma kallikrein	Human	 10.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602225	384988150							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662347	CC(C)c1nnc2C(N(CCn12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C25H22ClFN8O4/c1-13(2)21-30-31-22-20(23(36)28-15-8-6-14(7-9-15)25(38)39)33(10-11-34(21)22)24(37)17-12-35(32-29-17)18-5-3-4-16(26)19(18)27/h3-9,12-13,20H,10-11H2,1-2H3,(H,28,36)(H,38,39)	UNPXKQNGNGYHMC-UHFFFAOYSA-N	335997	4-(7-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-3-isopropyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-8-carboxamido)benzoic acid::US9738655, Example 223	Plasma kallikrein	Human	 3508								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348885	384988151							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662348	COC(C)(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H37ClFN5O5/c1-36(2,48-3)24-14-17-41(18-15-24)29-8-4-6-27-26(29)16-19-42(32(27)33(44)40-25-12-10-22(11-13-25)35(46)47)34(45)23-20-39-43(21-23)30-9-5-7-28(37)31(30)38/h4-13,20-21,24,32H,14-19H2,1-3H3,(H,40,44)(H,46,47)	KOIPMQRRUHXKHA-UHFFFAOYSA-N	335998	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-methoxypropan-2-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 224	Plasma kallikrein	Human	 92.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602371	384988152							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662349	CC(CO)(CO)COC(C)(C)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C40H45ClFN5O7/c1-39(2,54-24-40(3,22-48)23-49)27-14-17-45(18-15-27)32-8-4-6-30-29(32)16-19-46(35(30)36(50)44-28-12-10-25(11-13-28)38(52)53)37(51)26-20-43-47(21-26)33-9-5-7-31(41)34(33)42/h4-13,20-21,27,35,48-49H,14-19,22-24H2,1-3H3,(H,44,50)(H,52,53)	LYLYQCQXDDERQN-UHFFFAOYSA-N	336000	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-(3-hydroxy-2-(hydroxymethyl)-2-methylpropoxy)propan-2-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 225	Plasma kallikrein	Human	 48.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626341	384988154							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662350	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C33H31ClFN7O5/c34-25-4-2-6-28(29(25)35)42-17-26(37-38-42)32(44)41-12-11-23-24(30(41)31(43)36-21-9-7-20(8-10-21)33(45)46)3-1-5-27(23)40-15-13-39(14-16-40)22-18-47-19-22/h1-10,17,22,30H,11-16,18-19H2,(H,36,43)(H,45,46)	OEFZJAZPDZGMHT-UHFFFAOYSA-N	336001	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 226	Plasma kallikrein	Human	 7.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602149	384988155							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662351	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C32H28ClF4N7O4/c33-23-4-2-6-26(27(23)34)44-17-24(39-40-44)30(46)43-12-11-21-22(28(43)29(45)38-20-9-7-19(8-10-20)31(47)48)3-1-5-25(21)42-15-13-41(14-16-42)18-32(35,36)37/h1-10,17,28H,11-16,18H2,(H,38,45)(H,47,48)	HLCWXSMXMUHDBM-UHFFFAOYSA-N	336004	4-(2-(1-(3-Chloro-2 fluorophenyl) 1H 1,2,3 triazolo-4-carbonyl) 5 (4(2,2,2 trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 229	Plasma kallikrein	Human	 124								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626281	384988158							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662352	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)C2=NOC(C2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H30ClF4N5O5/c34-24-5-1-4-23(28(24)35)27-17-25(40-48-27)31(45)43-12-11-21-22(29(43)30(44)39-20-9-7-19(8-10-20)32(46)47)3-2-6-26(21)42-15-13-41(14-16-42)18-33(36,37)38/h1-10,27,29H,11-18H2,(H,39,44)(H,46,47)/t27?,29-/m0/s1	NCKGZOIZIIDSIQ-ACEFPKFPSA-N	336005	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 230	Plasma kallikrein	Human	 12.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336005&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138805702	384988159							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662353	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCN(CC(F)(F)F)CC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C33H30ClF4N5O5/c34-24-5-1-4-23(28(24)35)25-17-27(48-40-25)31(45)43-12-11-21-22(29(43)30(44)39-20-9-7-19(8-10-20)32(46)47)3-2-6-26(21)42-15-13-41(14-16-42)18-33(36,37)38/h1-10,27,29H,11-18H2,(H,39,44)(H,46,47)/t27-,29-/m1/s1	OFIYZOXNLSDWIA-XRKRLSELSA-N	336006	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(2,2,2-trifluoroethyl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 231	Plasma kallikrein	Human	 1286								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626343	384988160							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662354	COC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN5O6/c1-46-35(45)21-8-10-22(11-9-21)38-33(43)32-25-4-3-7-29(41-16-14-40(15-17-41)23-19-47-20-23)24(25)12-13-42(32)34(44)30-18-28(39-48-30)26-5-2-6-27(36)31(26)37/h2-11,23,30,32H,12-20H2,1H3,(H,38,43)/t30-,32+/m1/s1	WYNQUZLUOKMEBB-BHYZAODMSA-N	336007	Methyl 4-((S)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 232	Plasma kallikrein	Human	 29.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602131	384988161							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662355	COC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCN(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H35ClFN5O6/c1-46-35(45)21-8-10-22(11-9-21)38-33(43)32-25-4-3-7-29(41-16-14-40(15-17-41)23-19-47-20-23)24(25)12-13-42(32)34(44)30-18-28(39-48-30)26-5-2-6-27(36)31(26)37/h2-11,23,30,32H,12-20H2,1H3,(H,38,43)/t30-,32-/m1/s1	WYNQUZLUOKMEBB-XLJNKUFUSA-N	336008	Methyl 4-((R)-2-((R)-3-(3-chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoate, 2 TFA salt::US9738655, Example 233	Plasma kallikrein	Human	 16.5								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626342	384988162							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662356	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCC(CC2)C2COC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C35H34ClFN4O6/c36-27-5-1-4-26(31(27)37)28-17-30(47-39-28)34(43)41-16-13-24-25(32(41)33(42)38-23-9-7-21(8-10-23)35(44)45)3-2-6-29(24)40-14-11-20(12-15-40)22-18-46-19-22/h1-10,20,22,30,32H,11-19H2,(H,38,42)(H,44,45)/t30-,32+/m1/s1	QWULNBLKJBJATC-BHYZAODMSA-N	336009	4-((1S)-2-(3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4-(oxetan-3-yl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 234	Plasma kallikrein	Human	 26.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626284	384988163							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662357	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccccc1F	InChI=1S/C32H31ClF2N4O4/c1-42-19-12-15-38(16-13-19)27-11-5-6-21-20(27)14-17-39(30(21)31(40)36-25-10-3-2-9-24(25)34)32(41)28-18-26(37-43-28)22-7-4-8-23(33)29(22)35/h2-11,19,28,30H,12-18H2,1H3,(H,36,40)/t28-,30+/m1/s1	FBKZJUBYSKDARQ-DGPALRBDSA-N	336010	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(2-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 235	Plasma kallikrein	Human	 478								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348911	384988164							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662358	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccccc1F	InChI=1S/C32H31ClF2N4O4/c1-42-19-12-15-38(16-13-19)27-11-5-6-21-20(27)14-17-39(30(21)31(40)36-25-10-3-2-9-24(25)34)32(41)28-18-26(37-43-28)22-7-4-8-23(33)29(22)35/h2-11,19,28,30H,12-18H2,1H3,(H,36,40)/t28-,30-/m1/s1	FBKZJUBYSKDARQ-PQHLKRTFSA-N	336011	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(2-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 236	Plasma kallikrein	Human	 172								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348975	384988165							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662359	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccc(F)c1	InChI=1S/C32H31ClF2N4O4/c1-42-21-11-14-38(15-12-21)27-10-4-7-23-22(27)13-16-39(30(23)31(40)36-20-6-2-5-19(34)17-20)32(41)28-18-26(37-43-28)24-8-3-9-25(33)29(24)35/h2-10,17,21,28,30H,11-16,18H2,1H3,(H,36,40)/t28-,30+/m1/s1	QVDOEOXJZQAZPB-DGPALRBDSA-N	336012	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(3-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 237	Plasma kallikrein	Human	 130								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348869	384988166							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662360	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccc(F)c1	InChI=1S/C32H31ClF2N4O4/c1-42-21-11-14-38(15-12-21)27-10-4-7-23-22(27)13-16-39(30(23)31(40)36-20-6-2-5-19(34)17-20)32(41)28-18-26(37-43-28)24-8-3-9-25(33)29(24)35/h2-10,17,21,28,30H,11-16,18H2,1H3,(H,36,40)/t28-,30-/m1/s1	QVDOEOXJZQAZPB-PQHLKRTFSA-N	336013	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(3-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 238	Plasma kallikrein	Human	 172								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348871	384988167							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662361	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C32H31ClF2N4O4/c1-42-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(34)9-11-20)32(41)28-18-26(37-43-28)24-5-2-6-25(33)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)/t28-,30+/m1/s1	XEUVRDLOIIIIHG-DGPALRBDSA-N	336014	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(4-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 239	Plasma kallikrein	Human	 84.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348952	384988168							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662362	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C32H31ClF2N4O4/c1-42-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(34)9-11-20)32(41)28-18-26(37-43-28)24-5-2-6-25(33)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)/t28-,30-/m1/s1	XEUVRDLOIIIIHG-PQHLKRTFSA-N	336015	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)- N-(4-fluorophenyl)-5- (4-methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 240	Plasma kallikrein	Human	 172								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348765	384988169							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662363	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccnc1	InChI=1S/C31H31ClFN5O4/c1-41-20-10-14-37(15-11-20)26-9-3-6-22-21(26)12-16-38(29(22)30(39)35-19-5-4-13-34-18-19)31(40)27-17-25(36-42-27)23-7-2-8-24(32)28(23)33/h2-9,13,18,20,27,29H,10-12,14-17H2,1H3,(H,35,39)/t27-,29+/m1/s1	BKEBYDDMOGLBNQ-PXJZQJOASA-N	336016	(S)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-N- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 241	Plasma kallikrein	Human	 66.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348835	384988170							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662364	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1cccnc1	InChI=1S/C31H31ClFN5O4/c1-41-20-10-14-37(15-11-20)26-9-3-6-22-21(26)12-16-38(29(22)30(39)35-19-5-4-13-34-18-19)31(40)27-17-25(36-42-27)23-7-2-8-24(32)28(23)33/h2-9,13,18,20,27,29H,10-12,14-17H2,1H3,(H,35,39)/t27-,29-/m1/s1	BKEBYDDMOGLBNQ-XRKRLSELSA-N	336017	(R)-2-((R)-3-(3-chloro- 2-fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-N- (pyridin-3-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide, TFA salt::US9738655, Example 242	Plasma kallikrein	Human	 1230								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348810	384988171							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662365	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1F)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-19-10-13-39(14-11-19)27-7-3-4-21-20(27)12-15-40(30(21)31(41)37-25-9-8-18(33(43)44)16-24(25)35)32(42)28-17-26(38-46-28)22-5-2-6-23(34)29(22)36/h2-9,16,19,28,30H,10-15,17H2,1H3,(H,37,41)(H,43,44)/t28-,30+/m1/s1	BRVVKZBEEFTKFV-DGPALRBDSA-N	336018	4-((S)-2-((R)-3-(3- chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamide)-3- fluorobenzoic acid, TFA salt::US9738655, Example 243	Plasma kallikrein	Human	 37.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360916	384988172							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662366	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1F)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-19-10-13-39(14-11-19)27-7-3-4-21-20(27)12-15-40(30(21)31(41)37-25-9-8-18(33(43)44)16-24(25)35)32(42)28-17-26(38-46-28)22-5-2-6-23(34)29(22)36/h2-9,16,19,28,30H,10-15,17H2,1H3,(H,37,41)(H,43,44)/t28-,30-/m1/s1	BRVVKZBEEFTKFV-PQHLKRTFSA-N	336019	4-((R)-2-((R)-3-(3- chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5- carbonyl)-5-(4- methoxypiperidin- 1-yl)-1,2,3,4- tetrahydroisoquinoline- 1-carboxamido)-3- fluorobenzoic acid, TFA salt::US9738655, Example 244	Plasma kallikrein	Human	 635								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348926	384988173							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662367	Cn1ncnc1-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H22ClFN8O4/c1-37-26(32-15-33-37)20-5-2-4-19-18(20)12-13-38(25(19)27(40)34-17-10-8-16(9-11-17)29(42)43)28(41)22-14-39(36-35-22)23-7-3-6-21(30)24(23)31/h2-11,14-15,25H,12-13H2,1H3,(H,34,40)(H,42,43)	RMAYSVYLVSTKER-UHFFFAOYSA-N	336020	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(1-methyl-1H-1,2,4-triazol-5-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 245	Plasma kallikrein	Human	 68.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602031	384988174							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662368	Cn1cnc(c1)-c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H23ClFN7O4/c1-37-14-23(33-16-37)20-4-2-5-21-19(20)12-13-38(27(21)28(40)34-18-10-8-17(9-11-18)30(42)43)29(41)24-15-39(36-35-24)25-7-3-6-22(31)26(25)32/h2-11,14-16,27H,12-13H2,1H3,(H,34,40)(H,42,43)	YIYZFYYPRWABJD-UHFFFAOYSA-N	336021	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(1-methyl-1H-imidazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 246	Plasma kallikrein	Human	 29.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602346	384988175							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662369	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3-n2cnnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C29H22ClFN6O5/c30-21-5-1-4-20(25(21)31)22-13-24(42-35-22)28(39)37-12-11-18-19(3-2-6-23(18)36-14-32-33-15-36)26(37)27(38)34-17-9-7-16(8-10-17)29(40)41/h1-10,14-15,24,26H,11-13H2,(H,34,38)(H,40,41)/t24-,26+/m1/s1	VZRPGIGGABVQRY-RSXGOPAZSA-N	336022	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 247	Plasma kallikrein	Human	 9.20								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602032	384988176							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662370	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3-n2cnnc2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C29H22ClFN6O5/c30-21-5-1-4-20(25(21)31)22-13-24(42-35-22)28(39)37-12-11-18-19(3-2-6-23(18)36-14-32-33-15-36)26(37)27(38)34-17-9-7-16(8-10-17)29(40)41/h1-10,14-15,24,26H,11-13H2,(H,34,38)(H,40,41)/t24-,26-/m1/s1	VZRPGIGGABVQRY-AOYPEHQESA-N	336023	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 248	Plasma kallikrein	Human	 83.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602179	384988177							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662371	OC(=O)c1ccc(NC(=O)C2N(CCc3c2cccc3-n2cnnc2)C(=O)c2cn(nn2)-c2cccc(Cl)c2F)cc1	InChI=1S/C28H20ClFN8O4/c29-20-4-2-6-23(24(20)30)38-13-21(34-35-38)27(40)37-12-11-18-19(3-1-5-22(18)36-14-31-32-15-36)25(37)26(39)33-17-9-7-16(8-10-17)28(41)42/h1-10,13-15,25H,11-12H2,(H,33,39)(H,41,42)	DVVGYZRXNJAFET-UHFFFAOYSA-N	336024	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4H-1,2,4-triazol-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 249	Plasma kallikrein	Human	 20.4								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602366	384988178							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662372	Cc1ncn(n1)-c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O5/c1-16-33-15-38(35-16)24-7-3-4-20-19(24)12-13-37(27(20)28(39)34-18-10-8-17(9-11-18)30(41)42)29(40)25-14-23(36-43-25)21-5-2-6-22(31)26(21)32/h2-11,15,25,27H,12-14H2,1H3,(H,34,39)(H,41,42)/t25-,27+/m1/s1	DKXUHQBHEBTMRA-VPUSJEBWSA-N	336025	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-1H-1,2,4-triazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 250	Plasma kallikrein	Human	 6.80								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602048	384988179							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662373	Cc1ncn(n1)-c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C30H24ClFN6O5/c1-16-33-15-38(35-16)24-7-3-4-20-19(24)12-13-37(27(20)28(39)34-18-10-8-17(9-11-18)30(41)42)29(40)25-14-23(36-43-25)21-5-2-6-22(31)26(21)32/h2-11,15,25,27H,12-14H2,1H3,(H,34,39)(H,41,42)/t25-,27-/m1/s1	DKXUHQBHEBTMRA-XNMGPUDCSA-N	336026	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-1H-1,2,4-triazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 251	Plasma kallikrein	Human	 601								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602070	384988180							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662374	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(30(25)31(41)37-22-10-8-20(9-11-22)33(43)44)32(42)21-18-36-40(19-21)28-7-3-5-26(34)29(28)35/h2-11,18-19,23,30H,12-17H2,1H3,(H,37,41)(H,43,44)	RWHNCKXIRHTDDM-UHFFFAOYSA-N	336027	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 252	Plasma kallikrein	Human	 42.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348805	384988181							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662375	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1nnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-19-29(37-38-41(19)27-8-4-6-25(34)28(27)35)32(43)40-18-15-23-24(5-3-7-26(23)39-16-13-22(46-2)14-17-39)30(40)31(42)36-21-11-9-20(10-12-21)33(44)45/h3-12,22,30H,13-18H2,1-2H3,(H,36,42)(H,44,45)	DWRSBCWFVOSCSL-UHFFFAOYSA-N	336028	4-(2-(1-(3-chloro-2- fluorophenyl)-5-methyl-1H- 1,2,3-triazole-4-cabonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 253	Plasma kallikrein	Human	 156								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348977	384988182							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662376	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClF2N6O5/c1-46-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(28(22)30(42)36-19-7-5-18(6-8-19)32(44)45)31(43)25-17-41(38-37-25)29-24(34)10-9-23(33)27(29)35/h2-10,17,20,28H,11-16H2,1H3,(H,36,42)(H,44,45)	BSVVTWVVLQCLSV-UHFFFAOYSA-N	336029	4-(2-(1-(3-chloro-2,6- difluorophenyl)-1H-1,2,3- triazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 254	Plasma kallikrein	Human	 26.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348855	384988183							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662377	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-46-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(31(25)32(42)37-22-10-8-20(9-11-22)34(44)45)33(43)21-18-29(41)40(19-21)28-7-3-5-26(35)30(28)36/h2-11,21,23,31H,12-19H2,1H3,(H,37,42)(H,44,45)	FVMSTJUBRSUZEY-UHFFFAOYSA-N	336030	4-(2-(1-(3-chloro-2- fluorophenyl)-5-oxopyrrolidine- 3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 255::US9738655, Example 260	Plasma kallikrein	Human	 218								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348888	384988184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662378	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,37,41)(H,43,44)	STEFBFVBPIATQL-UHFFFAOYSA-N	336031	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 256::US9738655, Example 257	Plasma kallikrein	Human	 198								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348852	384988185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662379	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,37,41)(H,43,44)	STEFBFVBPIATQL-UHFFFAOYSA-N	336031	4-(2-(3-(3-chloro-2,6- difluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 256::US9738655, Example 257	Plasma kallikrein	Human	 24.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348852	384988185							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662380	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H37ClN4O5/c1-44-27-13-17-37(18-14-27)30-7-3-6-29-28(30)15-19-39(31(29)32(40)36-25-10-8-22(9-11-25)34(42)43)33(41)23-12-16-38(21-23)26-5-2-4-24(35)20-26/h2-11,20,23,27,31H,12-19,21H2,1H3,(H,36,40)(H,42,43)	SDSUGQWNKGNWPZ-UHFFFAOYSA-N	336033	4-(2-(1-(3-chlorophenyl) pyrrolidine-3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 258::US9738655, Example 261	Plasma kallikrein	Human	 1624								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348789	384988186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662381	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1C)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33ClFN5O5/c1-20-26(19-37-41(20)29-8-4-6-27(35)30(29)36)33(43)40-18-15-24-25(5-3-7-28(24)39-16-13-23(46-2)14-17-39)31(40)32(42)38-22-11-9-21(10-12-22)34(44)45/h3-12,19,23,31H,13-18H2,1-2H3,(H,38,42)(H,44,45)	UCDVYJZKTAJIGN-UHFFFAOYSA-N	336034	4-(2-(1-(3-chloro-2- fluorophenyl)-5-methyl-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 259	Plasma kallikrein	Human	 77.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348864	384988187							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662382	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CN(C(=O)C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-46-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(31(25)32(42)37-22-10-8-20(9-11-22)34(44)45)33(43)21-18-29(41)40(19-21)28-7-3-5-26(35)30(28)36/h2-11,21,23,31H,12-19H2,1H3,(H,37,42)(H,44,45)	FVMSTJUBRSUZEY-UHFFFAOYSA-N	336030	4-(2-(1-(3-chloro-2- fluorophenyl)-5-oxopyrrolidine- 3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 255::US9738655, Example 260	Plasma kallikrein	Human	 4750								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348888	384988184							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662383	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H37ClN4O5/c1-44-27-13-17-37(18-14-27)30-7-3-6-29-28(30)15-19-39(31(29)32(40)36-25-10-8-22(9-11-25)34(42)43)33(41)23-12-16-38(21-23)26-5-2-4-24(35)20-26/h2-11,20,23,27,31H,12-19,21H2,1H3,(H,36,40)(H,42,43)	SDSUGQWNKGNWPZ-UHFFFAOYSA-N	336033	4-(2-(1-(3-chlorophenyl) pyrrolidine-3-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 258::US9738655, Example 261	Plasma kallikrein	Human	 891								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348789	384988186							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662384	CC(C)(O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H36ClFN4O6/c1-35(2,46)21-13-16-40(17-14-21)28-8-4-5-24-23(28)15-18-41(31(24)32(42)38-22-11-9-20(10-12-22)34(44)45)33(43)29-19-27(39-47-29)25-6-3-7-26(36)30(25)37/h3-12,21,29,31,46H,13-19H2,1-2H3,(H,38,42)(H,44,45)	CBUOZCLOWILCLC-UHFFFAOYSA-N	336040	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(2-hydroxypropan-2- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 262::US9738655, Example 263	Plasma kallikrein	Human	 4.36								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348803	384988191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662385	CC(C)(O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H36ClFN4O6/c1-35(2,46)21-13-16-40(17-14-21)28-8-4-5-24-23(28)15-18-41(31(24)32(42)38-22-11-9-20(10-12-22)34(44)45)33(43)29-19-27(39-47-29)25-6-3-7-26(36)30(25)37/h3-12,21,29,31,46H,13-19H2,1-2H3,(H,38,42)(H,44,45)	CBUOZCLOWILCLC-UHFFFAOYSA-N	336040	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(2-hydroxypropan-2- yl)piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 262::US9738655, Example 263	Plasma kallikrein	Human	 68.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348803	384988191							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662386	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nc1O)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O6/c1-46-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)31(42)36-20-10-8-19(9-11-20)33(44)45)32(43)24-18-40(37-30(24)41)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,42)(H,37,41)(H,44,45)	JHRMBOAVPWDUPH-UHFFFAOYSA-N	336042	4-(2-(1-(3-chloro-2- fluorophenyl)-3-hydroxy-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 264	Plasma kallikrein	Human	 11.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348797	384988192							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662387	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClF2N4O6/c1-45-20-11-14-39(15-12-20)26-4-2-3-22-21(26)13-16-40(30(22)31(41)37-19-7-5-18(6-8-19)33(43)44)32(42)27-17-25(38-46-27)28-24(35)10-9-23(34)29(28)36/h2-10,17,20,30H,11-16H2,1H3,(H,37,41)(H,43,44)	DPNLDCMWYAQGGL-UHFFFAOYSA-N	336043	4-(2-(3-(3-chloro-2,6- difluorophenyl)isoxazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 265	Plasma kallikrein	Human	 178								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348968	384988193							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662388	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1(C)CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-34(19-27(38-46-34)25-6-3-7-26(35)29(25)36)33(44)40-18-15-23-24(5-4-8-28(23)39-16-13-22(45-2)14-17-39)30(40)31(41)37-21-11-9-20(10-12-21)32(42)43/h3-12,22,30H,13-19H2,1-2H3,(H,37,41)(H,42,43)	FQAXKURWFFUWDN-UHFFFAOYSA-N	336044	4-(2-(3-(3-chloro-2- fluorophenyl)-5-methyl-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 266::US9738655, Example 267	Plasma kallikrein	Human	 687								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348791	384988194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662389	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1(C)CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H34ClFN4O6/c1-34(19-27(38-46-34)25-6-3-7-26(35)29(25)36)33(44)40-18-15-23-24(5-4-8-28(23)39-16-13-22(45-2)14-17-39)30(40)31(41)37-21-11-9-20(10-12-21)32(42)43/h3-12,22,30H,13-19H2,1-2H3,(H,37,41)(H,42,43)	FQAXKURWFFUWDN-UHFFFAOYSA-N	336044	4-(2-(3-(3-chloro-2- fluorophenyl)-5-methyl-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 266::US9738655, Example 267	Plasma kallikrein	Human	 354								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348791	384988194							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662390	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(no1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,18,21,30H,12-17H2,1H3,(H,36,40)(H,42,43)	FYOLOKHABDOZTA-UHFFFAOYSA-N	336046	4-(2-(3-(3-chloro-2- fluorophenyl)isoxazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 268	Plasma kallikrein	Human	 178								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348848	384988195							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662391	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(ns1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O5S/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,18,21,30H,12-17H2,1H3,(H,36,40)(H,42,43)	ZBMLIFNYLFHWTC-UHFFFAOYSA-N	336047	4-(2-(3-(3-chloro-2- fluorophenyl)isothiazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 269	Plasma kallikrein	Human	 205								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348829	384988196							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662392	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnc(s1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O5S/c1-44-21-12-15-38(16-13-21)26-7-3-4-23-22(26)14-17-39(29(23)30(40)37-20-10-8-19(9-11-20)33(42)43)32(41)27-18-36-31(45-27)24-5-2-6-25(34)28(24)35/h2-11,18,21,29H,12-17H2,1H3,(H,37,40)(H,42,43)	VPZJMGJFKCWLAF-UHFFFAOYSA-N	336048	4-(2-(2-(3-chloro-2- fluorophenyl)thiazole-5- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 270	Plasma kallikrein	Human	 269								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348782	384988197							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662393	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)	FBWNGNXFIOJJRU-UHFFFAOYSA-N	336049	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 271	Plasma kallikrein	Human	 7.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348773	384988198							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662394	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m1/s1	FBWNGNXFIOJJRU-SSEXGKCCSA-N	336050	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 272	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348867	384988199							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662395	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-22-12-15-38(16-13-22)27-6-2-4-24-23(27)14-17-40(30(24)31(41)37-21-10-8-20(9-11-21)33(43)44)32(42)26-18-39(19-36-26)28-7-3-5-25(34)29(28)35/h2-11,18-19,22,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m0/s1	FBWNGNXFIOJJRU-PMERELPUSA-N	336051	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid, TFA salt::US9738655, Example 273	Plasma kallikrein	Human	 7.65								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360909	384988200							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662396	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)	ZHBIFHSCHDUCTJ-UHFFFAOYSA-N	336052	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 274	Plasma kallikrein	Human	 4.87								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348843	384988201							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662397	COc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C27H21ClFN5O5/c1-39-22-7-2-4-18-17(22)12-13-33(24(18)25(35)30-16-10-8-15(9-11-16)27(37)38)26(36)20-14-34(32-31-20)21-6-3-5-19(28)23(21)29/h2-11,14,24H,12-13H2,1H3,(H,30,35)(H,37,38)	LBKUAODILILVMN-UHFFFAOYSA-N	336053	4-(2-(1-(3-chloro-2- fluoroplienyl)-1H-1,2,3-triazole- 4-carbonyl)-5-methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 275	Plasma kallikrein	Human	 11.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360851	384988202							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662398	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN5O6/c1-40(2)33(44)20-13-16-41(17-14-20)28-8-4-5-24-23(28)15-18-42(31(24)32(43)38-22-11-9-21(10-12-22)35(46)47)34(45)29-19-27(39-48-29)25-6-3-7-26(36)30(25)37/h3-12,20,29,31H,13-19H2,1-2H3,(H,38,43)(H,46,47)	KSKNDDJIIWDYJR-UHFFFAOYSA-N	336054	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(dimethylcarbamoyl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 278::US9738655, Example 279	Plasma kallikrein	Human	 1.98								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348906	384988203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662399	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN5O6/c1-40(2)33(44)20-13-16-41(17-14-20)28-8-4-5-24-23(28)15-18-42(31(24)32(43)38-22-11-9-21(10-12-22)35(46)47)34(45)29-19-27(39-48-29)25-6-3-7-26(36)30(25)37/h3-12,20,29,31H,13-19H2,1-2H3,(H,38,43)(H,46,47)	KSKNDDJIIWDYJR-UHFFFAOYSA-N	336054	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-(dimethylcarbamoyl) piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 278::US9738655, Example 279	Plasma kallikrein	Human	 30.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348906	384988203							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662400	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein	Human	 283								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662401	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein	Human	 79.0								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662402	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein	Human	 1.87								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662403	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN5O6/c1-37-14-15-38(17-27(37)40)25-7-3-4-21-20(25)12-13-39(29(21)30(41)35-19-10-8-18(9-11-19)32(43)44)31(42)26-16-24(36-45-26)22-5-2-6-23(33)28(22)34/h2-11,26,29H,12-17H2,1H3,(H,35,41)(H,43,44)	SRDPHAPHNIXEMB-UHFFFAOYSA-N	336056	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methyl-3-oxopiperazin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 280::US9738655, Example 281::US9738655, Example 282::US9738655, Example 283	Plasma kallikrein	Human	 75.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348900	384988204							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662404	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H28ClFN6O5/c1-37-14-15-38(17-27(37)41)25-6-2-4-22-21(25)12-13-40(29(22)30(42)36-20-10-8-19(9-11-20)32(44)45)31(43)24-16-39(18-35-24)26-7-3-5-23(33)28(26)34/h2-11,16,18,29H,12-15,17H2,1H3,(H,36,42)(H,44,45)	HZAQQZFPWMLEIS-UHFFFAOYSA-N	336061	4-(2-(1-(3-chloro-2- fluorophenyl)-1H-imidazole-4- carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 284	Plasma kallikrein	Human	 6.25								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348764	384988206							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662405	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)/t29-/m0/s1	OERFGGVKNYUNRK-LJAQVGFWSA-N	336062	(S)-4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 285	Plasma kallikrein	Human	 19.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348858	384988207							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662406	COC1CCN(CC1)c1cccc2[C@@H](N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)/t29-/m1/s1	OERFGGVKNYUNRK-GDLZYMKVSA-N	336063	(R)-4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 286	Plasma kallikrein	Human	 3286								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348884	384988208							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662407	CN1CCN(CC1=O)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m0/s1	ZHBIFHSCHDUCTJ-NDEPHWFRSA-N	336064	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperizin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 287	Plasma kallikrein	Human	 1.82								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360859	384988209							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662408	CN1CCN(CC1=O)c1cccc2[C@@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C31H27ClFN7O5/c1-37-14-15-38(17-26(37)41)24-6-2-4-21-20(24)12-13-39(28(21)29(42)34-19-10-8-18(9-11-19)31(44)45)30(43)23-16-40(36-35-23)25-7-3-5-22(32)27(25)33/h2-11,16,28H,12-15,17H2,1H3,(H,34,42)(H,44,45)/t28-/m1/s1	ZHBIFHSCHDUCTJ-MUUNZHRXSA-N	336065	(R)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4-methyl-3- oxopiperazin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 288	Plasma kallikrein	Human	 824								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348969	384988210							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662409	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN4O7/c32-22-5-1-4-21(27(22)33)23-15-25(44-35-23)30(40)37-12-11-19-20(3-2-6-24(19)36-13-14-43-16-26(36)38)28(37)29(39)34-18-9-7-17(8-10-18)31(41)42/h1-10,25,28H,11-16H2,(H,34,39)(H,41,42)/t25-,28+/m1/s1	HUJNCDQHFCQWPY-NAKRPHOHSA-N	336066	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (3-oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid,::US9738655, Example 289	Plasma kallikrein	Human	 2.63								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336066&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348866	384988211							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662410	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2=O)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H26ClFN4O7/c32-22-5-1-4-21(27(22)33)23-15-25(44-35-23)30(40)37-12-11-19-20(3-2-6-24(19)36-13-14-43-16-26(36)38)28(37)29(39)34-18-9-7-17(8-10-18)31(41)42/h1-10,25,28H,11-16H2,(H,34,39)(H,41,42)/t25-,28-/m1/s1	HUJNCDQHFCQWPY-LEAFIULHSA-N	336067	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (3-oxomorpholino)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 290	Plasma kallikrein	Human	 101								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336067&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360801	384988212							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662411	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCCCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H30ClFN4O5/c33-24-8-4-7-23(28(24)34)25-18-27(43-36-25)31(40)38-17-14-21-22(6-5-9-26(21)37-15-2-1-3-16-37)29(38)30(39)35-20-12-10-19(11-13-20)32(41)42/h4-13,27,29H,1-3,14-18H2,(H,35,39)(H,41,42)/t27-,29+/m1/s1	DZKVUSJHEHTSJV-PXJZQJOASA-N	336068	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 291	Plasma kallikrein	Human	 15.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348895	384988213							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662412	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCCCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C32H30ClFN4O5/c33-24-8-4-7-23(28(24)34)25-18-27(43-36-25)31(40)38-17-14-21-22(6-5-9-26(21)37-15-2-1-3-16-37)29(38)30(39)35-20-12-10-19(11-13-20)32(41)42/h4-13,27,29H,1-3,14-18H2,(H,35,39)(H,41,42)/t27-,29-/m1/s1	DZKVUSJHEHTSJV-XRKRLSELSA-N	336069	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (piperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid, TFA salt::US9738655, Example 292	Plasma kallikrein	Human	 758								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360773	384988214							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662413	COc1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H23ClFN3O6/c1-38-22-7-3-4-18-17(22)12-13-33(25(18)26(34)31-16-10-8-15(9-11-16)28(36)37)27(35)23-14-21(32-39-23)19-5-2-6-20(29)24(19)30/h2-11,23,25H,12-14H2,1H3,(H,31,34)(H,36,37)/t23-,25+/m1/s1	JMRJXBGKNVHKIB-NOZRDPDXSA-N	336070	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamide)benzoic acid::US9738655, Example 293	Plasma kallikrein	Human	 3.24								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360914	384988215							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662414	COc1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C28H23ClFN3O6/c1-38-22-7-3-4-18-17(22)12-13-33(25(18)26(34)31-16-10-8-15(9-11-16)28(36)37)27(35)23-14-21(32-39-23)19-5-2-6-20(29)24(19)30/h2-11,23,25H,12-14H2,1H3,(H,31,34)(H,36,37)/t23-,25-/m1/s1	JMRJXBGKNVHKIB-ILBGXUMGSA-N	336071	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- methoxy-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 294	Plasma kallikrein	Human	 111								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348787	384988216							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662415	OC(=O)c1ccc(NC(=O)[C@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN4O6/c32-23-5-1-4-22(27(23)33)24-17-26(43-35-24)30(39)37-12-11-20-21(3-2-6-25(20)36-13-15-42-16-14-36)28(37)29(38)34-19-9-7-18(8-10-19)31(40)41/h1-10,26,28H,11-17H2,(H,34,38)(H,40,41)/t26-,28+/m1/s1	OUHGEEOLVXEYAO-IAPPQJPRSA-N	336072	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- morpholino-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 295	Plasma kallikrein	Human	 2.44								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348932	384988217							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662416	OC(=O)c1ccc(NC(=O)[C@@H]2N(CCc3c2cccc3N2CCOCC2)C(=O)[C@H]2CC(=NO2)c2cccc(Cl)c2F)cc1	InChI=1S/C31H28ClFN4O6/c32-23-5-1-4-22(27(23)33)24-17-26(43-35-24)30(39)37-12-11-20-21(3-2-6-25(20)36-13-15-42-16-14-36)28(37)29(38)34-19-9-7-18(8-10-19)31(40)41/h1-10,26,28H,11-17H2,(H,34,38)(H,40,41)/t26-,28-/m1/s1	OUHGEEOLVXEYAO-IXCJQBJRSA-N	336073	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- morpholino-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 296	Plasma kallikrein	Human	 186								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121360852	384988218							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662417	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)c(Cl)ccc1C(F)(F)F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF4N4O6/c1-48-20-11-14-42(15-12-20)26-4-2-3-22-21(26)13-16-43(30(22)31(44)40-19-7-5-18(6-8-19)33(46)47)32(45)27-17-25(41-49-27)28-23(34(37,38)39)9-10-24(35)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,40,44)(H,46,47)	YCGVFCIHVNNBFQ-UHFFFAOYSA-N	336074	4-(2-(3-(3-chloro-2-fluoro-6- (trifluoromethyl)phenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 297::US9738655, Example 298	Plasma kallikrein	Human	 1281								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348831	384988219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662418	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1c(F)c(Cl)ccc1C(F)(F)F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H31ClF4N4O6/c1-48-20-11-14-42(15-12-20)26-4-2-3-22-21(26)13-16-43(30(22)31(44)40-19-7-5-18(6-8-19)33(46)47)32(45)27-17-25(41-49-27)28-23(34(37,38)39)9-10-24(35)29(28)36/h2-10,20,27,30H,11-17H2,1H3,(H,40,44)(H,46,47)	YCGVFCIHVNNBFQ-UHFFFAOYSA-N	336074	4-(2-(3-(3-chloro-2-fluoro-6- (trifluoromethyl)phenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 297::US9738655, Example 298	Plasma kallikrein	Human	 1010								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348831	384988219							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662419	CO[C@@H]1CCN(C1)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c1-43-20-12-14-37(17-20)26-7-3-4-22-21(26)13-15-38(29(22)30(39)35-19-10-8-18(9-11-19)32(41)42)31(40)27-16-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,20,27,29H,12-17H2,1H3,(H,35,39)(H,41,42)/t20-,27-,29-/m1/s1	HRMKSRKSQRTIIL-VXLYDYDQSA-N	336076	4-((R)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- ((R)-3-methoxypyrrolidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 299	Plasma kallikrein	Human	 316								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348839	384988220							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662420	CO[C@@H]1CCN(C1)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN4O6/c1-43-20-12-14-37(17-20)26-7-3-4-22-21(26)13-15-38(29(22)30(39)35-19-10-8-18(9-11-19)32(41)42)31(40)27-16-25(36-44-27)23-5-2-6-24(33)28(23)34/h2-11,20,27,29H,12-17H2,1H3,(H,35,39)(H,41,42)/t20-,27-,29+/m1/s1	HRMKSRKSQRTIIL-LEFTWQHSSA-N	336077	4-((S)-2-((R)-3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- ((R)-3-methoxypyrrolidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 300	Plasma kallikrein	Human	 4.15								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348794	384988221							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662421	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Plasma kallikrein	Human	 1963								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662422	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Plasma kallikrein	Human	 232								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662423	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(30(23)31(40)36-20-10-8-19(9-11-20)33(42)43)32(41)28-18-26(37-45-28)24-5-2-6-25(34)29(24)35/h2-11,21,28,30H,12-18H2,1H3,(H,36,40)(H,42,43)	BLFBDNXENKDPOA-UHFFFAOYSA-N	336080	4-(2-(3-(3-chloro-2- fluorophenyl)-4,5- dihydroisoxazole-5-carbonyl)-5- (4-methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 303::US9738655, Example 304::US9738655, Example 305	Plasma kallikrein	Human	 31.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348793	384988224							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662424	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H36ClFN4O5/c1-45-24-13-17-38(18-14-24)28-6-2-4-26-25(28)15-19-40(31(26)32(41)37-23-10-8-21(9-11-23)34(43)44)33(42)22-12-16-39(20-22)29-7-3-5-27(35)30(29)36/h2-11,22,24,31H,12-20H2,1H3,(H,37,41)(H,43,44)	XXEHXWAALBKPOQ-UHFFFAOYSA-N	336083	4-(2-(1-(3-Chloro-2-fluorophenyl)pyrrolidine-3-carbonyl) 5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 307::US9738655, Example 308	Plasma kallikrein	Human	 593								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601967	384988225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662425	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1CCN(C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H36ClFN4O5/c1-45-24-13-17-38(18-14-24)28-6-2-4-26-25(28)15-19-40(31(26)32(41)37-23-10-8-21(9-11-23)34(43)44)33(42)22-12-16-39(20-22)29-7-3-5-27(35)30(29)36/h2-11,22,24,31H,12-20H2,1H3,(H,37,41)(H,43,44)	XXEHXWAALBKPOQ-UHFFFAOYSA-N	336083	4-(2-(1-(3-Chloro-2-fluorophenyl)pyrrolidine-3-carbonyl) 5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 307::US9738655, Example 308	Plasma kallikrein	Human	 79.7								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601967	384988225							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662426	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClFN6O5/c1-46-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(42)38-20-10-8-19(9-11-20)33(44)45)32(43)24-18-37-41(30(24)36)27-7-3-5-25(34)28(27)35/h2-11,18,21,29H,12-17,36H2,1H3,(H,38,42)(H,44,45)	OERFGGVKNYUNRK-UHFFFAOYSA-N	336085	4-(2-(5-amino-1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 309	Plasma kallikrein	Human	 28.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348841	384988226							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662427	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1coc(n1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClFN4O6/c1-44-21-12-15-38(16-13-21)27-7-3-4-23-22(27)14-17-39(29(23)30(40)36-20-10-8-19(9-11-20)33(42)43)32(41)26-18-45-31(37-26)24-5-2-6-25(34)28(24)35/h2-11,18,21,29H,12-17H2,1H3,(H,36,40)(H,42,43)	DSJQQMSCVFIBAC-UHFFFAOYSA-N	336086	4-(2-(2-(3-chloro-2- fluorophenyl)oxazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4-tetrahydroisoquinoline- 1-carboxamido)benzoic acid, TFA salt::US9738655, Example 310	Plasma kallikrein	Human	 610								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348778	384988227							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662428	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(n[nH]1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O			336087	4-(2-(3-(3-chlorophenyl)-1H- pyrazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 311::US9738655, Example 316	Plasma kallikrein	Human	 787								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752707	384988228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662429	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(cn1)-c1c(F)ccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H30ClF2N5O5/c1-46-21-11-14-39(15-12-21)27-4-2-3-23-22(27)13-16-41(29(23)31(42)38-20-7-5-19(6-8-20)33(44)45)32(43)26-17-40(18-37-26)30-25(35)10-9-24(34)28(30)36/h2-10,17-18,21,29H,11-16H2,1H3,(H,38,42)(H,44,45)	NUPTVFLTOJMODJ-UHFFFAOYSA-N	336088	4-(2-(1-(3-chloro-2,6- difluorophenyl)-1H-imidazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 312	Plasma kallikrein	Human	 27.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348774	384988229							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662430	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1ccncc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H33N7O5/c1-44-23-11-16-37(17-12-23)27-4-2-3-25-24(27)13-18-38(28(25)30(40)36-21-7-5-20(6-8-21)32(42)43)31(41)26-19-35-39(29(26)33)22-9-14-34-15-10-22/h2-10,14-15,19,23,28H,11-13,16-18,33H2,1H3,(H,36,40)(H,42,43)	MIVMVOVFTPYYTQ-UHFFFAOYSA-N	336089	4-(2-(5-amino-1-(pyridin-4-yl)- 1H-pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 313	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348806	384988230							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662431	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H30ClFN6O5/c1-45-21-12-15-38(16-13-21)26-6-2-4-23-22(26)14-17-39(29(23)30(41)35-20-10-8-19(9-11-20)32(43)44)31(42)25-18-40(37-36-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H,35,41)(H,43,44)/t29-/m0/s1	AVKKDSOYYJOTLE-LJAQVGFWSA-N	336090	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-1,2,3-triazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 314	Plasma kallikrein	Human	 10.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348916	384988231							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662432	COC1CCN(CC1)c1cccc2[C@H](N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31ClFN5O5/c1-45-23-12-15-38(16-13-23)27-6-2-4-25-24(27)14-17-39(30(25)31(41)37-22-10-8-20(9-11-22)33(43)44)32(42)21-18-36-40(19-21)28-7-3-5-26(34)29(28)35/h2-11,18-19,23,30H,12-17H2,1H3,(H,37,41)(H,43,44)/t30-/m0/s1	RWHNCKXIRHTDDM-PMERELPUSA-N	336091	(S)-4-(2-(1-(3-chloro-2- fluorophenyl)-1H-pyrazole-4- carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 315	Plasma kallikrein	Human	 19.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348804	384988232							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662433	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cc(n[nH]1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O			336087	4-(2-(3-(3-chlorophenyl)-1H- pyrazole-5-carbonyl)-5-(4- methoxypiperidin-1-yl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 311::US9738655, Example 316	Plasma kallikrein	Human	 578								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752707	384988228							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662434	CN(C)C(=O)C1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H35ClFN7O5/c1-41(2)33(46)20-13-16-42(17-14-20)27-7-3-5-24-23(27)15-18-43(30(24)32(45)40-22-11-9-21(10-12-22)35(48)49)34(47)25-19-39-44(31(25)38)28-8-4-6-26(36)29(28)37/h3-12,19-20,30H,13-18,38H2,1-2H3,(H,40,45)(H,48,49)	LWVFYGGVTSBNPF-UHFFFAOYSA-N	336093	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(dimethylcarbamoyl)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 317	Plasma kallikrein	Human	 41.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602265	384988233							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662435	CN1CCN(CC1=O)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H29ClFN7O5/c1-38-14-15-39(17-26(38)42)24-6-2-4-21-20(24)12-13-40(28(21)30(43)37-19-10-8-18(9-11-19)32(45)46)31(44)22-16-36-41(29(22)35)25-7-3-5-23(33)27(25)34/h2-11,16,28H,12-15,17,35H2,1H3,(H,37,43)(H,45,46)	KXECQFQEVMSQTL-UHFFFAOYSA-N	336094	4-(2-(5-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-methyl-3-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 318	Plasma kallikrein	Human	 21.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601538	384988234							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662436	CN(C)CCOC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1N)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C36H39ClFN7O5/c1-42(2)19-20-50-24-13-16-43(17-14-24)29-7-3-5-26-25(29)15-18-44(32(26)34(46)41-23-11-9-22(10-12-23)36(48)49)35(47)27-21-40-45(33(27)39)30-8-4-6-28(37)31(30)38/h3-12,21,24,32H,13-20,39H2,1-2H3,(H,41,46)(H,48,49)	RLBBCCQWYWHBBU-UHFFFAOYSA-N	336095	4-(2-(3-Amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl)-5-(4-(2-(dimethylamino)ethoxy)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 319	Plasma kallikrein	Human	 6.41								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602078	384988235							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662437	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H32ClN5O4/c1-38-14-16-39(17-15-38)30-7-3-6-29-28(30)12-13-40(31(29)32(41)37-27-10-8-22(9-11-27)34(43)44)33(42)25-18-24(20-36-21-25)23-4-2-5-26(35)19-23/h2-11,18-21,31H,12-17H2,1H3,(H,37,41)(H,43,44)	HPPADHZZFREPQU-UHFFFAOYSA-N	336096	4-(2-(5-(3-Chlorophenyl)nicotinoyl)-5-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 320	Plasma kallikrein	Human	 124								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602034	384988236							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662438	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1ccccc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33N5O4/c1-37-16-18-38(19-17-37)30-9-5-8-29-28(30)14-15-39(31(29)32(40)36-27-12-10-24(11-13-27)34(42)43)33(41)26-20-25(21-35-22-26)23-6-3-2-4-7-23/h2-13,20-22,31H,14-19H2,1H3,(H,36,40)(H,42,43)	LOCAZELFDYLNGC-UHFFFAOYSA-N	336097	4-(5-(4-Methylpiperazin-1-yl)-2-(5-phenylnicotinoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 321::US9738655, Example 326	Plasma kallikrein	Human	 177								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601369	384988237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662439	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)C1=NC=C[N](=C1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H32ClFN5O5/c1-46-23-12-16-39(17-13-23)28-6-2-4-25-24(28)14-18-41(31(25)32(42)38-22-10-8-21(9-11-22)34(44)45)33(43)27-20-40(19-15-37-27)29-7-3-5-26(35)30(29)36/h2-11,15,19-20,23,31H,12-14,16-18H2,1H3,(H,38,42)(H,44,45)	OLVDIBOPUAHCNU-UHFFFAOYSA-N	336098	4-(2-(4-(3-Chloro-2-fluorophenyl)picolinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 322	Plasma kallikrein	Human	 138								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			138752708	384988238							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662440	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-25-12-15-40(16-13-25)30-7-3-5-28-27(30)14-17-41(32(28)33(42)39-24-10-8-21(9-11-24)35(44)45)34(43)23-18-22(19-38-20-23)26-4-2-6-29(36)31(26)37/h2-11,18-20,25,32H,12-17H2,1H3,(H,39,42)(H,44,45)	YTLXZIUVYLFAJM-UHFFFAOYSA-N	336099	4-(2-(5-(3-Chloro-2-fluorophenyl)nicotinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 323	Plasma kallikrein	Human	 99.2								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601670	384988239							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662441	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1ccnc(c1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-24-13-17-40(18-14-24)30-7-3-4-26-25(30)15-19-41(32(26)33(42)39-23-10-8-21(9-11-23)35(44)45)34(43)22-12-16-38-29(20-22)27-5-2-6-28(36)31(27)37/h2-12,16,20,24,32H,13-15,17-19H2,1H3,(H,39,42)(H,44,45)	IDTDQUJKOQHEEX-UHFFFAOYSA-N	336100	4-(2-(2-(3-Chloro-2-fluorophenyl)isonicotinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 324	Plasma kallikrein	Human	 958								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602159	384988240							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662442	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cccc(n1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H32ClFN4O5/c1-46-23-15-18-40(19-16-23)30-10-3-5-25-24(30)17-20-41(32(25)33(42)38-22-13-11-21(12-14-22)35(44)45)34(43)29-9-4-8-28(39-29)26-6-2-7-27(36)31(26)37/h2-14,23,32H,15-20H2,1H3,(H,38,42)(H,44,45)	MOWBZALNHWFSAX-UHFFFAOYSA-N	336101	4-(2-(6-(3-Chloro-2-fluorophenyl)picolinoyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 325	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601512	384988241							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662443	CN1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cncc(c1)-c1ccccc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C34H33N5O4/c1-37-16-18-38(19-17-37)30-9-5-8-29-28(30)14-15-39(31(29)32(40)36-27-12-10-24(11-13-27)34(42)43)33(41)26-20-25(21-35-22-26)23-6-3-2-4-7-23/h2-13,20-22,31H,14-19H2,1H3,(H,36,40)(H,42,43)	LOCAZELFDYLNGC-UHFFFAOYSA-N	336097	4-(5-(4-Methylpiperazin-1-yl)-2-(5-phenylnicotinoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 321::US9738655, Example 326	Plasma kallikrein	Human	 2000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601369	384988237							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662444	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1ccnc(C)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H34N6O5/c1-21-18-25(10-14-34-21)39-20-23(19-35-39)32(41)38-17-13-27-28(4-3-5-29(27)37-15-11-26(44-2)12-16-37)30(38)31(40)36-24-8-6-22(7-9-24)33(42)43/h3-10,14,18-20,26,30H,11-13,15-17H2,1-2H3,(H,36,40)(H,42,43)	UKMKWFZGYUGHDQ-UHFFFAOYSA-N	336103	4-(5-(4-Methoxypiperidin-1-yl)-2-(1-(2-methylpyridin-4-yl)-1H-pyrazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 327	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602027	384988242							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662445	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cc(Cl)ccn1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H31ClN6O5/c1-44-24-10-14-37(15-11-24)27-4-2-3-26-25(27)12-16-38(29(26)30(40)36-23-7-5-20(6-8-23)32(42)43)31(41)21-18-35-39(19-21)28-17-22(33)9-13-34-28/h2-9,13,17-19,24,29H,10-12,14-16H2,1H3,(H,36,40)(H,42,43)	UTRAREPQGBRVSK-UHFFFAOYSA-N	336104	4-(2-(1-(5-chloropyridin-3- yl)-1H-pyrazole-4-carbonyl)- 5-(4-methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 328	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121357627	384988243							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662446	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccc(Cl)c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H32ClN5O5/c1-44-26-12-15-37(16-13-26)29-7-3-6-28-27(29)14-17-38(30(28)31(40)36-24-10-8-21(9-11-24)33(42)43)32(41)22-19-35-39(20-22)25-5-2-4-23(34)18-25/h2-11,18-20,26,30H,12-17H2,1H3,(H,36,40)(H,42,43)	RESLNCPFDIUSRS-UHFFFAOYSA-N	336105	4-(2-(1-(3-chlorophenyl)-1H- pyrazole-4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, TFA salt::US9738655, Example 329	Plasma kallikrein	Human	 229								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626288	384988244							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662447	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1cccnc1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C32H32N6O5/c1-43-25-11-15-36(16-12-25)28-6-2-5-27-26(28)13-17-37(29(27)30(39)35-23-9-7-21(8-10-23)32(41)42)31(40)22-18-34-38(20-22)24-4-3-14-33-19-24/h2-10,14,18-20,25,29H,11-13,15-17H2,1H3,(H,35,39)(H,41,42)	CXGWBRHGBOMOMU-UHFFFAOYSA-N	336106	4-(5-(4-methoxypiperidin-1- yl)-2-(1-(pyridin-3-yl)-1H- pyrazolc-4-carbonyl)-1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid, 2 TFA salt::US9738655, Example 330	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626289	384988245							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662448	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cnn(c1)-c1ccc2nonc2c1)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H31N7O6/c1-45-24-11-14-38(15-12-24)29-4-2-3-26-25(29)13-16-39(30(26)31(41)35-22-7-5-20(6-8-22)33(43)44)32(42)21-18-34-40(19-21)23-9-10-27-28(17-23)37-46-36-27/h2-10,17-19,24,30H,11-16H2,1H3,(H,35,41)(H,43,44)	LPIYTZNUEQITRK-UHFFFAOYSA-N	336107	4-(2-(1-(benzo[c][1,2,5] oxadiazol-5-yl)-1H-pyrazole- 4-carbonyl)-5-(4- methoxypiperidin-1-yl)- 1,2,3,4- tetrahydroisoquinoline-1- carboxamido)benzoic acid::US9738655, Example 331	Plasma kallikrein	Human	 6000								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			121348853	384988246							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662449	CC(=C)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C29H23ClFN5O4/c1-16(2)19-5-3-6-21-20(19)13-14-35(26(21)27(37)32-18-11-9-17(10-12-18)29(39)40)28(38)23-15-36(34-33-23)24-8-4-7-22(30)25(24)31/h3-12,15,26H,1,13-14H2,2H3,(H,32,37)(H,39,40)	JCVXAUSYJPWAPW-UHFFFAOYSA-N	336108	4-(2-(1-(3-Chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(prop-1-en-2-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid::US9738655, Example 333	Plasma kallikrein	Human	 61.3								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601361	384988247							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662450	Nc1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C26H20ClFN6O4/c27-18-4-2-6-21(22(18)28)34-13-20(31-32-34)25(36)33-12-11-16-17(3-1-5-19(16)29)23(33)24(35)30-15-9-7-14(8-10-15)26(37)38/h1-10,13,23H,11-12,29H2,(H,30,35)(H,37,38)	XWNDSMYHTNPVSM-UHFFFAOYSA-N	336109	4-(5-Amino-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 334	Plasma kallikrein	Human	 6.26								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602158	384988248							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662451	COC1CCN(CC1)c1cccc2C(N(CCc12)C(=O)c1cn(nn1)-c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(N)=O	InChI=1S/C32H31ClFN7O4/c1-45-21-12-15-39(16-13-21)26-6-2-4-23-22(26)14-17-40(29(23)31(43)36-20-10-8-19(9-11-20)30(35)42)32(44)25-18-41(38-37-25)27-7-3-5-24(33)28(27)34/h2-11,18,21,29H,12-17H2,1H3,(H2,35,42)(H,36,43)	QYVCEYOGBUMRBR-UHFFFAOYSA-N	336110	N-(4-Carbamoylphenyl)-2-(1-(3-chloro-2-fluorophenyl)-1H-1,2,3-triazole-4-carbonyl)-5-(4-methoxypiperidin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 335	Plasma kallikrein	Human	 96.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117601484	384988249							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662452	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31+/m1/s1	PULGOHDYZKUKTQ-MVSFAKPFSA-N	336111	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 336	Plasma kallikrein	Human	 1.40								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626262	384988250							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662453	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31-/m1/s1	PULGOHDYZKUKTQ-GRKNLSHJSA-N	336112	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 337	Plasma kallikrein	Human	 68.1								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626318	384988251							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662454	CC(C)c1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31-/m0/s1	PULGOHDYZKUKTQ-IZEXYCQBSA-N	336116	4-((S)-2-((S)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 338	Plasma kallikrein	Human	 251								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626232	384988255							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662455	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C35H33ClFN7O5/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(10-12-21)35(47)48)34(46)28-17-26(41-49-28)24-6-3-7-25(36)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)(H,47,48)/t28-,31+/m0/s1	PULGOHDYZKUKTQ-QCENPCRXSA-N	336117	4-((R)-2-((S)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 339	Plasma kallikrein	Human	 84.6								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626320	384988256							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662456	Cc1nnc2CN(CCn12)c1cccc2[C@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClFN7O5/c1-18-37-38-28-17-40(14-15-41(18)28)26-7-3-4-22-21(26)12-13-42(30(22)31(43)36-20-10-8-19(9-11-20)33(45)46)32(44)27-16-25(39-47-27)23-5-2-6-24(34)29(23)35/h2-11,27,30H,12-17H2,1H3,(H,36,43)(H,45,46)/t27-,30+/m1/s1	QNQFMFYHIZXXRE-OFSOJUDTSA-N	336113	4-((S)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 340	Plasma kallikrein	Human	 13.8								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626347	384988252							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662457	Cc1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(cc1)C(O)=O	InChI=1S/C33H29ClFN7O5/c1-18-37-38-28-17-40(14-15-41(18)28)26-7-3-4-22-21(26)12-13-42(30(22)31(43)36-20-10-8-19(9-11-20)33(45)46)32(44)27-16-25(39-47-27)23-5-2-6-24(34)29(23)35/h2-11,27,30H,12-17H2,1H3,(H,36,43)(H,45,46)/t27-,30-/m1/s1	QNQFMFYHIZXXRE-POURPWNDSA-N	336114	4-((R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-5-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid, TFA salt::US9738655, Example 341	Plasma kallikrein	Human	 46.9								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117626234	384988253							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
662458	CC(C)c1nnc2CN(CCn12)c1cccc2[C@@H](N(CCc12)C(=O)[C@H]1CC(=NO1)c1cccc(Cl)c1F)C(=O)Nc1ccc(F)cc1	InChI=1S/C34H32ClF2N7O3/c1-19(2)32-40-39-29-18-42(15-16-43(29)32)27-8-4-5-23-22(27)13-14-44(31(23)33(45)38-21-11-9-20(36)10-12-21)34(46)28-17-26(41-47-28)24-6-3-7-25(35)30(24)37/h3-12,19,28,31H,13-18H2,1-2H3,(H,38,45)/t28-,31-/m1/s1	CHAUNDCRDVOXQH-GRKNLSHJSA-N	336118	(R)-2-((R)-3-(3-Chloro-2-fluorophenyl)-4,5-dihydroisoxazole-5-carbonyl)-N-(4-fluorophenyl)-5-(3-isopropyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide, TFA salt::US9738655, Example 343	Plasma kallikrein	Human	 114								US Patent		10.7270/Q2BG2R3R		aid1797039	US9738655	Pinto, DJ; Clarke, CG; Smith, II, LM; Orwat, MJ; Jeon, Y; Corte, JR	8/22/2017	7/1/2019	Bristol-Myers Squibb Co.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			117602061	384988257							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3